<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000530.pub3" GROUP_ID="ARI" ID="169299081614135697" MERGED_FROM="" MODIFIED="2014-07-02 23:06:05 +0100" MODIFIED_BY="Liz Dooley" NOTES="&lt;p&gt;May 2013 &lt;/p&gt;&lt;p&gt;Please note that we did not include a summary of findings table, because the included studies have been reported so heterogeneously, that it was not possible to create a reasonable and well structured table.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2014-07-03 08:05:50 +1000" NOTES_MODIFIED_BY="Liz  Dooley" REVIEW_NO="A032" REVMAN_SUB_VERSION="5.3.3 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="11.0">
<COVER_SHEET MODIFIED="2014-07-02 23:06:05 +0100" MODIFIED_BY="Liz Dooley">
<TITLE MODIFIED="2013-06-05 14:48:15 +1000" MODIFIED_BY="[Empty name]">Echinacea for preventing and treating the common cold</TITLE>
<CONTACT MODIFIED="2014-07-02 23:06:05 +0100" MODIFIED_BY="Liz Dooley"><PERSON ID="86720042233588233351111115230255" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Marlies</FIRST_NAME><LAST_NAME>Karsch-Völk</LAST_NAME><POSITION>Research Associate</POSITION><EMAIL_1>karsch@tum.de</EMAIL_1><ADDRESS><DEPARTMENT>Institute of General Practice</DEPARTMENT><ORGANISATION>Klinikum Rechts der Isar</ORGANISATION><ADDRESS_1>Orleansstrasse 47</ADDRESS_1><CITY>München</CITY><ZIP>81667</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+89 614 658 912</PHONE_1><FAX_1>+89 614 658 915</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2014-07-02 23:06:05 +0100" MODIFIED_BY="Liz Dooley"><PERSON ID="86720042233588233351111115230255" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Marlies</FIRST_NAME><LAST_NAME>Karsch-Völk</LAST_NAME><POSITION>Research Associate</POSITION><EMAIL_1>karsch@tum.de</EMAIL_1><ADDRESS><DEPARTMENT>Institute of General Practice</DEPARTMENT><ORGANISATION>Klinikum Rechts der Isar</ORGANISATION><ADDRESS_1>Orleansstrasse 47</ADDRESS_1><CITY>München</CITY><ZIP>81667</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+89 614 658 912</PHONE_1><FAX_1>+89 614 658 915</FAX_1></ADDRESS></PERSON><PERSON ID="18797" ROLE="AUTHOR"><PREFIX>A/Prof</PREFIX><FIRST_NAME>Bruce</FIRST_NAME><LAST_NAME>Barrett</LAST_NAME><SUFFIX>MD PhD</SUFFIX><EMAIL_1>Bruce.Barrett@fammed.wisc.edu</EMAIL_1><ADDRESS><DEPARTMENT>Department of Family Medicine</DEPARTMENT><ORGANISATION>University of Wisconsin - Madison</ORGANISATION><ADDRESS_1>777 South Mills</ADDRESS_1><CITY>Madison</CITY><ZIP>WI 53715</ZIP><REGION>Wisconsin</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 608 263 2220</PHONE_1><FAX_1>+1 608 263 5813</FAX_1></ADDRESS></PERSON><PERSON ID="85664715705711284962111120233815" ROLE="AUTHOR"><FIRST_NAME>David</FIRST_NAME><LAST_NAME>Kiefer</LAST_NAME><EMAIL_1>dockiefer@gmail.com</EMAIL_1><EMAIL_2>dkiefer2@wisc.edu</EMAIL_2><MOBILE_PHONE>+1 206 550 8566</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Family Medicine</DEPARTMENT><ORGANISATION>University of Wisconsin - Madison</ORGANISATION><ADDRESS_1>1100 Delaplaine Court</ADDRESS_1><CITY>Madison</CITY><ZIP>53715</ZIP><REGION>Wisconsin</REGION><COUNTRY CODE="US">USA</COUNTRY></ADDRESS></PERSON><PERSON ID="18798" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Rudolf</FIRST_NAME><LAST_NAME>Bauer</LAST_NAME><POSITION>Director</POSITION><EMAIL_1>rudolf.bauer@uni-graz.at</EMAIL_1><ADDRESS><DEPARTMENT>Institute of Pharmaceutical Sciences, Department of Pharmacognosy</DEPARTMENT><ORGANISATION>Karl-Franzens-University</ORGANISATION><ADDRESS_1>Universitätsplatz 4</ADDRESS_1><CITY>Graz</CITY><ZIP>A-8010</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+43 316 380 8700</PHONE_1><PHONE_2>+43 316 380 9860</PHONE_2></ADDRESS></PERSON><PERSON ID="18799" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Karin</FIRST_NAME><LAST_NAME>Ardjomand-Woelkart</LAST_NAME><EMAIL_1>Ka.Woelkart@uni-graz.at</EMAIL_1><ADDRESS><DEPARTMENT>Institute of Pharmaceutical Sciences, Department of Pharmacognosy</DEPARTMENT><ORGANISATION>Karl-Franzens-University</ORGANISATION><ADDRESS_1>Universitätsplatz 4</ADDRESS_1><CITY>Graz</CITY><ZIP>A-8010</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+43 316 380 8700</PHONE_1><FAX_1>+43 316 380 9860</FAX_1></ADDRESS></PERSON><PERSON ID="5894" ROLE="AUTHOR"><PREFIX>A/Prof</PREFIX><FIRST_NAME>Klaus</FIRST_NAME><LAST_NAME>Linde</LAST_NAME><POSITION>Research Co-ordinator</POSITION><EMAIL_1>klaus.linde@tum.de</EMAIL_1><ADDRESS><DEPARTMENT>Institute of General Practice</DEPARTMENT><ORGANISATION>Klinikum Rechts der Isar</ORGANISATION><ADDRESS_1>Orleansstrasse 47</ADDRESS_1><CITY>München</CITY><ZIP>81667</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 89 614 658 912</PHONE_1><FAX_1>+49 89 614 658 915</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2014-07-02 23:08:05 +1000" MODIFIED_BY="Marlies Karsch-Völk">
<UP_TO_DATE>
<DATE DAY="5" MONTH="6" YEAR="2013"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="5" MONTH="6" YEAR="2013"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="5" MONTH="6" YEAR="2015"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="1997"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="1999"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2014"/>
</DATES>
<WHATS_NEW MODIFIED="2014-07-03 08:05:50 +1000" MODIFIED_BY="Liz  Dooley">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2014-07-03 08:05:50 +1000" MODIFIED_BY="Liz  Dooley">
<DATE DAY="2" MONTH="7" YEAR="2014"/>
<DESCRIPTION>
<P>A mistake in the Abstract regarding treatment trials reporting data on the duration of colds has been corrected.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2014-07-02 23:12:58 +1000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2014-07-02 23:12:53 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="5" MONTH="6" YEAR="2013"/>
<DESCRIPTION>
<P>Change to authorship byline: new first author Marlies Karsch-Völk. Dieter Melchart was not involved in this update.</P>
<P>Inclusion criteria changed: now only randomized controlled trials and also studies on induced rhinovirus infections included.</P>
<P>Outcome measures changed: duration of cold is now a primary outcome of treatment trials.</P>
<P>Conclusions changed: possibly slight effect of <I>Echinacea</I> in the prevention of colds. Evidence for treatment effectiveness is weak.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-07-02 23:12:58 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="5" MONTH="6" YEAR="2013"/>
<DESCRIPTION>
<P>Searches updated. Seven new studies were included (<LINK REF="STD-Barrett-2010" TYPE="STUDY">Barrett 2010</LINK>; <LINK REF="STD-Hall-2007" TYPE="STUDY">Hall 2007</LINK>; <LINK REF="STD-Jawad-2012" TYPE="STUDY">Jawad 2012</LINK>; <LINK REF="STD-O_x0027_Neill-2008" TYPE="STUDY">O'Neill 2008</LINK>; <LINK REF="STD-Tiralongo-2012" TYPE="STUDY">Tiralongo 2012</LINK>; <LINK REF="STD-Turner-2005" TYPE="STUDY">Turner 2005</LINK>; <LINK REF="STD-Zhang-2003" TYPE="STUDY">Zhang 2003</LINK>). Two formerly excluded studies are now<B> </B>included (<LINK REF="STD-Sperber-2004" TYPE="STUDY">Sperber 2004</LINK>; <LINK REF="STD-Turner-2000" TYPE="STUDY">Turner 2000</LINK>).</P>
<P>One formerly included study is now excluded (<LINK REF="STD-Spasov-2004" TYPE="STUDY">Spasov 2004</LINK>) and 12 new trials were excluded (<LINK REF="STD-Di-Pierro-2012" TYPE="STUDY">Di Pierro 2012</LINK>; <LINK REF="STD-Hauke-2002" TYPE="STUDY">Hauke 2002</LINK>; <LINK REF="STD-Heinen_x002d_Kammerer-2005" TYPE="STUDY">Heinen-Kammerer 2005</LINK>; <LINK REF="STD-Isbaniah-2011" TYPE="STUDY">Isbaniah 2011</LINK>; <LINK REF="STD-Minetti-2011" TYPE="STUDY">Minetti 2011</LINK>; <LINK REF="STD-Narimanian-2005" TYPE="STUDY">Narimanian 2005</LINK>; <LINK REF="STD-Naser-2005" TYPE="STUDY">Naser 2005</LINK>; <LINK REF="STD-Saunders-2007" TYPE="STUDY">Saunders 2007</LINK>; <LINK REF="STD-Schapowal-2009" TYPE="STUDY">Schapowal 2009</LINK>; <LINK REF="STD-Schoop-2006a" TYPE="STUDY">Schoop 2006a</LINK>; <LINK REF="STD-Wahl-2008" TYPE="STUDY">Wahl 2008</LINK>; <LINK REF="STD-Yakoot-2011" TYPE="STUDY">Yakoot 2011</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-07-02 23:10:40 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="15" MONTH="3" YEAR="2010"/>
<DESCRIPTION>
<P>Searches conducted</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-05-22 07:03:59 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="6" MONTH="8" YEAR="2009"/>
<DESCRIPTION>
<P>Contact details updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-08-06 16:11:37 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="8" MONTH="5" YEAR="2009"/>
<DESCRIPTION>
<P>Contact details updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-05-08 16:31:43 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="16" MONTH="1" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2009-05-08 16:31:43 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="5" MONTH="10" YEAR="2007"/>
<DESCRIPTION>
<P>Conclusions remain unchanged.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-04-14 14:48:05 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="12" MONTH="9" YEAR="2005"/>
<DESCRIPTION>
<P>Searches conducted.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="FEEDBACK" MODIFIED="2008-04-14 14:52:26 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="6" YEAR="2005"/>
<DESCRIPTION>
<P>Feedback and reply added.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-04-14 14:48:30 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="16" MONTH="11" YEAR="1998"/>
<DESCRIPTION>
<P>Review first published.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Centre for Complementary Medicine Research, Technische Universität München</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Institute of Pharmaceutical Sciences, Department of Pharmacognosy, Karl-Franzens-University, Graz</NAME>
<COUNTRY CODE="AT">Austria</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Department of Family Medicine, University of Wisconsin</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>National Center for Complementary and Alternative Medicine at the U.S. National Institutes of Health (RO1 AT001428)</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Robert Wood Johnson Foundation Generalist Physician Scholars Program</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2014-07-02 23:18:36 +1000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2013-11-05 08:31:59 +1000" MODIFIED_BY="Jenny Bellorini">
<TITLE MODIFIED="2013-04-18 20:48:49 +1000" MODIFIED_BY="[Empty name]">Echinacea for preventing and treating the common cold</TITLE>
<SUMMARY_BODY MODIFIED="2013-11-05 08:31:59 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Preparations of the plant <I>Echinacea</I> are widely used in some European countries and in North America for common colds. <I>Echinacea</I> preparations available on the market differ greatly as different types (species) and parts (herb, root or both) of the plant are used, different manufacturing methods (drying, alcoholic extraction or pressing out the juice from fresh plants) are used and sometimes also other herbs are added.</P>
<P>We reviewed 24 controlled clinical trials with 4631 participants investigating the effectiveness of several different <I>Echinacea</I> preparations for preventing and treating common colds or induced rhinovirus infections. Our review shows that a variety of products prepared from different <I>Echinacea</I> species, different plant parts and in a different form have been compared to placebo in randomized trials. Due to the significant differences in the preparations tested, it was difficult to draw strong conclusions. Five trials were rated as having a low risk of bias in all five categories of the Cochrane 'Risk of bias' tool. Five more trials were rated as low risk of bias, having an unclear risk of bias in only one category. Eight trials were rated as having a high risk of bias in at least one category and the remaining six as having an unclear risk of bias.</P>
<P>The majority of trials investigated whether taking <I>Echinacea</I> preparations after the onset of cold symptoms shortens the duration, compared with placebo. Although it seems possible that some <I>Echinacea</I> products are more effective than a placebo for treating colds, the overall evidence for clinically relevant treatment effects is weak. In general, trials investigating <I>Echinacea</I> for preventing colds did not show statistically significant reductions in illness occurrence. However, nearly all prevention trials pointed in the direction of small preventive effects. The number of patients dropping out or reporting adverse effects did not differ significantly between treatment and control groups in prevention and treatment trials. However, in prevention trials there was a trend towards a larger number of patients dropping out due to adverse events in the treatment groups.</P>
<P>The evidence is current to July 2013.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2014-07-02 23:18:36 +1000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>
<I>Echinacea </I>plant preparations (family <I>Asteraceae</I>) are widely used in Europe and North America for common colds. Most consumers and physicians are not aware that products available under the term <I>Echinacea</I> differ appreciably in their composition, mainly due to the use of variable plant material, extraction methods and the addition of other components.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2013-10-23 18:26:08 +1000" MODIFIED_BY="[Empty name]">
<P>To assess whether there is evidence that <I>Echinacea</I> preparations are effective and safe compared to placebo in the prevention and treatment of the common cold.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-10-23 18:08:30 +1000" MODIFIED_BY="[Empty name]">
<P>We searched CENTRAL 2013, Issue 5, MEDLINE (1946 to May week 5, 2013), EMBASE (1991 to June 2013), CINAHL (1981 to June 2013), AMED (1985 to February 2012), LILACS (1981 to June 2013), Web of Science (1955 to June 2013), CAMBASE (no time limits), the Centre for Complementary Medicine Research (1988 to September 2007), WHO ICTRP and clinicaltrials.gov (last searched 5 June 2013), screened references and asked experts in the field about published and unpublished studies.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2013-10-25 09:08:09 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trials (RCTs) comparing mono-preparations of <I>Echinacea</I> with placebo.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2013-10-31 10:33:48 +1000" MODIFIED_BY="Jenny Bellorini">
<P>At least two review authors independently assessed eligibility and trial quality and extracted data. The primary efficacy outcome was the number of individuals with at least one cold in prevention trials and the duration of colds in treatment trials. For all included trials the primary safety and acceptability outcome was the number of participants dropping out due to adverse events. We assessed trial quality using the Cochrane 'Risk of bias' tool.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2014-07-02 23:18:36 +1000" MODIFIED_BY="[Empty name]">
<P>Twenty-four double-blind trials with 4631 participants including a total of 33 comparisons of <I>Echinacea</I> preparations and placebo met the inclusion criteria. A variety of different <I>Echinacea</I> preparations based on different species and parts of plant were used. Evidence from seven trials was available for preparations based on the aerial parts of <I>Echinacea purpurea. </I>
</P>
<P>Ten trials were considered to have a low risk of bias, six to have an unclear risk of bias and eight to have a high risk of bias. Ten trials with 13 comparisons investigated prevention and 15 trials with 20 comparisons investigated treatment of colds (one trial addressed both prevention and treatment).</P>
<P>Due to the strong clinical heterogeneity of the studies we refrained from pooling for the main analysis. None of the 12 prevention comparisons reporting the number of patients with at least one cold episode found a statistically significant difference. However a <I>post hoc </I>pooling of their results, suggests a relative risk reduction of 10% to 20%. Of the six treatment trials reporting data on the duration of colds, only two showed a significant effect of <I>Echinacea </I>over placebo. The number of patients dropping out or reporting adverse effects did not differ significantly between treatment and control groups in prevention and treatment trials. However, in prevention trials there was a trend towards a larger number of patients dropping out due to adverse events in the treatment groups.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2014-01-17 22:26:04 +1000" MODIFIED_BY="Jenny Bellorini">
<P>
<I>Echinacea </I>products have not here been shown to provide benefits for treating colds, although, it is possible there is a weak benefit from some <I>Echinacea </I>products<I>: </I>the results of individual prophylaxis trials consistently show positive (if non-significant) trends, although potential effects are of questionable clinical relevance.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2014-01-17 22:27:53 +1000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2013-10-25 09:43:27 +1000" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2013-10-23 23:06:50 +1000" MODIFIED_BY="[Empty name]">
<P>Common cold is the most frequent disease in humans. A large US-American survey showed that over 70% of the population annually was suffering from at least one viral respiratory tract infection. The authors concluded that the economic burden in the USA was almost USD 40 billion annually (<LINK REF="REF-Fendrick-2003" TYPE="REFERENCE">Fendrick 2003</LINK>). Viral agents causing common colds are mostly picornaviruses (rhinoviruses and enteroviruses), coronaviruses, adenoviruses, parainfluenza viruses and respiratory syncytial viruses (<LINK REF="REF-Denny-1995" TYPE="REFERENCE">Denny 1995</LINK>; <LINK REF="REF-Monto-1987" TYPE="REFERENCE">Monto 1987</LINK>). The incidence of the common cold has a peak in the winter months. There are several different hypotheses and explanations for this. One is that cooling of the nasal airway decreases the effectiveness of local respiratory defenses such as mucociliary clearance and leucocyte phagocytosis (<LINK REF="REF-Eccles-2002" TYPE="REFERENCE">Eccles 2002</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2013-10-23 23:07:37 +1000" MODIFIED_BY="[Empty name]">
<P>Extracts of the plant <I>Echinacea </I>(of the family <I>Asteraceae</I>) are widely used by consumers and practitioners in some European countries and in the US for preventing and treating upper respiratory tract infections (<LINK REF="REF-Barrett-2003" TYPE="REFERENCE">Barrett 2003</LINK>). In the US mainstream market, <I>Echinacea</I> preparations are among the second top-selling herbal products (<LINK REF="REF-Blumenthal-2005" TYPE="REFERENCE">Blumenthal 2005</LINK>).</P>
<P>Assessment of the effectiveness of <I>Echinacea</I> preparations is complicated by the limited comparability of the available preparations for the following reasons.</P>
<OL>
<LI>Three different species are in medical use: <I>Echinacea purpurea</I> (<I>E. purpurea</I>),<I> Echinacea pallida </I>(<I>E. pallida</I>) and <I>Echinacea angustifolia</I> (<I>E. angustifolia</I>).</LI>
<LI>Different parts of the plant are used (root, herb, flower or whole plant).</LI>
<LI>Different methods of extraction are used.</LI>
<LI>In some preparations other plant extracts or homeopathic components are added.</LI>
</OL>
<P>The evidence available from clinical trials on its effectiveness has been considered inconsistent in several reviews (<LINK REF="REF-Barrett-1999" TYPE="REFERENCE">Barrett 1999</LINK>; <LINK REF="REF-Caruso-2005" TYPE="REFERENCE">Caruso 2005</LINK>; <LINK REF="REF-Linde-2006" TYPE="REFERENCE">Linde 2006</LINK>; <LINK REF="REF-Melchart-1994" TYPE="REFERENCE">Melchart 1994</LINK>; <LINK REF="REF-Melchart-1999" TYPE="REFERENCE">Melchart 1999</LINK>).<B> </B>Two meta-analyses pooling trials using different heterogeneous <I>Echinacea</I> preparations for the treatment of induced rhinovirus infections (<LINK REF="REF-Schoop-2006b" TYPE="REFERENCE">Schoop 2006b</LINK>) or the common cold (<LINK REF="REF-Shah-2007" TYPE="REFERENCE">Shah 2007</LINK>) found more positive results for the effect of <I>Echinacea. </I>These results have to be interpreted with caution, as the great heterogeneity of tested <I>Echinacea</I> preparations makes comparison and pooling of data methodologically questionable.</P>
</INTERVENTION>
<THEORY MODIFIED="2013-10-25 09:24:22 +1000" MODIFIED_BY="[Empty name]">
<P>The exact mechanisms of action for the immunomodulating effects of <I>Echinacea </I>preparations are unclear. Four classes of compounds are known to contribute to the immunomodulatory activity of <I>Echinacea</I> extracts: alkamides, glycoproteins, polysaccharides and caffeic acid derivatives (CADs). Phenolic compounds include caffeic, cichoric, caftaric and chlorogenic acid, as well as cynarin and echinacoside and are found in differing concentrations in the roots of both <I>E. angustifolia</I> and <I>E. purpurea </I>but also in the aerial parts of <I>E. purpurea</I>. Alkamides (alkylamides; fatty acid amides) are characteristic constituents of <I>E. angustifolia </I>roots, but are also found in roots and aerial parts of <I>E. purpurea</I>. Flavonoids, essential oils, polyacetylenes, ketones and pyrrolizidine alkaloids have also been isolated from <I>Echinacea</I> species. It is important to note that the pharmacologic effects associated with the constituents of <I>Echinacea</I> may result from independent or synergistic interactions with single or multiple constituents.</P>
<P>
<I>E. purpurea</I> extracts rich in glycoproteins, polysaccharides and CADs have long been reported to demonstrate immunoactivity. Research in mice more than two decades ago demonstrated activation of macrophages and natural killer cells (<LINK REF="REF-Bauer-1989" TYPE="REFERENCE">Bauer 1989</LINK>). Since then, numerous studies have supported these findings and have reported a variety of additional effects on adaptive and innate immune mechanisms (<LINK REF="REF-Chavez-2007" TYPE="REFERENCE">Chavez 2007</LINK>; <LINK REF="REF-Gurbuz-2010" TYPE="REFERENCE">Gurbuz 2010</LINK>; <LINK REF="STD-Hall-2007" TYPE="STUDY">Hall 2007</LINK>; <LINK REF="REF-Ramasahayam-2011" TYPE="REFERENCE">Ramasahayam 2011</LINK>; <LINK REF="REF-Ritchie-2011" TYPE="REFERENCE">Ritchie 2011</LINK>; <LINK REF="REF-Sadigh_x002d_Eteghad-2011" TYPE="REFERENCE">Sadigh-Eteghad 2011</LINK>; <LINK REF="REF-Yamada-2011" TYPE="REFERENCE">Yamada 2011</LINK>; <LINK REF="REF-Zhai-2007" TYPE="REFERENCE">Zhai 2007</LINK>).  </P>
<P>In contrast, early research on alkamide-rich extracts of <I>E. angustifolia</I> and <I>E. purpurea</I> suggested anti-inflammatory activity (<LINK REF="REF-M_x00fc_ller_x002d_Jakic-1994" TYPE="REFERENCE">Müller-Jakic 1994</LINK>). Since then, however, studies have reported immunoactivity attributable to alkamides (<LINK REF="REF-Lalone-2009" TYPE="REFERENCE">Lalone 2009</LINK>; <LINK REF="REF-Matthias-2008" TYPE="REFERENCE">Matthias 2008</LINK>) and have suggested that influences on inflammatory pathways are complex, with both pro- and anti-inflammatory effects reported (<LINK REF="REF-Birt-2008" TYPE="REFERENCE">Birt 2008</LINK>; <LINK REF="REF-Qiang-2013" TYPE="REFERENCE">Qiang 2013</LINK>; <LINK REF="REF-Yu-2013" TYPE="REFERENCE">Yu 2013</LINK>). <I>Echinacea</I> alkamides have been shown to be absorbed into the blood (<LINK REF="REF-Matthias-2005" TYPE="REFERENCE">Matthias 2005</LINK>; <LINK REF="REF-Woelkart-2005b" TYPE="REFERENCE">Woelkart 2005b</LINK>; <LINK REF="REF-Woelkart-2006" TYPE="REFERENCE">Woelkart 2006</LINK>; <LINK REF="REF-Woelkart-2008" TYPE="REFERENCE">Woelkart 2008</LINK>) and appear to exert a variety of effects through the endocannabinoid system (<LINK REF="REF-Chicca-2009" TYPE="REFERENCE">Chicca 2009</LINK>; <LINK REF="REF-Woelkart-2005a" TYPE="REFERENCE">Woelkart 2005a</LINK>; <LINK REF="REF-Woelkart-2007" TYPE="REFERENCE">Woelkart 2007</LINK>). Research on the effects of gene expression and signaling pathways is well underway (<LINK REF="REF-Altamirano_x002d_Dimas-2007" TYPE="REFERENCE">Altamirano-Dimas 2007</LINK>; <LINK REF="REF-Gertsch-2004" TYPE="REFERENCE">Gertsch 2004</LINK>; <LINK REF="REF-Uluisik-2012" TYPE="REFERENCE">Uluisik 2012</LINK>).</P>
<P>In addition to research on immune and inflammatory pathways, indications of antiviral activity have been reported (<LINK REF="REF-Bodinet-2002" TYPE="REFERENCE">Bodinet 2002</LINK>; <LINK REF="REF-Ghaemi-2009" TYPE="REFERENCE">Ghaemi 2009</LINK>; <LINK REF="REF-Sharma-2006" TYPE="REFERENCE">Sharma 2006</LINK>). Finally, recent research suggests potential anti-anxiety properties (<LINK REF="REF-Haller-2013" TYPE="REFERENCE">Haller 2013</LINK>), potentially due to neuro-synaptic modulation in the hippocampus (<LINK REF="REF-Hajos-2012" TYPE="REFERENCE">Hajos 2012</LINK>).</P>
<P>In summary, while it is clear that various<I> Echinacea</I> extracts and constituents have demonstrated pharmacological activities in a variety of biological assays, there is as yet no evidence-based conceptual framework to explain how<I> Echinacea</I> might effectively prevent or treat acute respiratory infections.  </P>
</THEORY>
<IMPORTANCE MODIFIED="2013-10-25 09:43:27 +1000" MODIFIED_BY="[Empty name]">
<P>The common cold has a high prevalence and although it is a self limiting condition effective treatment options which lessen the severity and duration of symptoms would be of major importance. <I>Echinacea</I> products are widely used but their effectiveness is uncertain. We completed a first version of this review in 1998 (<LINK REF="REF-Melchart-1999" TYPE="REFERENCE">Melchart 1999</LINK>), updated it in 2006 (<LINK REF="REF-Linde-2006" TYPE="REFERENCE">Linde 2006</LINK>) and again in 2008 (<LINK REF="REF-Linde-2008" TYPE="REFERENCE">Linde 2008</LINK>). The last literature search was conducted in 2007 and did not detect new publications on the issue. Now, six years later, several new trials have been published and evidence may have changed. Therefore, a major update of this review was necessary.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2013-10-23 18:27:17 +1000" MODIFIED_BY="Jenny Bellorini">
<P>To assess whether there is evidence that <I>Echinacea</I> preparations are effective and safe compared to placebo in the prevention and treatment of the common cold.</P>
</OBJECTIVES>
<METHODS MODIFIED="2013-10-25 09:01:20 +1000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2008-05-12 09:13:55 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trials (RCTs).</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>We included studies if participants were:</P>
<OL>
<LI>individuals with non-specific viral upper respiratory tract infections (URTIs) with a clinical diagnoses of common cold, influenza-like syndrome or viral URTI (it was not possible to apply a standard definition of common cold across all trials);</LI>
<LI>volunteers without acute URTIs but treated for preventative purposes (prevention studies);</LI>
<LI>volunteers without acute URTIs but challenged with rhinovirus treated for preventative or therapeutic purposes (or both).</LI>
</OL>
<P>We did not include studies of individuals suffering from other URTIs with a defined etiology (for example influenza) or a more specific symptomatology (for example acute sinusitis, angina tonsillaris).</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2013-10-23 18:27:20 +1000" MODIFIED_BY="[Empty name]">
<P>We included trials of oral <I>Echinacea</I> mono-preparations versus placebo. We excluded trials on combinations of <I>Echinacea</I> and other herbs and trials comparing <I>Echinacea</I> with no treatment or another treatment than placebo.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2013-10-23 19:56:23 +1000" MODIFIED_BY="[Empty name]">
<P>Selected trials had to include clinical outcome measures related to occurrence (prevention studies) and severity or duration of infections (prevention and treatment studies). We excluded trials focusing solely on physiological parameters (such as phagocytosis activity). We did not include or exclude studies based on their primary outcome measure if at least one clinically relevant outcome measure listed above was reported.</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2013-10-23 19:32:04 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>The primary efficacy outcome measure for prevention trials was the number of participants experiencing at least one cold episode.</LI>
<LI>The primary efficacy outcome measure for treatment trials was duration in days.</LI>
<LI>The primary outcome for safety and acceptability for both prevention and treatment trials was the number of participants dropping out due to side effects or adverse events.</LI>
</UL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2013-10-23 19:56:23 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>Secondary efficacy outcome measures for prevention trials were the number of participants experiencing more than one cold episode; cold duration in days; severity scores.</LI>
<LI>Secondary efficacy outcome measures for treatment trials were total severity and duration measures (e.g. area under the curve); severity of symptoms at days two to four and at days 5 to 10; in trials with very early onset of treatment also the number of participants who developed the 'full picture of a cold'.</LI>
<LI>Secondary safety and acceptability outcome measures for both prevention and treatment trials were the total number of drop-outs and the number of participants reporting side effects or adverse events.</LI>
</UL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-10-23 23:11:34 +1000" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2013-10-23 23:11:34 +1000" MODIFIED_BY="[Empty name]">
<P>For this 2013 update we searched for new studies published since the last publication of our review and also searched for older trials. This was done as search methods have evolved over time and the inclusion criteria of our reviews have changed considerably.</P>
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) 2013, Issue 5, part of <I>The Cochrane Library</I>, www.thecochranelibrary.com (accessed 5 June 2013) which contains the Acute Respiratory Infections Group's Specialized Register, MEDLINE (1946 to May week 4, 2013), EMBASE (1991 to June 2013), CINAHL (1981 to June 2013), AMED (1985 to February 2012), LILACS (1981 to June 2013) and Web of Science (1955 to June 2013).</P>
<P>We used the following search strategy to search CENTRAL and MEDLINE. We combined the MEDLINE search strategy with the Cochrane Highly Sensitive Search Strategy for identifying randomized trials in MEDLINE: sensitivity-maximizing version (2008 revision); Ovid format (<LINK REF="REF-Lefebvre-2011" TYPE="REFERENCE">Lefebvre 2011</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="5">MEDLINE (Ovid)</HEADING>
<P>1 Echinacea/<BR/>2 echinac*.tw.<BR/>3 coneflower*.tw.<BR/>4 ("E. purpurea" or "E. angustifolia" or "E. pallida").tw.<BR/>5 1 or 2 or 3 or 4</P>
<P>We adapted the search strategy to search EMBASE (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>), CINAHL (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>), AMED (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>), LILACS (<LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>) and Web of Science (<LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>). Searches for the first review (published in 1999) and the 2007 update are described in <LINK REF="APP-06" TYPE="APPENDIX">Appendix 6</LINK>.</P>
</SUBSECTION>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2013-10-08 17:42:17 +1000" MODIFIED_BY="[Empty name]">
<P>We searched WHO ICTRP and clinicaltrials.gov (latest search 8 October 2012), the Centre for Complementary Medicine Research (1988 to September 2007) and CAMBASE (latest search 5 June 2013). We screened bibliographies of identified trials and review articles for further potentially relevant publications. We contacted experts in the field and asked about further published and unpublished studies.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2013-10-25 09:01:20 +1000" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>One review author (MKV) screened the titles and abstracts, where available, of all identified references and eliminated non-human studies and trials without a control group. We obtained and checked further copies of all other references for eligibility. At least two review authors independently checked all potentially relevant publications or reports identified by the screening process for fulfillment of the selection criteria. We resolved disagreements by discussion. We assessed eligibility of trials in which one of the review authors was involved by review authors not involved in the trial.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2013-10-23 18:27:26 +1000" MODIFIED_BY="[Empty name]">
<P>At least two authors independently extracted descriptive information on patients, interventions, outcomes, results, drop-outs and side effects using a standard data extraction form. Details on extraction of outcomes used for analyses are described below. Trials in which review authors were involved were extracted and assessed by review authors not involved in the trial. We contacted trial authors or manufacturers and sponsors and asked them to provide lacking or additional data if the information in the available publications or reports was incomplete. A pharmacist with specific expertise on <I>Echinacea</I> (KAW) extracted information on the <I>Echinacea</I> preparations.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2013-10-23 23:12:44 +1000" MODIFIED_BY="[Empty name]">
<P>At least two authors independently assessed the methodological quality of the included trials using the Cochrane 'Risk of bias' tool (<LINK REF="REF-Higgins-2011b" TYPE="REFERENCE">Higgins 2011b</LINK>). We assessed the generation of the random sequence, allocation concealment, blinding, incomplete outcome data and selective reporting. For an overall assessment we considered as low risk of bias only trials in which at least four of the five items were rated as low risk and none high risk. Any trial with one or more items rated as high risk was considered high risk in the overall assessment. The remaining trials were considered as unclear risk.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2013-10-25 09:01:20 +1000" MODIFIED_BY="[Empty name]">
<P>For dichotomous efficacy outcomes we calculated risk ratios (RR) and for safety/adverse event outcomes we calculated odds ratios (OR). For continuous efficacy outcomes we calculated mean differences (MD) if the same scale of measure was used (e.g. number of days) and standardized MD if measurement tools or scales varied. For all effect estimates we calculated 95% confidence intervals (CI).</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>In all trials individual patients were randomized. However, in one trial (<LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>) investigating early self treatment more than one cold could be treated by participants (on average participants treated about 1.5 cold episodes) and the results for duration and severity presented in the publication were based on the number of cold episodes. For effect size calculation we used the number of cold episodes, because using the number of patients would only lead to a small change of the weight of this trial.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>In case of missing outcome data we tried to obtain additional information from study authors. If, in case of continuous outcomes, means were presented but standard deviations were missing we calculated standard deviations from standard errors, P values or confidence intervals as described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> Section 7.7.3 (<LINK REF="REF-Higgins-2011a" TYPE="REFERENCE">Higgins 2011a</LINK>). In case of missing dichotomous data we assumed that no event occurred.</P>
</MISSING_DATA>
<DATA_SYNTHESIS MODIFIED="2013-10-23 23:15:56 +1000" MODIFIED_BY="[Empty name]">
<P>We expected a priori that meaningful quantitative meta-analyses of the studies would not be possible for the following reasons: 1) a variety of <I>Echinacea</I> preparations are used in trials (phytochemical comparability is unclear); 2) the approach of studies differs (some investigate prevention, some self treatment, some treatment, some treatment and/or prevention of experimentally induced colds); 3) outcome measures differ in the trials; and 4) the presentation of results in available reports often includes insufficient detail to allow effect size estimation. However, we aimed to calculate effect size estimates for relevant outcome measures in single trials whenever possible. If an outcome was probably measured but data for effect size calculation were not reported we documented this.</P>
<P>For our main analysis we had predefined criteria to consider pooling (fixed-effect model) of data from different trials: 1) treatment given for the same purpose (prevention or treatment); 2) use of the same or a very similar (regarding plant species, part and extraction mode) preparation and in similar dosage; and 3) at least two trials that met the criteria 1 and 2. Because of these criteria we ended up with multiple subgroups and most subgroups consisted of only one trial (with a maximum of two trials when criteria were met for pooling) we decided to run additional exploratory random-effects meta-analyses including all available trials regardless of the type of <I>Echinacea</I> product tested. For these meta-analyses studies with more than one <I>Echinacea</I> group were entered only once (pooling data from the <I>Echinacea</I> groups) to avoid duplicate use of placebo data. The meta-analyses serve to provide a crude overview of the overall direction and magnitude of the available study results and to investigate consistency and heterogeneity of the findings. We considered pooled effect sizes as clinically interpretable &#8211; at least with caution &#8211; when a) at least two-thirds of trials measuring an outcome actually could be included in the meta-analysis; b) at least five trials could be pooled; c) the I² statistic was &#8804; 40%; and d) the P value of the Chi² test for heterogeneity was &#8805; 0.25. All other pooled effect sizes were not considered clinically interpretable and only used to check whether results differed between studies.</P>
<P>Duration of colds was analyzed and reported in highly variable manner in the primary studies. While only two presented MD with some measure of variability (the measure we would have preferred for meta-analysis), some provided median duration and P values from log rank text, Cox regression or a Wilcoxon rank sum test. According to our protocol we included only the two trials reporting mean duration. To provide at least a crude summary of study findings in a post hoc secondary analysis we used an overall estimate of effect for each study rather than summary data for each intervention group for an inverse variance analysis. For this exploratory analysis we interpreted medians as means for calculating the MD and calculated standard errors as if P values were derived from a t-test. We did not pool findings from individual studies due these liberal assumptions and the heterogeneity of the study findings but included the resulting forest plot only for giving a graphical impression of the overall evidence.</P>
<P>In general we used the number of patients randomized when calculating effect estimates for dichotomous outcome and the number of patients analyzed for continuous measures. However, for some study approaches this was considered inappropriate. For example, in five trials of self treatment, participants were randomized to receive an <I>Echinacea</I> product or placebo medication to take at home but told to take their medication only in case a cold occurred. In these cases we used the number of patients in whom a cold actually occurred for analyses.</P>
<P>In the case of pooling we examined heterogeneity between trials by calculating a Chi² test, the I² statistic and the Tau² statistic. An I² statistic value of 0% to 40% was not considered to be important heterogeneity; 40% to 60% was considered moderate heterogeneity; 60% to 90% was considered substantial and an I<SUP>2 </SUP>statistic value greater than 90% indicated considerable heterogeneity (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). We generated funnel plots for meta-analyses including at least four studies. We carried out all calculations in <LINK REF="REF-RevMan-2012" TYPE="REFERENCE">RevMan 2012</LINK>, version 5.2.</P>
</DATA_SYNTHESIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2014-01-17 22:27:05 +1000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2013-10-25 09:51:31 +1000" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>The database searches identified a total of 556 hits (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>). Three additional records were identified through other sources. We identified a total of 82 full-text articles describing trials which tested preparations of <I>Echinacea</I> in humans (alone or in combination with other plant extracts).</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Twenty-four studies (in 29 publications) met the inclusion criteria (<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table). Of these, 15 had been included in the previous version of the review (<LINK REF="STD-Barrett-2002" TYPE="STUDY">Barrett 2002</LINK>; <LINK REF="STD-Brinkeborn-1999" TYPE="STUDY">Brinkeborn 1999</LINK>; <LINK REF="STD-Br_x00e4_unig-1992" TYPE="STUDY">Bräunig 1992</LINK>; <LINK REF="STD-Dorn-1997" TYPE="STUDY">Dorn 1997</LINK>; <LINK REF="STD-Galea-1996" TYPE="STUDY">Galea 1996</LINK>; <LINK REF="STD-Goel-2004" TYPE="STUDY">Goel 2004</LINK>; <LINK REF="STD-Goel-2005" TYPE="STUDY">Goel 2005</LINK>; <LINK REF="STD-Grimm-1999" TYPE="STUDY">Grimm 1999</LINK>; <LINK REF="STD-Hoheisel-1997" TYPE="STUDY">Hoheisel 1997</LINK>; <LINK REF="STD-Kim-2002a" TYPE="STUDY">Kim 2002a</LINK>; <LINK REF="STD-Lindenmuth-2000" TYPE="STUDY">Lindenmuth 2000</LINK>; <LINK REF="STD-Melchart-1998" TYPE="STUDY">Melchart 1998</LINK>; <LINK REF="STD-Schulten-2001" TYPE="STUDY">Schulten 2001</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>; <LINK REF="STD-Yale-2004" TYPE="STUDY">Yale 2004</LINK>), two of the now included studies on induced colds had initially been excluded in the previous version of the review (<LINK REF="STD-Sperber-2004" TYPE="STUDY">Sperber 2004</LINK>; <LINK REF="STD-Turner-2000" TYPE="STUDY">Turner 2000</LINK>) and seven studies have been newly included (<LINK REF="STD-Barrett-2010" TYPE="STUDY">Barrett 2010</LINK>; <LINK REF="STD-Hall-2007" TYPE="STUDY">Hall 2007</LINK>; <LINK REF="STD-Jawad-2012" TYPE="STUDY">Jawad 2012</LINK>; <LINK REF="STD-O_x0027_Neill-2008" TYPE="STUDY">O'Neill 2008</LINK>; <LINK REF="STD-Tiralongo-2012" TYPE="STUDY">Tiralongo 2012</LINK>; <LINK REF="STD-Turner-2005" TYPE="STUDY">Turner 2005</LINK>; <LINK REF="STD-Zhang-2003" TYPE="STUDY">Zhang 2003</LINK>). One study (<LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>) was in children, the other 23 in adults. Three trials (<LINK REF="STD-Brinkeborn-1999" TYPE="STUDY">Brinkeborn 1999</LINK>; <LINK REF="STD-Br_x00e4_unig-1992" TYPE="STUDY">Bräunig 1992</LINK>; <LINK REF="STD-Melchart-1998" TYPE="STUDY">Melchart 1998</LINK>; <LINK REF="STD-Turner-2005" TYPE="STUDY">Turner 2005</LINK>) had more than one experimental group receiving an <I>Echinacea</I> product (different dosage in one and different extracts in three) so there were a total of 33 comparisons of an <I>Echinacea</I> preparation with placebo. One study had both a placebo and a no treatment control group (<LINK REF="STD-Kim-2002a" TYPE="STUDY">Kim 2002a</LINK>) and one study had a no treatment and an unblinded <I>Echinacea</I> group in addition to the blinded <I>Echinacea</I> and placebo groups (<LINK REF="STD-Barrett-2010" TYPE="STUDY">Barrett 2010</LINK>).</P>
<P>Twelve trials originated from the USA, five from Germany, three from Canada, two from Sweden, one from the United Kingdom and one from Australia. Two trials from the USA and one from Canada were only available as unpublished manuscripts (<LINK REF="STD-Galea-1996" TYPE="STUDY">Galea 1996</LINK>; <LINK REF="STD-Kim-2002a" TYPE="STUDY">Kim 2002a</LINK>; <LINK REF="STD-Zhang-2003" TYPE="STUDY">Zhang 2003</LINK>).</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2013-10-25 09:51:31 +1000" MODIFIED_BY="[Empty name]">
<P>Forty-nine studies (in 53 publications) did not meet the inclusion criteria (<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table; <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>). In 19 studies <I>Echinacea</I> in combination with other remedies was used. Eleven studies examined other conditions than common cold. Six studies examined other conditions than common cold using <I>Echinacea</I> in combination with other remedies. Ten studies were not randomized controlled trials, five of which also examined other conditions than common cold. Four studies only examined laboratory measurement results, without clinical outcomes and three of them examined other conditions than common cold.</P>
<P>Among the 49 excluded studies there was one which was included in the previous version of this review (<LINK REF="STD-Spasov-2004" TYPE="STUDY">Spasov 2004</LINK>). It was an unblinded study without placebo control.</P>
<SUBSECTION>
<HEADING LEVEL="3">Study approaches</HEADING>
<P>As described in the methods section, we separated prevention trials (treatment of healthy volunteers without cold symptoms to avoid occurrence of colds or reduce severity and duration of occurring cold) and treatment trials (treatment of individuals with colds or of early cold symptoms).</P>
<P>Ten studies were prevention trials (with a total of 13 <I>Echinacea</I> groups). In four of these trials 431 healthy volunteers (<LINK REF="STD-Hall-2007" TYPE="STUDY">Hall 2007</LINK>) or persons being challenged by inoculation with rhinovirus (<LINK REF="STD-Sperber-2004" TYPE="STUDY">Sperber 2004</LINK>; <LINK REF="STD-Turner-2000" TYPE="STUDY">Turner 2000</LINK>; <LINK REF="STD-Turner-2005" TYPE="STUDY">Turner 2005</LINK>) were treated over a shorter period (two to four weeks). Six trials including 1391 participants (<LINK REF="STD-Grimm-1999" TYPE="STUDY">Grimm 1999</LINK>; <LINK REF="STD-Jawad-2012" TYPE="STUDY">Jawad 2012</LINK>; <LINK REF="STD-Melchart-1998" TYPE="STUDY">Melchart 1998</LINK>; <LINK REF="STD-O_x0027_Neill-2008" TYPE="STUDY">O'Neill 2008</LINK>; <LINK REF="STD-Tiralongo-2012" TYPE="STUDY">Tiralongo 2012</LINK>; <LINK REF="STD-Zhang-2003" TYPE="STUDY">Zhang 2003</LINK>) treated healthy volunteers over a longer period (6 to 16 weeks) for preventative purposes.</P>
<P>Fifteen studies (with 20 comparisons) were categorized as treatment trials, but among these studies two different approaches were used: five placebo-controlled trials with a total of seven <I>Echinacea</I> groups (<LINK REF="STD-Brinkeborn-1999" TYPE="STUDY">Brinkeborn 1999</LINK>; <LINK REF="STD-Galea-1996" TYPE="STUDY">Galea 1996</LINK>; <LINK REF="STD-Goel-2004" TYPE="STUDY">Goel 2004</LINK>; <LINK REF="STD-Goel-2005" TYPE="STUDY">Goel 2005</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>) investigated self treatment. Healthy volunteers were randomized and instructed to start treatment only if they caught a cold. These trials randomized a total of 1910 participants (range 150 to 559). However, 846 did not start treatment as they did not catch a cold during the study period; therefore only 1064 (62 to 436) actually started treatment. In 10 trials with a total of 13 <I>Echinacea</I> groups (<LINK REF="STD-Barrett-2002" TYPE="STUDY">Barrett 2002</LINK>; <LINK REF="STD-Barrett-2010" TYPE="STUDY">Barrett 2010</LINK>; <LINK REF="STD-Br_x00e4_unig-1992" TYPE="STUDY">Bräunig 1992</LINK>; <LINK REF="STD-Dorn-1997" TYPE="STUDY">Dorn 1997</LINK>; <LINK REF="STD-Hoheisel-1997" TYPE="STUDY">Hoheisel 1997</LINK>; <LINK REF="STD-Kim-2002a" TYPE="STUDY">Kim 2002a</LINK>; <LINK REF="STD-Lindenmuth-2000" TYPE="STUDY">Lindenmuth 2000</LINK>; <LINK REF="STD-Schulten-2001" TYPE="STUDY">Schulten 2001</LINK>; <LINK REF="STD-Turner-2005" TYPE="STUDY">Turner 2005</LINK>; <LINK REF="STD-Yale-2004" TYPE="STUDY">Yale 2004</LINK>) individuals with cold symptoms were randomized and treated. These 10 trials included a total of 1538 participants (range 57 to 359 in each). Typically, they tried to start treatment as early as possible. Three trials (<LINK REF="STD-Hoheisel-1997" TYPE="STUDY">Hoheisel 1997</LINK>; <LINK REF="STD-Schulten-2001" TYPE="STUDY">Schulten 2001</LINK>; <LINK REF="STD-Turner-2005" TYPE="STUDY">Turner 2005</LINK>) explicitly not only investigated duration and severity of symptoms but also tried to prevent the development of a 'full cold' by treatment of first symptoms. Two of these trials were performed in industrial plants where employees could access treatment very fast (<LINK REF="STD-Hoheisel-1997" TYPE="STUDY">Hoheisel 1997</LINK>; <LINK REF="STD-Schulten-2001" TYPE="STUDY">Schulten 2001</LINK>). Development of a "full cold" was also tested by one trial examining experimental rhinovirus colds (<LINK REF="STD-Turner-2005" TYPE="STUDY">Turner 2005</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Echinacea preparations tested</HEADING>
<P>In the 33 experimental groups of the 24 included trials, widely different <I>Echinacea</I> preparations were used (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). A large proportion of the preparations used in the trials were pressed juices (stabilized with alcohol), alcohol tinctures or tablets made from dried extracts. In six trials preparations from the pressed juice of the aerial parts of <I>E. purpurea</I> were used (<LINK REF="STD-Grimm-1999" TYPE="STUDY">Grimm 1999</LINK>; <LINK REF="STD-Hoheisel-1997" TYPE="STUDY">Hoheisel 1997</LINK>; <LINK REF="STD-Schulten-2001" TYPE="STUDY">Schulten 2001</LINK>; <LINK REF="STD-Sperber-2004" TYPE="STUDY">Sperber 2004</LINK> <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>; <LINK REF="STD-Yale-2004" TYPE="STUDY">Yale 2004</LINK>). In five of these six trials (<LINK REF="STD-Grimm-1999" TYPE="STUDY">Grimm 1999</LINK>; <LINK REF="STD-Hoheisel-1997" TYPE="STUDY">Hoheisel 1997</LINK>; <LINK REF="STD-Schulten-2001" TYPE="STUDY">Schulten 2001</LINK>; <LINK REF="STD-Sperber-2004" TYPE="STUDY">Sperber 2004</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>) the same product was used. Preparations based on <I>E. purpurea</I> root alone were used in two trials, with three experimental groups (<LINK REF="STD-Br_x00e4_unig-1992" TYPE="STUDY">Bräunig 1992</LINK>; <LINK REF="STD-Zhang-2003" TYPE="STUDY">Zhang 2003</LINK>). An identical product based on a mixture of <I>E. purpurea</I> root (5%) and herb (95%) was used in two trials with three experimental groups (<LINK REF="STD-Brinkeborn-1999" TYPE="STUDY">Brinkeborn 1999</LINK>; <LINK REF="STD-Jawad-2012" TYPE="STUDY">Jawad 2012</LINK>). One of these trials (<LINK REF="STD-Brinkeborn-1999" TYPE="STUDY">Brinkeborn 1999</LINK>) tested two different concentrations of the same product. Two trials by the same study group (<LINK REF="STD-Goel-2004" TYPE="STUDY">Goel 2004</LINK>; <LINK REF="STD-Goel-2005" TYPE="STUDY">Goel 2005</LINK>) investigated the effectiveness of an extract of 'various' parts of <I>E. purpurea</I>. The particular aspect of this preparation was that it was standardized for its content of three bioactive components (alkamides, cichoric acid and polysaccharides).</P>
<P>The 14 remaining <I>Echinacea</I> preparations were only used in one trial each: tinctures or extracts prepared from <I>E. pallida</I> root (<LINK REF="STD-Dorn-1997" TYPE="STUDY">Dorn 1997</LINK>), <I>E. angustifolia</I> root (<LINK REF="STD-Melchart-1998" TYPE="STUDY">Melchart 1998</LINK>) or <I>E. angustifolia</I>, without information on the plant parts used (<LINK REF="STD-Galea-1996" TYPE="STUDY">Galea 1996</LINK>); a dried plant preparation based on 50% <I>E. angustifolia</I> root, 25% <I>E. purpurea</I> root and 25% <I>E. purpurea</I> herb (<LINK REF="STD-Barrett-2002" TYPE="STUDY">Barrett 2002</LINK>); a preparation based on <I>E. purpurea </I>root and <I>E. angustofolia </I>root<I>, </I>without information on extraction details (<LINK REF="STD-Barrett-2010" TYPE="STUDY">Barrett 2010</LINK>); a tincture from 80% <I>E. purpure</I>a herb and 20% <I>E. angustifoli</I>a root (<LINK REF="STD-Kim-2002a" TYPE="STUDY">Kim 2002a</LINK>); a preparation based on an extract of <I>E. purpurea </I>root and <I>E. angustofolia </I>root (extraction details not reported) (<LINK REF="STD-Tiralongo-2012" TYPE="STUDY">Tiralongo 2012</LINK>); a 4% phenolic extract of <I>E. purpurea</I> and <I>E. angustofolia</I> (<LINK REF="STD-Turner-2000" TYPE="STUDY">Turner 2000</LINK>); three preparations based on <I>E. angustofolia</I> root using three different extraction methods (20% alcohol; 60% alcohol and CO<SUB>2</SUB>) (<LINK REF="STD-Turner-2005" TYPE="STUDY">Turner 2005</LINK>); two kinds of <I>E. purpurea</I> capsules (parts and extraction details not reported (<LINK REF="STD-Hall-2007" TYPE="STUDY">Hall 2007</LINK>; <LINK REF="STD-O_x0027_Neill-2008" TYPE="STUDY">O'Neill 2008</LINK>); and a tea preparation based on dry extracts from the aerial parts of <I>E. purpurea</I> and <I>E. angustifolia</I> (<LINK REF="STD-Lindenmuth-2000" TYPE="STUDY">Lindenmuth 2000</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Outcome measurement</HEADING>
<P>All 10 prevention trials investigated the occurrence of cold. Other outcomes, like the number of people with more than one cold episode, duration and severity scores were only measured in some of the prevention trials. Among the self treatment and treatment trials, methods for outcome measurements and the results actually presented varied greatly (there were differences regarding instruments used, timing of measurements, type of analysis and descriptive statistics).</P>
</SUBSECTION>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>'Risk of bias' judgements are given in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table and in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>. We rated five trials (<LINK REF="STD-Barrett-2002" TYPE="STUDY">Barrett 2002</LINK>; <LINK REF="STD-Barrett-2010" TYPE="STUDY">Barrett 2010</LINK>; <LINK REF="STD-Brinkeborn-1999" TYPE="STUDY">Brinkeborn 1999</LINK>; <LINK REF="STD-Goel-2004" TYPE="STUDY">Goel 2004</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>) as having a low risk of bias in all five categories of the Cochrane 'Risk of bias' tool (<LINK REF="REF-Higgins-2011b" TYPE="REFERENCE">Higgins 2011b</LINK>). We rated five more trials as low risk of bias, having an unclear risk of bias in only one category. We rated eight trials as having a high risk of bias (<LINK REF="STD-Br_x00e4_unig-1992" TYPE="STUDY">Bräunig 1992</LINK>; <LINK REF="STD-Dorn-1997" TYPE="STUDY">Dorn 1997</LINK>; <LINK REF="STD-Galea-1996" TYPE="STUDY">Galea 1996</LINK>; <LINK REF="STD-Hoheisel-1997" TYPE="STUDY">Hoheisel 1997</LINK>; <LINK REF="STD-Jawad-2012" TYPE="STUDY">Jawad 2012</LINK>; <LINK REF="STD-Lindenmuth-2000" TYPE="STUDY">Lindenmuth 2000</LINK>; <LINK REF="STD-O_x0027_Neill-2008" TYPE="STUDY">O'Neill 2008</LINK>; <LINK REF="STD-Zhang-2003" TYPE="STUDY">Zhang 2003</LINK>) and six as having an unclear risk of bias.</P>
<ALLOCATION MODIFIED="2013-10-23 19:48:06 +1000" MODIFIED_BY="[Empty name]">
<P>Random sequence generation was performed appropriately in at least 17 studies. Additional information by authors and sponsors was taken into account. In one study (<LINK REF="STD-Lindenmuth-2000" TYPE="STUDY">Lindenmuth 2000</LINK>), allocation to groups appeared to follow an alternating sequence rather than true randomization. However, the allocation process was handled by an independent and blinded secretary after inclusion of participants in the trial. This study was already included in the previous version of the review. An adequate method of concealment was used in at least 14 studies (taking into account additional information received from authors and sponsors). In 10 studies sufficiently detailed information on allocation concealment was not reported.</P>
</ALLOCATION>
<BLINDING MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>All 24 trials were described as blinded. In 16 trials we considered the risk of performance and detection bias as low. One older trial was not adequately blinded (<LINK REF="STD-Br_x00e4_unig-1992" TYPE="STUDY">Bräunig 1992</LINK>). In this three-armed trial, one <I>Echinacea</I> group received 180 drops daily while the other <I>Echinacea</I> group and the placebo group received 90 drops. One trial was performed among employees of the manufacturer (<LINK REF="STD-Schulten-2001" TYPE="STUDY">Schulten 2001</LINK>) who may have recognized the taste of their <I>Echinacea</I> product; the success of blinding was not tested. In one trial capsules filled with vegetable oil were used as placebo and may have been distinguishable from <I>Echinacea</I> capsules by taste (<LINK REF="STD-Galea-1996" TYPE="STUDY">Galea 1996</LINK>). In two more trials (<LINK REF="STD-Hoheisel-1997" TYPE="STUDY">Hoheisel 1997</LINK>; <LINK REF="STD-Lindenmuth-2000" TYPE="STUDY">Lindenmuth 2000</LINK>) <I>Echinacea</I> preparation and placebo could possibly have been distinguishable by taste. Thirteen trials reported a test for the success of blinding. In 11 trials blinding seemed to have been successful while in two there was evidence of some unblinding (<LINK REF="STD-Melchart-1998" TYPE="STUDY">Melchart 1998</LINK>) or major unblinding (<LINK REF="STD-Zhang-2003" TYPE="STUDY">Zhang 2003</LINK>).</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2013-06-28 09:44:15 +1000" MODIFIED_BY="[Empty name]">
<P>The risk of attrition bias was considered low in 14 trials, having reported less than 20% attrition and performed an intention-to-treat analysis or reported generally less than 5% attrition. The risk of attrition bias was unclear in three and high in seven trials.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>We assessed 17 trials as having a low risk of reporting bias. In four trials important relevant outcomes are not reported/examined (<LINK REF="STD-Br_x00e4_unig-1992" TYPE="STUDY">Bräunig 1992</LINK>; <LINK REF="STD-Hall-2007" TYPE="STUDY">Hall 2007</LINK>; <LINK REF="STD-Hoheisel-1997" TYPE="STUDY">Hoheisel 1997</LINK>; <LINK REF="STD-Jawad-2012" TYPE="STUDY">Jawad 2012</LINK>). In two trials the reports are not systematically biased, but outcomes have been reported insufficiently to allow effect size calculation (<LINK REF="STD-Galea-1996" TYPE="STUDY">Galea 1996</LINK>; <LINK REF="STD-Schulten-2001" TYPE="STUDY">Schulten 2001</LINK>).</P>
</SELECTIVE_REPORTING>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2014-01-17 22:27:05 +1000" MODIFIED_BY="Jenny Bellorini">
<SUBSECTION>
<HEADING LEVEL="3">Primary outcomes for prevention trials and for treatment or self treatment trials</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary efficacy outcome measure for prevention trials:<I> </I>number of participants experiencing at least one cold episode</HEADING>
<P>Nine of the 10 prevention trials reported the number of patients experiencing at least one cold. None of the 12 comparisons of <I>Echinacea</I> preparations and placebo in these nine trials (<LINK REF="STD-Grimm-1999" TYPE="STUDY">Grimm 1999</LINK>; <LINK REF="STD-Hall-2007" TYPE="STUDY">Hall 2007</LINK>; <LINK REF="STD-Melchart-1998" TYPE="STUDY">Melchart 1998</LINK>; <LINK REF="STD-O_x0027_Neill-2008" TYPE="STUDY">O'Neill 2008</LINK>; <LINK REF="STD-Sperber-2004" TYPE="STUDY">Sperber 2004</LINK>; <LINK REF="STD-Tiralongo-2012" TYPE="STUDY">Tiralongo 2012</LINK>; <LINK REF="STD-Turner-2000" TYPE="STUDY">Turner 2000</LINK>; <LINK REF="STD-Turner-2005" TYPE="STUDY">Turner 2005</LINK>; <LINK REF="STD-Zhang-2003" TYPE="STUDY">Zhang 2003</LINK>) demonstrated statistically significant results in comparison to placebo (<LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>).</P>
<P>Only two trials investigated the same <I>Echinacea</I> product; the pooled risk ratio (RR) also did not show significant effects over placebo (RR 0.82, 95% confidence interval (CI) 0.67 to 1.02; P = 0.07). However, in our exploratory meta-analysis pooling all trials (1167 patients totally), regardless of the product used, prophylactic treatment with <I>Echinacea</I> products was associated with a reduced risk of experiencing a cold (RR 0.83, 95% CI 0.75 to 0.92; P &lt; 0.001). Study findings were highly consistent across studies with an I² statistic of 0%, a Tau² of 0.00 and a P value of 0.98 in the Chi² test for heterogeneity. The funnel plot showed some asymmetry (Eggers test p = 0.03) but point estimates in the single trials were similar and including only the four most precise trials in meta-analysis reduced the pooled estimate only marginally (RR 0.85, 95% CI 0.75 to 0.96). We could not include the largest prevention study (<LINK REF="STD-Jawad-2012" TYPE="STUDY">Jawad 2012</LINK>) in the quantitative analyses as it did not report the number of patients with at least one cold but only the total number of cold episodes. There were 149 cold episodes in the <I>Echinacea</I> group versus 188 in the placebo group; this finding seems very compatible with the reduced RR suggested by our meta-analysis.</P>
<P>The observed risk ratio of 0.83 in our meta-analysis corresponds to an absolute risk reduction of 10% (95% CI 5% to 16%) and a number needed to treat of 10 (95% CI 6 to 20). As more participants in the control groups experienced a cold the absolute risk reduction in the four most precise trials was 11% (94% CI 4% to 19%) and the number needed to treat 9 (95% CI 5 to 25) in spite of the slightly larger risk ratio of 0.85.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Primary efficacy outcome measure for treatment or self treatment trials: duration in days</HEADING>
<P>Only one trial of a mixture of 50% <I>E. angustifolia</I> root, 25% <I>E. purpurea</I> root and 25% <I>E. purpurea</I> herb (<LINK REF="STD-Barrett-2002" TYPE="STUDY">Barrett 2002</LINK>) and one trial of a mixture of <I>E. purpurea</I> root and <I>E. angustifolia</I> root (<LINK REF="STD-Barrett-2010" TYPE="STUDY">Barrett 2010</LINK>) reported the mean duration of colds (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>; <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). Neither trial found a significant difference compared to placebo. A total of six trials could be included in our post hoc secondary inverse variance analysis also using other data on duration (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>). Study findings were heterogeneous (I² statistic = 77%, Tau² = 0.88, P = 0.0002 in Chi² test) with two trials (<LINK REF="STD-Lindenmuth-2000" TYPE="STUDY">Lindenmuth 2000</LINK>; <LINK REF="STD-Schulten-2001" TYPE="STUDY">Schulten 2001</LINK>) finding a significantly shorter duration in the <I>Echinacea</I> group.  </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Primary safety and acceptability outcome for prevention trials: number of participants dropping out due to side effects or adverse events</HEADING>
<P>Our main outcome measure for the safety and acceptability analysis, the number of patients dropping out due to adverse effects, was reported in eight comparisons in seven studies (<LINK REF="STD-Grimm-1999" TYPE="STUDY">Grimm 1999</LINK>; <LINK REF="STD-Jawad-2012" TYPE="STUDY">Jawad 2012</LINK>; <LINK REF="STD-Melchart-1998" TYPE="STUDY">Melchart 1998</LINK>; <LINK REF="STD-O_x0027_Neill-2008" TYPE="STUDY">O'Neill 2008</LINK>; <LINK REF="STD-Sperber-2004" TYPE="STUDY">Sperber 2004</LINK>; <LINK REF="STD-Tiralongo-2012" TYPE="STUDY">Tiralongo 2012</LINK>; <LINK REF="STD-Turner-2000" TYPE="STUDY">Turner 2000</LINK>; see <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>; <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>). There were no significant differences in the single trials but the confidence intervals are wide as the number of patients dropping out was generally low. If study findings were pooled regardless of the <I>Echinacea</I> product used (heterogeneity indicators I² statistic = 0%; Tau² = 0.00; P = 0.87 in Chi² test) 2.4% in <I>Echinacea</I> groups dropped out from the studies due to side effects compared to 0.8% from the placebo groups (odds ratio (OR) 2.17, 95% CI 0.85 to 5.53; P = 0.10).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Primary safety and acceptability outcome for treatment or self treatment trials: number of participants dropping out due to side effects or adverse events</HEADING>
<P>For 11 trials (14 comparisons) the number of patients dropping out due to side or adverse effects could be extracted. Only three of 1088 patients who received an <I>Echinacea</I> product and none of the 930 patients who received placebo dropped out for these reasons (<LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary outcomes for prevention trials and for treatment or self treatment trials</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Secondary efficacy outcome measures for prevention trials: number of participants experiencing more than one cold episode; cold duration in days; severity scores</HEADING>
<P>Three trials (with four comparisons) reported the number of patients with more than one cold episode (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). None of the trials found significant differences but confidence intervals were very wide. Four trials (with five comparisons) reported the duration of cold episode (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). Only one small trial (<LINK REF="STD-Hall-2007" TYPE="STUDY">Hall 2007</LINK>) found a very large (5.2 days on average) statistically significant effect over placebo. Point estimates in the other comparisons vary between 1.2 days shorter to 0.6 days longer duration in the <I>Echinacea</I> groups. Five trials (with seven comparisons) presented sufficient data for calculations on effect sizes for severity of cold episodes (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). Again, none of the single trials found a significant effect over placebo. However, as study findings were similar across trials (I² statistic = 0% and Tau² = 0.00 and P = 0.86 in Chi² test) we report the pooled standardized mean difference (SMD) for this outcome which is -0.24 (95% CI -0.07 to -0.40; P = 0.005), indicating a small effect over placebo.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary efficacy outcome measures for treatment or self treatment trials: total severity and duration measures; severity of symptoms at days two to four and at days 5 to 10; in trials with very early onset of treatment also the number of participants who developed the 'full picture of a cold'</HEADING>
<P>In nine trials (nine comparisons) measures integrating both severity and duration were presented in sufficient detail, or were provided by the authors, to calculate effect sizes (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>). The two trials on <I>E. purpurea</I> herb pressed juice preparations also reporting duration again reported conflicting results (<LINK REF="STD-Schulten-2001" TYPE="STUDY">Schulten 2001</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>). The pooled SMD was not significant (SMD -0.26, 95% CI -0.75 to 0.23; P = 0.30; I² statistic = 76%). This applies also to two trials testing a standardized extract of <I>E. purpurea</I> (SMD -0.18, 95% CI -0.57 to 0.21; P = 0.20; I² = 40%). Trials of other extracts did not find any significant differences. While heterogeneity seems limited (I² statistic = 17%; Tau² 0.00; P = 0.29 in Chi² test) our SMD from meta-analysis of all available studies has to be interpreted with great caution (SMD -0.09, 95% CI -0.20 to 0.02; P = 0.10). Data on severity scores after two to four days (<LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>) and five to 10 days of treatment (<LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>) were reported in seven trials (eight comparisons) and eight trials (11 comparisons), respectively. Significant differences were found in two comparisons after two to four days and four comparisons after five to 10 days. As study findings were heterogeneous (I² statistic = 76% and 90%, respectively) we do not report a pooled effect estimate of all pooled data. For the standardized <I>E. purpurea</I> extract tested in two trials pooled SMDs were non-significant (after two to four days: SMD -0.20, 95% CI -0.88 to 0.48; P = 0.56 and after five to 10 days SMD -0.31, 95% CI -0.75 to -1.00; P = 0.18). Only three trials reported the number of patients developing a "full" cold after the early treatment of prodromes (self treatment) (<LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>). For the two studies using the same <I>Echinacea</I> product (<I>E. purpurea</I> herb pressed juice) the pooled RR was non-significant (RR 0.79, 95% CI 0.54 to 1.14; P = 0.21).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary safety and acceptability outcomes for prevention trials: total number of drop-outs and the number of participants reporting side effects or adverse events</HEADING>
<P>For 12 comparisons in nine trials the number of patients dropping out (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>) has been reported. Two studies reported that significantly more patients were dropping out in the <I>Echinacea</I> group than in the placebo group (<LINK REF="STD-Jawad-2012" TYPE="STUDY">Jawad 2012</LINK> and the comparison using <I>E. angustofolia</I> root extracted with CO<SUB>2</SUB> in <LINK REF="STD-Turner-2005" TYPE="STUDY">Turner 2005</LINK>). The other trials found no significant differences in the number of drop-outs. As study results seem broadly consistent (I² statistic = 8%, Tau² = 0.02; P = 0.37 in Chi² test) we also report pooled results. The percentage of participants in the <I>Echinacea</I> groups terminating studies early was 12.7% compared to 9.0% in the placebo groups (OR 1.37, 95% CI 0.98 to 1.91; P = 0.06). For nine comparisons in eight trials the number of persons reporting adverse effects (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>) has been reported. Results were non-significant in all trials except for one trial which found significantly fewer persons reporting adverse effects in the placebo group (<LINK REF="STD-Zhang-2003" TYPE="STUDY">Zhang 2003</LINK>). In most of the trials there was a trend towards fewer adverse effects in the placebo groups. As some heterogeneity cannot be ruled out (I² statistic = 25%, Tau² = 0.10; P = 0.23 in Chi² test) our pooled findings are hard to interpret. 11.8% versus 8.6% of patients reported side or adverse effects (RR 1.49, 95% CI 0.95 to 2.35; P = 0.09).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary safety and acceptability outcomes for treatment or self treatment trials: total number of drop-outs and the number of participants reporting side effects or adverse events</HEADING>
<P>Numbers of participants dropping out were similar in <I>Echinacea</I> and placebo groups in the trials presenting these data (<LINK REF="CMP-002.08" TYPE="ANALYSIS">Analysis 2.8</LINK> to <LINK REF="CMP-002.09" TYPE="ANALYSIS">Analysis 2.9</LINK>), except for <I>E. angustofolia</I> root extracted with 60% ethanol which led to more drop-outs in the <I>Echinacea</I> group (<LINK REF="STD-Turner-2005" TYPE="STUDY">Turner 2005</LINK>). The number of patients reporting adverse effects did not differ significantly between treatment and control groups in the single trials. Heterogeneity was low (I² statistic = 0%, Tau² = 0.00, P = 0.84 Chi² test). Meta-analysis showed a significant difference in the number of patients reporting side effects in the placebo groups (32.6%) and in the treatment groups (34.1%) (OR 1.28, 95% CI 1.02 to 1.60, P = 0.03). One trial in children using a preparation made from pressed juice of <I>E. purpurea</I> herb found an increased frequency of rash in the experimental group (<LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2014-01-08 20:21:37 +1000" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2013-10-24 00:38:12 +1000" MODIFIED_BY="[Empty name]">
<P>Our review shows that a variety of products prepared from different <I>Echinacea</I> species, different plant parts and in different forms have been compared to placebo in randomized trials. These preparations contain quite different amounts of bioactive components and hence are not biochemically comparable. Furthermore, trial approaches and methods for cold assessment were highly variable. Taken together, results from prevention trials suggest that a number of <I>Echinacea</I> products slightly reduce the risk of getting a cold in healthy individuals. If this conclusion is true, the lack of significance in individual trials could be due to a lack of statistical power (too few patients included in single studies). Although it seems possible that some <I>Echinacea</I> products also have effects over placebo for treating colds, the overall evidence for clinically relevant treatment effects over placebo is weak.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2014-01-08 20:21:37 +1000" MODIFIED_BY="[Empty name]">
<P>For our review we could identify and include three unpublished trials which did not find significant effects over placebo (<LINK REF="STD-Galea-1996" TYPE="STUDY">Galea 1996</LINK>; <LINK REF="STD-Kim-2002a" TYPE="STUDY">Kim 2002a</LINK>; <LINK REF="STD-Zhang-2003" TYPE="STUDY">Zhang 2003</LINK>). We are also aware of at least one further unpublished, negative trial from the USA. During the search for an earlier review on <I>Echinacea</I> (<LINK REF="REF-Melchart-1994" TYPE="REFERENCE">Melchart 1994</LINK>) one of the authors was informed by an expert in the field through personal communication that there were several negative trials from Germany (however, possibly partly of combinations). It seems possible that there are additional unpublished trials, though we think that it is unlikely that the conclusions of our review would change substantially; the evidence regarding treatment effects is weak and cannot justify recommendations to take <I>Echinacea</I> or a specific product. All single prevention trials included in our review yielded non-significant results. Particularly in smaller trials, P values were far from statistically significant. </P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>The great heterogeneity of preparations tested makes conclusions difficult. Several of the newer trials tested products which were standardized on the content of a bioactive ingredient. However, the available research indicates that the clinical effects of (some) <I>Echinacea</I> preparations are likely to be due to several components which may have synergistic effects. Two of the tested products were standardized for known bioactive components, namely alkamides, cichoric acid and polysaccharides (<LINK REF="STD-Goel-2004" TYPE="STUDY">Goel 2004</LINK>; <LINK REF="STD-Goel-2005" TYPE="STUDY">Goel 2005</LINK>; <LINK REF="STD-Tiralongo-2012" TYPE="STUDY">Tiralongo 2012</LINK>). Components (or one component) of the study medication have been analyzed and documented for several trials (<LINK REF="STD-Barrett-2002" TYPE="STUDY">Barrett 2002</LINK>; <LINK REF="STD-Barrett-2010" TYPE="STUDY">Barrett 2010</LINK>; <LINK REF="STD-Galea-1996" TYPE="STUDY">Galea 1996</LINK>; <LINK REF="STD-Jawad-2012" TYPE="STUDY">Jawad 2012</LINK>; <LINK REF="STD-Melchart-1998" TYPE="STUDY">Melchart 1998</LINK>; <LINK REF="STD-Turner-2000" TYPE="STUDY">Turner 2000</LINK>; <LINK REF="STD-Turner-2005" TYPE="STUDY">Turner 2005</LINK>; <LINK REF="STD-Yale-2004" TYPE="STUDY">Yale 2004</LINK>; <LINK REF="STD-Zhang-2003" TYPE="STUDY">Zhang 2003</LINK>). Testing preparations that have been standardized to specific components seems like a desirable way to move forward. The quality of the included trials was heterogeneous as we considered 38% of the trials to have a high risk of bias while we considered 42% of the trials to have a low risk of bias.</P>
<P>In 2005, a further systematic review on the effectiveness of <I>Echinacea</I> for the treatment (not prevention) of colds was published (<LINK REF="REF-Caruso-2005" TYPE="REFERENCE">Caruso 2005</LINK>). The authors concluded that the possible therapeutic effectiveness of <I>Echinacea</I> had not been established. A major criticism was that most studies (apart from two negative trials) lacked a proof of blinding. While we agree that successful blinding is crucial for the validity of a trial, we find it problematic to overemphasize this criterion when assessing the available evidence. First, the vast majority (93%) of placebo-controlled RCTs provide no evidence of blinding success and, of those that do, the majority report less than satisfactory results (<LINK REF="REF-Fergusson-2004" TYPE="REFERENCE">Fergusson 2004</LINK>). Second, participant guesses at the end of a trial are also influenced by the perceived outcome and are not necessarily evidence of bias. Nevertheless, we agree with the authors of this review that the available evidence is far from convincing and that a lack of blinding can be a relevant problem in trials of <I>Echinacea</I> products.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2013-10-24 00:40:39 +1000" MODIFIED_BY="[Empty name]">
<P>Study selection and data extraction were performed by at least two review authors independently. Studies in which one of the authors were involved were handled by another review author. We checked study findings entered for effect size calculation against the original publications. However, it was a major challenge for the authors of this review to summarize the results of the included studies in a manner that is both concise and reflects the heterogeneity adequately. In our main analysis we did not pool studies unless they clearly investigated comparable <I>Echinacea</I> products. Yet, deviating from our protocol, we included some pooled estimates from meta-analysis across different <I>Echinacea</I> preparations in the text. We believe that this decision is justified as a) it allows us to check whether study findings are consistent across studies and products and b) it provides a crude idea of the possible size of potential effects. However, we urge that these results have to be interpreted with caution and should not be interpreted as 'average' effects of <I>Echinacea</I> products.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>A meta-analysis (<LINK REF="REF-Schoop-2006b" TYPE="REFERENCE">Schoop 2006b</LINK>) of the three trials on induced rhinovirus infections included in our review (<LINK REF="STD-Sperber-2004" TYPE="STUDY">Sperber 2004</LINK>; <LINK REF="STD-Turner-2000" TYPE="STUDY">Turner 2000</LINK>; <LINK REF="STD-Turner-2005" TYPE="STUDY">Turner 2005</LINK>) found that the likelihood of participants experiencing a clinical cold was significantly lower in the <I>Echinacea</I> groups. The results were pooled, although different <I>Echinacea</I> preparations were examined in the trials. These findings could indicate that the trials were too small to detect a small effect of the tested preparations. This conclusion is consistent with our results.</P>
<P>In 2007 another meta-analysis of RCTs investigating the effectiveness of <I>Echinacea</I> products for preventing and treating common colds was published (<LINK REF="REF-Shah-2007" TYPE="REFERENCE">Shah 2007</LINK>). This review drew more favorable conclusions, especially on the effect of <I>Echinacea</I> on the cold duration, than we do. <LINK REF="REF-Shah-2007" TYPE="REFERENCE">Shah 2007</LINK> used different inclusion criteria and also included trials investigating combinations of <I>Echinacea. </I>These authors heavily relied on meta-analysis, pooling findings from studies investigating very different <I>Echinacea</I> preparations and from treatment and prevention trials in one analysis. If all these trials are interpreted as investigating the same treatment for the same purpose, then the evidence can be considered as more positive and the conclusions reasonable. For our main analysis we refrained from pooling studies testing different <I>Echinacea</I> preparations.</P>
<P>Other complementary and alternative medicine (CAM) interventions for prevention and treatment have been investigated in systematic reviews. The evidence that vitamin C supplementation or probiotics used for prevention of the common cold, and zinc used for treatment of the common cold, are effective (<LINK REF="REF-Hao-2011" TYPE="REFERENCE">Hao 2011</LINK>; <LINK REF="REF-Hemil_x00e4_-2013" TYPE="REFERENCE">Hemilä 2013</LINK>; <LINK REF="REF-Singh-2013a" TYPE="REFERENCE">Singh 2013a</LINK>) is stronger than the evidence for <I>Echinacea</I>. Evidence for the effects of other CAM interventions is similarly limited (<I>Pelargonium sidoides</I>, <LINK REF="REF-Timmer-2009" TYPE="REFERENCE">Timmer 2009</LINK>) or even weaker (saline nasal irrigation, <LINK REF="REF-Kassel-2010" TYPE="REFERENCE">Kassel 2010</LINK>; increased fluid intake <LINK REF="REF-Guppy-2011" TYPE="REFERENCE">Guppy 2011</LINK>; heated humidified air, <LINK REF="REF-Singh-2013b" TYPE="REFERENCE">Singh 2013b</LINK>; garlic, <LINK REF="REF-Lissiman-2012" TYPE="REFERENCE">Lissiman 2012</LINK>; and Chinese medical herbs, <LINK REF="REF-Zhang-2010" TYPE="REFERENCE">Zhang 2010</LINK>).</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2014-01-17 22:27:53 +1000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2014-01-17 22:27:53 +1000" MODIFIED_BY="[Empty name]">
<P>The most important recommendation for consumers and clinicians is to be aware that the available <I>Echinacea</I> products differ greatly. The overwhelming majority of these products have not been tested in clinical trials. It has been shown that labeling of products marketed in health food stores can be incorrect (<LINK REF="REF-Gilroy-2003" TYPE="REFERENCE">Gilroy 2003</LINK>). Our exploratory meta-analyses suggest that at least some <I>Echinacea</I> preparations may reduce the relative risk of catching a cold by 10% to 20%. A risk reduction of 15% would mean that if 500 out of 1000 persons receiving a placebo would catch a cold this figure would be 425 of 1000 persons with an <I>Echinacea</I> product. This is clearly a small effect of unclear clinical relevance. Furthermore, we cannot say which <I>Echinacea</I> products have an effect of this size, or a greater or lesser effect. While there are some hints that both alcoholic extracts and pressed juices that are based primarily on the aerial parts of <I>E. purpurea</I> have beneficial effects on cold symptoms in adults, the evidence for clinically relevant treatment effects is weak. There are still many remaining doubts due to the fact that not all trials using such preparations show even a trend towards an effect.</P>
<P>As randomized controlled trials include limited numbers of participants and often exclude persons with relevant co-morbidity, a review of such trials can only contribute limited knowledge on safety issues. The number of patients dropping out or reporting adverse effects did not differ significantly between treatment and control groups in prevention and treatment trials. However, in prevention trials there was a trend towards a larger number of patients dropping out due to side effects or reporting side effects in the treatment groups.The most relevant potential adverse effects of <I>Echinacea</I> preparations are probably allergic reactions (<LINK REF="REF-Huntley-2005" TYPE="REFERENCE">Huntley 2005</LINK>; <LINK REF="REF-Mullins-2002" TYPE="REFERENCE">Mullins 2002</LINK>). One trial suggested an absolute 5% increase in rash in children (<LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>). Parenteral application of <I>Echinacea</I> preparation should be discouraged, as there is no evidence of either safety or effectiveness.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>In principle, further research is clearly desirable given the widespread use of <I>Echinacea</I> products. However, given the multiplicity and diversity of products on the market applying the knowledge gained from such studies will remain a challenge to persons without in-depth knowledge of herbal preparations. The use of chemically well-defined preparations is recommended to improve comparability of results from different studies. It would be desirable if experts in research on common colds could develop recommendations for a core set of outcome measures to be used and reported in randomized clinical trials. Trials investigating the prevention of colds need large sample sizes as the potential effects of <I>Echinacea</I> products are likely to be small.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2013-12-04 09:13:29 +1000" MODIFIED_BY="Liz Dooley">
<P>We would like to thank Sarah Thorning (Trials Search Co-ordinator of the Cochrane ARI Group) for her help with the literature search and Liz Dooley (Managing Editor of the Cochrane ARI Group) for her patience when waiting for this update to be completed. Furthermore we would like to thank Dieter Melchart for his contribution to the previous versions of the review. The authors would also like to thank the following people for commenting on drafts of this review: Janet Wale, Ann Fonfa, Ajima Olaghere, Steven Yale, Zaina AlBalawi, Sree Nair, Mark Jones and Meenu Singh.Â We are indebted to the authors of primary studies who provided additional information, often to a considerable extent.</P>
<P>Bruce Barrett is supported by a K24 Mid-Career Investigator Award from the National Center for Complementary and Alternative Medicine at the U.S. National Institutes of Health.<BR/>David Kiefer is a post-doctoral research fellow, supported by a T32 National Research Service Award from the National Center for Complementary and Alternative Medicine at the U.S. National Institutes of Health.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Klaus Linde was involved in one, Karin Ardjomand-Woelkart in one, Bruce Barrett in two and Rudolf Bauer in four of the studies included in this review. Marlies Karsch-Völk and David Kiefer have no conflict of interest. Authors did not carry out data extraction or quality assessment of studies they were involved in.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Co-ordination of the review update: MKV<BR/>Planning of updates: MKV, KL, BB, DK<BR/>Searches in addition to searches done by the Cochrane ARI Group: MKV<BR/>Study selection, data extraction and quality assessment: MKV, KL, BB, DK<BR/>Extraction of pharmaceutical data/pharmaceutical expertise: KAW, RB<BR/>Statistical analyses: MKV, KL<BR/>Drafting of the manuscript: MKV, KL<BR/>Interpretation of results, critical feedback on draft versions: BB, DK, KAW, RB </P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Change to authorship byline: New first author is Marlies Karsch-Völk. Dieter Melchart was not involved in this update.<BR/>Inclusion criteria changed: Now only randomized controlled trials and also studies on induced rhinovirus infections have been included.<BR/>Outcome measures changed: Duration of cold is now a primary outcome of treatment trials.<BR/>
</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2013-03-07 21:22:49 +1000" MODIFIED_BY="[Empty name]"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2013-10-25 09:52:31 +1000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2013-10-25 09:52:31 +1000" MODIFIED_BY="Jenny Bellorini">
<INCLUDED_STUDIES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<STUDY DATA_SOURCE="MIX" ID="STD-Barrett-2002" NAME="Barrett 2002" YEAR="2002">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Barrett BP, Brown RL, Locken K, Maberry R, Bobula JA, D'Alessio D</AU>
<TI>Treatment of the common cold with unrefined Echinacea. A randomized, double-blind, placebo-controlled trial</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2002</YR>
<VL>137</VL>
<PG>939-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barrett-2010" MODIFIED="2013-05-24 13:45:39 +1000" MODIFIED_BY="[Empty name]" NAME="Barrett 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-05-21 18:38:59 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Barrett B, Brown R, Rakel D, Mundt M, Bone K, Barlow S</AU>
<TI>Echinacea for treating the common cold</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2010</YR>
<VL>153</VL>
<PG>769-77</PG>
<IDENTIFIERS MODIFIED="2012-12-14 19:14:49 +1000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE MODIFIED="2013-05-24 13:45:39 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barrett P, Brown R, Rakel D, Rabago D, Marchand L, Scheder J, et al</AU>
<TI>Placebo effects and the common cold: a randomized controlled trial</TI>
<SO>Annals of Family Medicine</SO>
<YR>2011</YR>
<VL>9</VL>
<PG>312-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Br_x00e4_unig-1992" NAME="Bräunig 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Br&amp;#228;unig B, Dorn M, Knick E. Echinaceae purpureae radix: zur St&amp;#228;rkung der k&amp;#246;rpereigenen Abwehr bei grippalen Infekten. Z Phytother 1992; 13:7-13.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bräunig B, Dorn M, Knick E</AU>
<TO>Echinaceae purpureae radix: zur Stärkung der körpereigenen Abwehr bei grippalen Infekten</TO>
<SO>Zeitschrift für Phytotherapie</SO>
<YR>1992</YR>
<VL>13</VL>
<PG>7-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Brinkeborn-1999" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Brinkeborn 1999" YEAR="1999">
<REFERENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brinkeborn R, Shah D, Geissbühler S, Degenring FH</AU>
<TI>Echinaforce for the treatment of the common cold. Results of a placebo-controlled double-blind trial in Sweden</TI>
<TO>Echinaforce zur Behandlung von akuten Erkältungen. Ergebnisse einer placebokontrollierten Doppelblindstudie in Schweden</TO>
<SO>Schweizerische Zeitschrift für Ganzheitsmedizin</SO>
<YR>1998</YR>
<VL>10</VL>
<PG>26-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Brinkeborn RM, Shah DV, Degenring FH</AU>
<TI>Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo-controlled, double-blind clinical trial</TI>
<SO>Phytomedicine</SO>
<YR>1999</YR>
<VL>6</VL>
<PG>1-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Dorn-1997" NAME="Dorn 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;Br&amp;#228;unig B, Knick E. Therapeutische Erfahrungen mit Echinacea pallida bei grippalen Infekten. Naturheilpraxis mit Naturmedizin 1993; 1:72-75.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bräunig B, Knick E</AU>
<TO>Therapeutische Erfahrungen mit Echinacea pallida bei grippalen Infekten</TO>
<SO>Naturheilpraxis mit Naturmedizin</SO>
<YR>1993</YR>
<VL>1</VL>
<PG>72-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Dorn M, Knick E, Lewith G. Placebo-controlled, double-blind study of Echinaceae pallidae radix in upper respiratory tract infections. Complementary Therapies in Medicine 1997; 5:40-42.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Dorn M, Knick E, Lewith G</AU>
<TI>Placebo-controlled, double-blind study of Echinaceae pallidae radix in upper respiratory tract infections</TI>
<SO>Complementary Therapies in Medicine</SO>
<YR>1997</YR>
<VL>5</VL>
<PG>40-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Galea-1996" NAME="Galea 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Still unpublished 08/10/07&lt;/p&gt;" PRIMARY="YES" TYPE="UNPUBLISHED">
<AU>Galea S, Thacker K</AU>
<TI>Double blind prospective trial investigating the effectiveness of a commonly prescribed herbal remedy in altering duration, severity and symptoms of the common cold</TI>
<SO>Unpublished report</SO>
<YR>1996</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Goel-2004" MODIFIED="2013-05-21 18:27:59 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Goel 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-05-21 18:27:59 +1000" MODIFIED_BY="Jenny Bellorini" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goel V, Lovlin R, Barton R, Lyon MR, Bauer R, Lee TDG, et al</AU>
<TI>Efficacy of a standardized echinacea preparation (Echinilin) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial</TI>
<SO>Journal of Clinical Pharmacy and Therapeutics</SO>
<YR>2004</YR>
<VL>29</VL>
<PG>75-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Goel-2005" MODIFIED="2013-05-21 18:28:28 +1000" MODIFIED_BY="[Empty name]" NAME="Goel 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-05-21 18:28:28 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Goel 2005 is now published - Phytotherapy Research (at the moment &amp;quot;research&amp;quot;) 2005;19:689-94.&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2013-05-21 18:28:28 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goel V, Lovlin R, Chang C, Slama JV, Barton R, Gahler R, et al</AU>
<TI>A proprietary extract from the Echinacea plant (Echinacea purpurea) enhances systemic immune response during a common cold</TI>
<SO>Phytotherapy Research</SO>
<YR>2005</YR>
<VL>19</VL>
<PG>689-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grimm-1999" MODIFIED="2008-02-05 09:10:11 +1000" MODIFIED_BY="[Empty name]" NAME="Grimm 1999" YEAR="1999">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Grimm W, Müller HH</AU>
<TI>A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections</TI>
<SO>American Journal of Medicine</SO>
<YR>1999</YR>
<VL>106</VL>
<PG>138-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Sch&amp;#246;neberger D. Einflu&amp;#223; der immunstimulierenden Wirkung von Pre&amp;#223;saft aus Herba Echinaceae purpureae auf Verlauf und Schweregrad von Erk&amp;#228;ltungskrankheiten. Forum Immunologie 1992; 2(8):18-22. [In fact, the Grimm 1999 study was first published by Schoeneberger 1992 in German and in a quite incomplete manner. The reference is correct]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schöneberger D</AU>
<TO>Einfluß der immunstimulierenden Wirkung von Preßsaft aus Herba Echinaceae purpureae auf Verlauf und Schweregrad von Erkältungskrankheiten</TO>
<SO>Forum Immunologie</SO>
<YR>1992</YR>
<VL>2</VL>
<NO>8</NO>
<PG>18-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hall-2007" MODIFIED="2013-05-21 18:39:32 +1000" MODIFIED_BY="[Empty name]" NAME="Hall 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-05-21 18:39:32 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hall H, Fahlmann MM, Engels HJ</AU>
<TI>Echinacea purpurea and mucosal immunity</TI>
<SO>International Journal of Sports Medicine</SO>
<YR>2007</YR>
<VL>28</VL>
<PG>792-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hoheisel-1997" NAME="Hoheisel 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;Hoheisel O, Sandberg M, Bertram S, Bulitta M, Sch&amp;#228;fer M. Die Behandlung mit Echinagard verk&amp;#252;rzt den Verlauf einer unkomplizierten Erk&amp;#228;ltung: Ergebnisse einer doppelblinden, placebokontrollierten klinischen Pr&amp;#252;fung. Eur J Clin Res 1997; 9:261-269.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hoheisel O, Sandberg M, Bertram S, Bulitta M, Schäfer M</AU>
<TI>Echinagard treatment shortens the course of the common cold: a double-blind, placebo-controlled clinical trial</TI>
<SO>European Journal of Clinical Research</SO>
<YR>1997</YR>
<VL>9</VL>
<PG>261-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Jawad-2012" MODIFIED="2013-05-21 18:29:41 +1000" MODIFIED_BY="[Empty name]" NAME="Jawad 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-05-21 18:29:41 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Jawad M, Schoop R, Suter A, Klein P, Eccles R</AU>
<TI>Safety and efficacy profile of Echinacea purpurea to prevent common cold episodes: A randomized, double-blind, placebo-controlled trial</TI>
<SO>Evidence-Based Complementary and Alternative Medicine</SO>
<YR>2012</YR>
<VL>2012</VL>
<PG>1-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-02-12 20:22:01 +1000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Kim-2002a" MODIFIED="2012-12-19 21:47:40 +1000" MODIFIED_BY="[Empty name]" NAME="Kim 2002a" YEAR="2002">
<REFERENCE NOTES="&lt;p&gt;Still unpublished 08/10/07&lt;/p&gt;" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Kim KH, Levitsky DA</AU>
<TI>Echinacea's effect on the common cold: a double-blind, placebo controlled, clinical trial</TI>
<SO>Unpublished report</SO>
<YR>2002</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lindenmuth-2000" NAME="Lindenmuth 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lindenmuth GF, Lindenmuth EB</AU>
<TI>The efficacy of Echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: a randomized, double-blind placebo-controlled study</TI>
<SO>Journal of Alternative and Complementary Medicine</SO>
<YR>2000</YR>
<VL>6</VL>
<PG>327-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Melchart-1998" NAME="Melchart 1998" YEAR="1998">
<REFERENCE NOTES="&lt;p&gt;Melchart D, Walther E, Linde K, Brandmaier R, Lersch C. Echinacea root extracts for the prevention of upper respiratory tract infections - a double-blind, placebo-controlled randomized trial. Arch Fam Med 1998;7 (in print).&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Melchart D, Walther E, Linde K, Brandmaier R, Lersch C</AU>
<TI>Echinacea root extracts for the prevention of upper respiratory tract infections - a double-blind, placebo-controlled randomized trial</TI>
<SO>Archives of Family Medicine</SO>
<YR>1998</YR>
<VL>7</VL>
<PG>541-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-O_x0027_Neill-2008" MODIFIED="2013-10-23 18:04:20 +1000" MODIFIED_BY="[Empty name]" NAME="O'Neill 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-10-23 18:04:14 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>O'Neil J, Hughes S, Lourie A, Zweifler J</AU>
<TI>Effects of echinacea on the frequency of upper respiratory tract symptoms: a randomized, double-blind, placebo-controlled trial</TI>
<SO>Annals of Allergy, Asthma &amp; Immunology</SO>
<YR>2008</YR>
<VL>100</VL>
<PG>384-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schulten-2001" NAME="Schulten 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schulten B, Bulitta M, Ballering-Brühl B, Köster U, Schäfer M</AU>
<TI>Efficacy of Echinacea purpurea in patients with a common cold. A placebo-controlled, randomised, double-blind clinical trial</TI>
<SO>Arzneimittel Forschung</SO>
<YR>2001</YR>
<VL>51</VL>
<NO>ii</NO>
<PG>563-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sperber-2004" MODIFIED="2013-05-24 13:47:11 +1000" MODIFIED_BY="[Empty name]" NAME="Sperber 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-05-24 13:47:11 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sperber SJ, Shah LP, Gilbert RD, Ritchey TW, Monto AS</AU>
<TI>Echinacea purpurea for prevention of experimental rhinovirus colds</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>2004</YR>
<VL>38</VL>
<PG>1367-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Taylor-2003" MODIFIED="2013-10-23 21:45:06 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Taylor 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-10-23 21:45:06 +1000" MODIFIED_BY="Jenny Bellorini" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Taylor JA, Weber W, Standish L, Quinn H, Goesling J, McGann M</AU>
<TI>Efficacy and safety of Echinacea in treating upper respiratory tract infections in children. A randomized controlled trial</TI>
<SO>JAMA</SO>
<YR>2003</YR>
<VL>290</VL>
<PG>2824-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-05-24 13:48:03 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weber W, Taylor JA, Van der Stoep A, Weiss NS, Standish LJ, Calabrese C</AU>
<TI>Echinacea purpurea for prevention of upper respiratory tract infections in children</TI>
<SO>Journal of Alternative and Complementary Medicine</SO>
<YR>2005</YR>
<VL>11</VL>
<NO>6</NO>
<PG>1021-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tiralongo-2012" MODIFIED="2013-05-21 18:31:00 +1000" MODIFIED_BY="[Empty name]" NAME="Tiralongo 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-05-21 18:31:00 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tiralongo E, Lea RA, Wee SS, Hanna MM, Griffiths LR</AU>
<TI>Randomised, double blind, placebo-controlled trial of Echinacea supplementation in air travellers</TI>
<SO>Evidence-Based Complementary and Alternative Medicine</SO>
<YR>2012</YR>
<VL>2012</VL>
<PG>1-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Turner-2000" MODIFIED="2012-12-14 20:46:33 +1000" MODIFIED_BY="[Empty name]" NAME="Turner 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-12-14 19:36:05 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Turner RB, Riker DK, Gangemi JD</AU>
<TI>Ineffectiveness of Echinacea for prevention of experimental rhinovirus colds</TI>
<SO>Antimicrobial Agents and Chemotherapy</SO>
<YR>2000</YR>
<VL>44</VL>
<PG>1708-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Turner-2005" MODIFIED="2013-05-21 18:31:21 +1000" MODIFIED_BY="[Empty name]" NAME="Turner 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-05-21 18:31:21 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Turner RB, Bauer R, Woelkart K, Hulsey TC, Gangemi D</AU>
<TI>An evaluation of Echinacea angustofolia in experimental rhinovirus infections</TI>
<SO>New England Journal of Medicine</SO>
<YR>2005</YR>
<VL>252</VL>
<PG>341-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Yale-2004" NAME="Yale 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yale SH, Liu K</AU>
<TI>Echinacea purpurea therapy for the treatment of the common cold. A randomized, double-blind, placebo-controlled clinical trial</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2004</YR>
<VL>164</VL>
<PG>1237-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Zhang-2003" MODIFIED="2013-05-24 13:48:56 +1000" MODIFIED_BY="[Empty name]" NAME="Zhang 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-05-24 13:48:56 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="UNPUBLISHED">
<AU>Zhang X, Lowe D, Badesha G, Ishaq S, Rai H, Williams P, et al</AU>
<TI>A double-blinded trial evaluating the effectiveness of Echinacea in countering upper respiratory tract infections</TI>
<SO>Unpublished report</SO>
<YR>2003</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-10-25 09:52:31 +1000" MODIFIED_BY="Jenny Bellorini">
<STUDY DATA_SOURCE="PUB" ID="STD-Baetgen-1984" NAME="Baetgen 1984" YEAR="1984">
<REFERENCE NOTES="&lt;p&gt;Baetgen D. Erfolge in der Keuchhusten-Behandlung mit Echinacin. Therapiewoche 1984;34:5115-5119.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baetgen D</AU>
<TO>Erfolge in der Keuchhusten-Behandlung mit Echinacin</TO>
<SO>Therapiewoche</SO>
<YR>1984</YR>
<VL>34</VL>
<PG>5115-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baetgen-1988" NAME="Baetgen 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baetgen D</AU>
<TO>Behandlung der akuten Bronchitis im Kindesalter</TO>
<SO>Therapiewoche Pädiatrie</SO>
<YR>1988</YR>
<VL>1</VL>
<PG>66-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bendel-1989" NAME="Bendel 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Bendel R, Bendel V, Renner K, Carstens V, Stolze K. Zusatzbehandlung mit Esberitox N bei Patientinnen mit chemo-strahlentherapeutischer Behandlung eines fortgeschrittenen Mammakarzinoms. Onkologie 1989; 12,3(suppl.):32-38.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bendel R, Bendel V, Renner K, Carstens V, Stolze K</AU>
<TO>Zusatzbehandlung mit Esberitox N bei Patientinnen mit chemo-strahlentherapeutischer Behandlung eines fortgeschrittenen Mammakarzinoms</TO>
<SO>Onkologie</SO>
<YR>1989</YR>
<VL>12</VL>
<NO>Suppl 3</NO>
<PG>32-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bendel-1990" NAME="Bendel 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Bendel R, Renner K, Stolze K. Zusatzbehandlung mit Esberitox bei Patientinnen mit kurativer adjuvanter Bestrahlung nach Mammakarzinom. Strahlentherapie und Onkologie 1988; 164,5:278-283.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bendel R, Renner K, Stolze K</AU>
<TO>Zusatzbehandlung mit Esberitox bei Patientinnen mit kurativer adjuvanter Bestrahlung nach Mammakarzinom</TO>
<SO>Strahlentherapie und Onkologie</SO>
<YR>1988</YR>
<VL>164</VL>
<NO>5</NO>
<PG>278-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Blumr_x00f6_der-1985" MODIFIED="2013-10-23 21:50:26 +1000" MODIFIED_BY="[Empty name]" NAME="Blumröder 1985" YEAR="1985">
<REFERENCE MODIFIED="2013-10-23 21:50:26 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Blumr&amp;#246;der WOv. Angina lacunaris - eine Untersuchung zum Thema &amp;quot;Steigerung der k&amp;#246;rpereigenen Abwehr&amp;quot;. Zeitschrift f&amp;#252;r Allgemeinmedizin 1985; 61,8:271-273.&lt;/p&gt;" NOTES_MODIFIED="2013-10-23 21:50:26 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Blumröder WOv</AU>
<TO>Angina lacunaris - eine Untersuchung zum Thema "Steigerung der körpereigenen Abwehr"</TO>
<SO>Zeitschrift für Allgemeinmedizin</SO>
<YR>1985</YR>
<VL>61</VL>
<NO>8</NO>
<PG>271-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coeugniet-1986" NAME="Coeugniet 1986" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;Coeugniet E, K&amp;#252;hnast R. Rezidivierende Candidiasis. Adjuvante Immuntherapie mit verschiedenen Echinacea-Darreichungsformen. Therapiewoche 1986; 36:3352-3358.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coeugniet E, Kühnast R</AU>
<TO>Rezidivierende Candidiasis. Adjuvante Immuntherapie mit verschiedenen Echinacea-Darreichungsformen</TO>
<SO>Therapiewoche</SO>
<YR>1986</YR>
<VL>36</VL>
<PG>3352-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cohen-2004" MODIFIED="2008-05-09 19:20:17 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Cohen 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-05-09 19:20:17 +1000" MODIFIED_BY="Jenny Bellorini" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cohen HA, Varsano I, Kahan E, Sarrell EM, Uziel Y</AU>
<TI>Effectiveness of an herbal preparation containing Echinacea, Propolis, and vitamin C in preventing respiratory tract infections in children. A randomized, double-blind, placebo-controlled, multicenter study</TI>
<SO>Archives of Pediatrics and Adolescent Medicine</SO>
<YR>2004</YR>
<VL>158</VL>
<PG>217-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cubasch-1992" NAME="Cubasch 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Cubasch H, Stocksmeier U. Deutliche Zunahme der T-Helferzellen. Therapiewoche 1992; 42:990-1000.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cubasch H, Stocksmeier U</AU>
<TO>Deutliche Zunahme der T-Helferzellen</TO>
<SO>Therapiewoche</SO>
<YR>1992</YR>
<VL>42</VL>
<PG>990-1000</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Di-Pierro-2012" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Di Pierro 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Di Pierro F, Rapacioli G, Ferrara T, Togni S</AU>
<TI>Use of a standardized extract from Echinacea angustofolia (Polinacea) for the prevention of respiratory tract infections</TI>
<SO>Alternative Medicine Review</SO>
<YR>2012</YR>
<VL>17</VL>
<PG>36-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Dorn-1989" NAME="Dorn 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Dorn M. Milderung grippaler Infekte durch ein pflanzliches Immunstimulans. Natur- und Ganzheitsmedizin 1989; 2:314-319.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dorn M</AU>
<TO>Milderung grippaler Infekte durch ein pflanzliches Immunstimulans</TO>
<SO>Natur- und Ganzheitsmedizin</SO>
<YR>1989</YR>
<VL>2</VL>
<PG>314-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ehringer-1968" NAME="Ehringer 1968" YEAR="1968">
<REFERENCE NOTES="&lt;p&gt;Ehringer H. Objektivierbare Venentonisierung nach oraler Gabe eines Kombinationspr&amp;#228;parates mit Ro&amp;#223;kastanienextrakt. Arzneim Forsch 1968;18:432-434.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ehringer H</AU>
<TO>Objektivierbare Venentonisierung nach oraler Gabe eines Kombinationspräparates mit Roßkastanienextrakt</TO>
<SO>Arzmeimittel-Forschung</SO>
<YR>1968</YR>
<VL>18</VL>
<PG>432-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Engel-1988" NAME="Engel 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Engel G. Behandlung grippaler Infekte mit einem hom&amp;#246;opathischen Komplexarzneimittel. Therapiewoche 1988;38:3586-3589.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Engel G</AU>
<TO>Behandlung grippaler Infekte mit einem homöopathischen Komplexarzneimittel</TO>
<SO>Therapiewoche</SO>
<YR>1988</YR>
<VL>38</VL>
<PG>3586-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Forth-1981" NAME="Forth 1981" YEAR="1981">
<REFERENCE NOTES="&lt;p&gt;Forth H, Beuscher N. Beeinflussung der H&amp;#228;ufigkeit banaler Erk&amp;#228;ltungsinfekte durch Esberitox. Zeitschrift f&amp;#252;r Allgemeinmedizin 1981; 57,32:2272-2275.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Forth H, Beuscher N</AU>
<TO>Beeinflussung der Häufigkeit banaler Erkältungsinfekte durch Esberitox</TO>
<SO>Zeitschrift für Allgemeinmedizin</SO>
<YR>1981</YR>
<VL>57</VL>
<NO>32</NO>
<PG>2272-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Freitag-1984" NAME="Freitag 1984" YEAR="1984">
<REFERENCE NOTES="&lt;p&gt;Freitag U, Stammwitz U. Reduzierte Krankheitsdauer bei Pertussis durch unspezifisches Immunstimulans. Der Kinderarzt 1984; 15:1068-1071.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Freitag U, Stammwitz U</AU>
<TO>Reduzierte Krankheitsdauer bei Pertussis durch unspezifisches Immunstimulans</TO>
<SO>Der Kinderarzt</SO>
<YR>1984</YR>
<VL>15</VL>
<PG>1068-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Freyer-1974" NAME="Freyer 1974" YEAR="1974">
<REFERENCE NOTES="&lt;p&gt;Freyer HU. H&amp;#228;ufigkeit banaler Infekte im Kindesalter und M&amp;#246;glichkeiten der Prophylaxe. Fortschr Med 1974; 92:165-168.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Freyer HU</AU>
<TO>Häufigkeit banaler Infekte im Kindesalter und Möglichkeiten der Prophylaxe</TO>
<SO>Fortschritte der Medizin</SO>
<YR>1974</YR>
<VL>92</VL>
<PG>165-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hauke-2002" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Hauke 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hauke W, Kohler G, Henneicke-von Zepelin HH, Freudenstein J</AU>
<TI>Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis) - A multicentric, prospective, double-blind, placebo-controlled study</TI>
<SO>Chemotherapy</SO>
<YR>2002</YR>
<VL>48</VL>
<NO>5</NO>
<PG>259-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heinen_x002d_Kammerer-2005" MODIFIED="2013-05-21 18:32:35 +1000" MODIFIED_BY="[Empty name]" NAME="Heinen-Kammerer 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-05-21 18:32:35 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heinen-Kammerer T, Holtmannspötter C, Schnabel S, Motzkat K, Kencke P, Rychlik R</AU>
<TI>Effectiveness of Echinacin in therapy of chronic recurrent respiratory disease</TI>
<TO>Nutzenbewertung der Therapie chronisch rezidivierender Atemwegsinfekte mit Echinacin</TO>
<SO>Das Gesundheitswesen</SO>
<YR>2005</YR>
<VL>67</VL>
<PG>296-301</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Helbig-1961" NAME="Helbig 1961" YEAR="1961">
<REFERENCE NOTES="&lt;p&gt;Helbig G. Unspezifische Reizk&amp;#246;rpertherapie zur Infektionsprophylaxe. Med Klin 1961; 56:1512-1514.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Helbig G</AU>
<TO>Unspezifische Reizkörpertherapie zur Infektionsprophylaxe</TO>
<SO>Medizinische Klinik</SO>
<YR>1961</YR>
<VL>56</VL>
<PG>1512-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Henneicke-1999" MODIFIED="2013-10-23 22:26:10 +1000" MODIFIED_BY="[Empty name]" NAME="Henneicke 1999" YEAR="1999">
<REFERENCE MODIFIED="2013-10-23 22:26:10 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Henneicke-von Zepelin HH, Hentschel C, Schnitker J, Kohnen R, Köhler G, Wüstenberg P</AU>
<TI>Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo controlled, multicentre study</TI>
<SO>Current Medical Research and Opinion</SO>
<YR>1999</YR>
<VL>15</VL>
<PG>214-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Henneicke-von-Zepelin HH, Hentschel C, Kohnen R, K&amp;#246;hler G, W&amp;#252;stenberg P. Plazebokontrollierte, randomisierte, doppelblinde, multizentrische klinische Pr&amp;#252;fung zur therapeutischen Wirksamkeit und Sicherheit von Esberitox N Tabletten bei Patienten mit akutem viralem Atemwegsinfekt (Erk&amp;#228;ltung). Abstractband, 8. Kongre&amp;#223; der Gesellschaft f&amp;#252;r Phytotherapie 1997, p 27.&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Henneicke-von-Zepelin HH, Hentschel C, Kohnen R, Köhler G, Wüstenberg P</AU>
<TO>Plazebokontrollierte, randomisierte, doppelblinde, multizentrische klinische Prüfung zur therapeutischen Wirksamkeit und Sicherheit von Esberitox N Tabletten bei Patienten mit akutem viralem Atemwegsinfekt (Erkältung)</TO>
<SO>Abstractband, 8. Kongreß der Gesellschaft für Phytotherapie</SO>
<YR>1997</YR>
<PG>27</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hill-1993" NAME="Hill 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Hill N, van Haselen RA. Clinical trial of a homeopathic insect after-bite treatment. HomInt R&amp;amp;D Newsletter 1993; 3/4:4-5.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hill N, van Haselen RA</AU>
<TI>Clinical trial of a homeopathic insect after-bite treatment</TI>
<SO>HomInt R&amp;D Newsletter</SO>
<YR>1993</YR>
<VL>3/4</VL>
<PG>4-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hill-1995" NAME="Hill 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Hill N, Stam C, Tuinder S, van Haselen RA. A placebo-controlled trial investigating the efficacy of a homeopathic after-bite gel in reducing mosquito-bite induced erythema. Eur J Clin Pharm 1995;49:103-108.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hill N, Stam C, Tuinder S, van Haselen RA</AU>
<TI>A placebo-controlled trial investigating the efficacy of a homeopathic after-bite gel in reducing mosquito-bite induced erythema</TI>
<SO>European Journal of Clinical Pharmacology</SO>
<YR>1995</YR>
<VL>49</VL>
<PG>103-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hill-1996" MODIFIED="2008-05-09 19:22:04 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Hill 1996" YEAR="1996">
<REFERENCE MODIFIED="2008-05-09 19:22:04 +1000" MODIFIED_BY="Jenny Bellorini" NOTES="&lt;p&gt;Hill N, Stam C, van Haselen RA. The efficacy of Prrrigweg gel in the treatment of insect bites: a double-blind, placebo-controlled clinical trial. Pharm World Sci 1996;18:35-41.&lt;/p&gt;" NOTES_MODIFIED="2008-05-09 19:22:04 +1000" NOTES_MODIFIED_BY="Jenny Bellorini" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hill N, Stam C, van Haselen RA</AU>
<TI>The efficacy of Prrrigweg gel in the treatment of insect bites: a double-blind, placebo-controlled clinical trial</TI>
<SO>Pharmacy World and Science</SO>
<YR>1996</YR>
<VL>18</VL>
<PG>35-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Isbaniah-2011" MODIFIED="2013-05-21 18:41:16 +1000" MODIFIED_BY="[Empty name]" NAME="Isbaniah 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-05-21 18:41:16 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Isbaniah F, Wiyono WH, Yunus F, Setiawati A, Totzke U, Verbruggen MA</AU>
<TI>Echinacea purpurea along with zinc, selenium and vitamin C to alleviate exacerbations of chronic obstructive pulmonary disease: Results from a randomized controlled trial</TI>
<SO>Journal of Clinical Pharmacy and Therapeutics</SO>
<YR>2011</YR>
<VL>36</VL>
<NO>5</NO>
<PG>568-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2002b" MODIFIED="2008-05-09 19:22:14 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Kim 2002b" YEAR="2002">
<REFERENCE MODIFIED="2008-05-09 19:22:14 +1000" MODIFIED_BY="Jenny Bellorini" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kim LS, Waters RF, Burkholder PM</AU>
<TI>Immunological activity of larch arabinogalactan and Echinacea: a preliminary, randomized, double-blind, placebo-controlled trial</TI>
<SO>Alternative Medicine Review</SO>
<YR>2002</YR>
<VL>7</VL>
<PG>138-49</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kleinschmidt-1965" NAME="Kleinschmidt 1965" YEAR="1965">
<REFERENCE NOTES="&lt;p&gt;Kleinschmidt H. Versuche zur Herabsetzung der Infektneigung bei Kleinkindern mit Esberitox. Therapie der Gegenwart 1965; 104,9:1258-1262.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kleinschmidt H</AU>
<TO>Versuche zur Herabsetzung der Infektneigung bei Kleinkindern mit Esberitox</TO>
<SO>Therapie der Gegenwart</SO>
<YR>1965</YR>
<VL>104</VL>
<NO>9</NO>
<PG>1258-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Melchart-1995a" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Melchart 1995a" YEAR="1995">
<REFERENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Jurcic K, Melchart D, Holzmann M, et al. Zwei Probandenstudien zur Stimulierung der Granulozytenphagozytose durch Echinacea-Extrakt-haltige Pr&amp;#228;parate. Z Phytother 1989; 10:67-70.&lt;/p&gt;" NOTES_MODIFIED="2013-10-23 22:59:43 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jurcic K, Melchart D, Holzmann M, et al</AU>
<TI>Zwei Probandenstudien zur Stimulierung der Granulozytenphagozytose durch Echinacea-Extrakt-haltige Präparate</TI>
<SO>Zeitschrift für Phytotherapie</SO>
<YR>1989</YR>
<VL>10</VL>
<PG>67-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Melchart D, Linde K, Worku F, et al. Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea. J Alternat Compl Med 1995; 1:145-160.&lt;/p&gt;" NOTES_MODIFIED="2013-10-23 22:59:43 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Melchart D, Linde K, Worku F, Sarkady L, Holzmann M, et al</AU>
<TI>Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea</TI>
<SO>Journal of Alternative and Complementary Medicine</SO>
<YR>1995</YR>
<VL>1</VL>
<PG>145-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Wagner H, Jurcic K, Doenicke A, Rosenhuber E, Behrens N. Die Beeinflussung der Phagozytosef&amp;#228;higkeit von Granulozyten durch hom&amp;#246;opathische Arzneipr&amp;#228;parate. In-vitro-Tests und kontrollierte Einfachblindstudien. Arzneim-Forsch 1986;36(II):1421-1425.&lt;/p&gt;" NOTES_MODIFIED="2013-10-23 22:59:43 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wagner H, Jurcic K, Doenicke A, Rosenhuber E, Behrens N</AU>
<TO>Die Beeinflussung der Phagozytosefähigkeit von Granulozyten durch homöopathische Arzneipräparate. In-vitro-Tests und kontrollierte Einfachblindstudien</TO>
<SO>Arzneimittel Forschung</SO>
<YR>1986</YR>
<VL>36</VL>
<NO>II</NO>
<PG>1421-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Melchart-1995b" MODIFIED="2013-10-25 09:52:31 +1000" MODIFIED_BY="[Empty name]" NAME="Melchart 1995b" YEAR="1995">
<REFERENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Jurcic K, Melchart D, Holzmann M, et al. Zwei Probandenstudien zur Stimulierung der Granulozytenphagozytose durch Echinacea-Extrakt-haltige Pr&amp;#228;parate. Z Phytother 1989; 10:67-70.&lt;/p&gt;" NOTES_MODIFIED="2013-10-23 22:59:43 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jurcic K, Melchart D, Holzmann M, et al</AU>
<TO>Zwei Probandenstudien zur Stimulierung der Granulozytenphagozytose durch Echinacea-Extrakt-haltige Präparate</TO>
<SO>Zeitschrift für Phytotherapie</SO>
<YR>1989</YR>
<VL>10</VL>
<PG>67-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-10-25 09:52:31 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Melchart D, Linde K, Worku F, et al. Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea. J Alternat Compl Med 1995; 1:145-160.&lt;/p&gt;" NOTES_MODIFIED="2013-10-25 09:52:31 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Melchart D, Linde K, Worku F, Sarkady L, Holzmann M, et al</AU>
<TI>Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea</TI>
<SO>Journal of Alternative and Complementary Medicine</SO>
<YR>1995</YR>
<VL>1</VL>
<PG>145-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Melchart-1995c" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Melchart 1995c" YEAR="1995">
<REFERENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Melchart D, Linde K, Worku F, et al. Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea. J Alternat Compl Med 1995; 1:145-160.&lt;/p&gt;" NOTES_MODIFIED="2013-10-23 22:59:43 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Melchart D, Linde K, Worku F, Sarkady L, Holzmann M, et al</AU>
<TI>Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea</TI>
<SO>Journal of Alternative and Complementary Medicine</SO>
<YR>1995</YR>
<VL>1</VL>
<PG>145-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Melchart-1995d" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Melchart 1995d" YEAR="1995">
<REFERENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Melchart D, Linde K, Worku F, et al. Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea. J Alternat Compl Med 1995; 1:145-160.&lt;/p&gt;" NOTES_MODIFIED="2013-10-23 22:59:43 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Melchart D, Linde K, Worku F, Sarkady L, Holzmann M, et al</AU>
<TI>Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea</TI>
<SO>Journal of Alternative and Complementary Medicine</SO>
<YR>1995</YR>
<VL>1</VL>
<PG>145-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Melchart-1995e" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Melchart 1995e" YEAR="1995">
<REFERENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Melchart D, Linde K, Worku F, et al. Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea. J Alternat Compl Med 1995; 1:145-160.&lt;/p&gt;" NOTES_MODIFIED="2013-10-23 22:59:43 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Melchart D, Linde K, Worku F, Sarkady L, Holzmann M, et al</AU>
<TI>Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea</TI>
<SO>Journal of Alternative and Complementary Medicine</SO>
<YR>1995</YR>
<VL>1</VL>
<PG>145-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Minetti-2011" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Minetti 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Minetti AM, Forti S, Tassone G, Torretta S, Pignataro L</AU>
<TI>Efficacy of complex herbal compound of Echinacea angustofolia (Imoviral<SUP>TM </SUP>Junior) in recurrent upper respiratory tract infections during pediatric age: preliminary results</TI>
<SO>Minerva Pediatrica</SO>
<YR>2011</YR>
<VL>63</VL>
<PG>177-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Narimanian-2005" MODIFIED="2013-06-18 17:33:20 +1000" MODIFIED_BY="[Empty name]" NAME="Narimanian 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-06-18 17:33:20 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Narimanian M, Badalyan M, Panosyan V, Gabrielyan E, Panossian A, Wikmann A, et al</AU>
<TI>Randomized trial of a fixed combination (KanJang) of herbal extracts containing Adhatoda vasica, Echinacea purpurea and Eleutherococcus senticosus in patients with upper respiratory tract infections</TI>
<SO>Phytomedicine</SO>
<YR>2005</YR>
<VL>12</VL>
<PG>539-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Naser-2005" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Naser 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Naser B, Lund B, Henneicke-von Zepelin HH, Köhler G, Lehmacher W, Scaglione F</AU>
<TI>A randomized, double-blind, placebo controlled clinical dose-response trial of an extract of Baptista, Echinacea and Thuja for the treatment of patients with common cold</TI>
<SO>Phytomedicine</SO>
<YR>2005</YR>
<VL>12</VL>
<PG>715-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pohl-1970" NAME="Pohl 1970" YEAR="1970">
<REFERENCE NOTES="&lt;p&gt;Pohl P. Zur Therapie der strahlenbedingten Leukopenie mit Esberitox. Therapie der Gegenwart 1970; 109,6:902-906.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pohl P</AU>
<TI>Zur Therapie der strahlenbedingten Leukopenie mit Esberitox</TI>
<SO>Therapie der Gegenwart</SO>
<YR>1970</YR>
<VL>109</VL>
<NO>6</NO>
<PG>902-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Quadripur-1976" MODIFIED="2013-10-24 00:49:02 +1000" MODIFIED_BY="[Empty name]" NAME="Quadripur 1976" YEAR="1976">
<REFERENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Quadripur SA. Medikament&amp;#246;se Beeinflussung der Phagozytosef&amp;#228;higkeit der Granulozyten. Therapie der Gegenwart 1976; 115,6:1072-1078.&lt;/p&gt;" NOTES_MODIFIED="2013-10-23 22:59:43 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Quadripur SA</AU>
<TO>Medikamentöse Beeinflussung der Phagozytosefähigkeit der Granulozyten</TO>
<SO>Therapie der Gegenwart</SO>
<YR>1976</YR>
<VL>115</VL>
<NO>6</NO>
<PG>1072-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Reitz-1990" NAME="Reitz 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Reitz HD. Immunmodulatoren mit pflanzlichen Wirkstoffen. 2. Teil: eine wissenschaftliche Studie am Beispiel Esberitox N. notabene medici 1990; 20:362-366.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reitz HD</AU>
<TO>Immunmodulatoren mit pflanzlichen Wirkstoffen. 2. Teil: eine wissenschaftliche Studie am Beispiel Esberitox N</TO>
<SO>Notabene Medici</SO>
<YR>1990</YR>
<VL>20</VL>
<PG>362-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sartor-1972" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Sartor 1972" YEAR="1972">
<REFERENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Sartor KJ. Zur Wirksamkeit von Esberitox in der Behandlung strahlenbedingter Leukopenien. Therapie der Gegenwart 1972; 111,8:1147-1150.&lt;/p&gt;" NOTES_MODIFIED="2013-10-23 22:59:43 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sartor KJ</AU>
<TO>Zur Wirksamkeit von Esberitox in der Behandlung strahlenbedingter Leukopenien</TO>
<SO>Therapie der Gegenwart</SO>
<YR>1972</YR>
<VL>111</VL>
<NO>8</NO>
<PG>1147-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Saunders-2007" MODIFIED="2013-06-18 17:36:51 +1000" MODIFIED_BY="[Empty name]" NAME="Saunders 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-18 17:36:51 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Saunders PR, Smith F, Schusky RW</AU>
<TI>Echinacea purpurea L. in children: safety, tolerability, compliance, and clinical effectiveness in upper respiratory tract infections</TI>
<SO>Canadian Journal of Physiology and Pharmacology</SO>
<YR>2007</YR>
<VL>85</VL>
<PG>1195-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scaglione-1995" NAME="Scaglione 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Scaglione F, Lund B. Efficacy in the treatment of the common cold of a preparation containing an Echinacea extract. Int J Immunotherapy 1995; 6:163-166.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Scaglione F, Lund B</AU>
<TI>Efficacy in the treatment of the common cold of a preparation containing an Echinacea extract</TI>
<SO>International Journal of Immunotherapy</SO>
<YR>1995</YR>
<VL>6</VL>
<PG>163-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schapowal-2009" MODIFIED="2013-10-23 22:36:06 +1000" MODIFIED_BY="[Empty name]" NAME="Schapowal 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-10-23 22:36:06 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schapowal A, Berger D, Klein P, Suter A</AU>
<TI>Echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial</TI>
<SO>European Journal of Medical Research</SO>
<YR>2009</YR>
<VL>14</VL>
<PG>406-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schmidt-1990" NAME="Schmidt 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Schmidt U, Albrecht M, Schenk N. Pflanzliches Immunstimulans senkt H&amp;#228;ufigkeit grippaler Infekte. Plazebokontrollierte Doppelblindstudie mit einem kombinierten Echinacea-Pr&amp;#228;parat mit 646 Studenten der K&amp;#246;lner Universit&amp;#228;t. Natur- und Ganzheitsmedizin 1990; 3,9:277-281.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schmidt U, Albrecht M, Schenk N</AU>
<TO>Pflanzliches Immunstimulans senkt Häufigkeit grippaler Infekte. Plazebokontrollierte Doppelblindstudie mit einem kombinierten Echinacea-Präparat mit 646 Studenten der Kölner Universität</TO>
<SO>Natur- und Ganzheitsmedizin</SO>
<YR>1990</YR>
<VL>3</VL>
<NO>9</NO>
<PG>277-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schoop-2006a" MODIFIED="2013-05-24 13:53:21 +1000" MODIFIED_BY="[Empty name]" NAME="Schoop 2006a" YEAR="2006">
<REFERENCE MODIFIED="2013-05-24 13:53:21 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schoop R, Büechi S, Suter A</AU>
<TI>Open, multicenter study to evaluate the tolerability and efficacy of Echinaforce forte tablets in athletes</TI>
<SO>Advances in Therapy</SO>
<YR>2006</YR>
<VL>23</VL>
<PG>823-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schwarz-2002" MODIFIED="2013-10-23 22:36:22 +1000" MODIFIED_BY="[Empty name]" NAME="Schwarz 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-10-23 22:36:22 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schwarz E, Metzler J, Diedrich JP, Freudenstein J, Bode C, Bode JC</AU>
<TI>Oral administration of freshly expressed juice of Echinacea purpurea herbs fail to stimulate the non-specific immune response in healthy young men: results of a double-blind, placebo-controlled crossover study</TI>
<SO>Journal of Immunology</SO>
<YR>2002</YR>
<VL>25</VL>
<PG>413-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Spasov-2004" MODIFIED="2012-12-11 18:33:15 +1000" MODIFIED_BY="[Empty name]" NAME="Spasov 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-12-11 18:33:15 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Spasov AA, Ostrovskij OV, Chernikov MV, Wikman G</AU>
<TI>Comparative controlled study of Andrographis paniculata fixed combination, Kan Jang and an Echinacea preparation as adjuvant, in the treatment of uncomplicated respiratory disease in children</TI>
<SO>Phytotherapy Research</SO>
<YR>2004</YR>
<VL>18</VL>
<PG>47-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stolze-1986" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Stolze 1986" YEAR="1986">
<REFERENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Stolze H, Forth H. Eine Antibiotikabehandlung kann durch zus&amp;#228;tzliche Immunstimulierung optimiert werden. Der Kassenarzt 1983; 23:43-48.&lt;/p&gt;" NOTES_MODIFIED="2013-10-23 22:59:43 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stolze H, Forth H</AU>
<TO>Eine Antibiotikabehandlung kann durch zusätzliche Immunstimulierung optimiert werden</TO>
<SO>Der Kassenarzt</SO>
<YR>1983</YR>
<VL>23</VL>
<PG>43-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thom-1997" NAME="Thom 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thom E, Wollan T</AU>
<TI>A controlled clinical study of Kanjang mixture in the treatment of uncomplicated upper respiratory tract infections</TI>
<SO>Phytotherapy Research</SO>
<YR>1997</YR>
<VL>11</VL>
<PG>207-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Timmermanns-1990" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Timmermanns 1990" YEAR="1990">
<REFERENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Timmermanns LM, Timmermanns LG. Mesure de l'activit&amp;#233; des extraits d'Echinaceae et de Sabal dans le traitement des m&amp;#233;gavessies idiopathiques chez la femme. Acta Urol Belg 1990; 58,2:43-59.&lt;/p&gt;" NOTES_MODIFIED="2013-10-23 22:59:43 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Timmermanns LM, Timmermanns LG</AU>
<TO>Mesure de l'activité des extraits d'Echinaceae et de Sabal dans le traitement des mégavessies idiopathiques chez la femme</TO>
<SO>Acta Urologica Belgica</SO>
<YR>1990</YR>
<VL>58</VL>
<NO>2</NO>
<PG>43-59</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vonau-2001" MODIFIED="2008-05-09 19:22:36 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Vonau 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-05-09 19:22:36 +1000" MODIFIED_BY="Jenny Bellorini" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vonau B, Chard S, Mandalia S, Wilkinson D, Barton SE</AU>
<TI>Does the extract of the plant Echinacea purpurea influence the clinical course of recurrent genital herpes</TI>
<SO>International Journal of STD and AIDS</SO>
<YR>2001</YR>
<VL>12</VL>
<PG>154-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vorberg-1984" NAME="Vorberg 1984" YEAR="1984">
<REFERENCE NOTES="&lt;p&gt;Vorberg G. Bei Erk&amp;#228;ltung unspezifische Immunabwehr stimulieren. &amp;#196;rztliche Praxis 1984; 36:97-98.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vorberg G</AU>
<TO>Bei Erkältung unspezifische Immunabwehr stimulieren</TO>
<SO>Ärztliche Praxis</SO>
<YR>1984</YR>
<VL>36</VL>
<PG>97-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Vorberg-1989" NAME="Vorberg 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Vorberg G, Schneider B. Pflanzliches Immunstimulans verk&amp;#252;rzt grippalen Infekt. Doppelblindstudie belegt die Steigerung der unspezifischen Infektabwehr. &amp;#196;rztl Forsch 1989; 36:3-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vorberg G, Schneider B</AU>
<TO>Pflanzliches Immunstimulans verkürzt grippalen Infekt. Doppelblindstudie belegt die Steigerung der unspezifischen Infektabwehr</TO>
<SO>Arzmeimittel-Forschung</SO>
<YR>1989</YR>
<VL>36</VL>
<PG>3-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wahl-2008" MODIFIED="2012-12-19 20:47:09 +1000" MODIFIED_BY="[Empty name]" NAME="Wahl 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-12-19 20:47:06 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wahl RA, Aldous MB, Worden KA, Grant KL</AU>
<TI>Echinacea purpurea and osteopathic manipulative treatment in children with recurrent otitis media: a randomized controlled trial</TI>
<SO>BMC Complementary and Alternative Medicine</SO>
<YR>2008</YR>
<VL>8</VL>
<PG>1-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yakoot-2011" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Yakoot 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yakoot M, Salem A</AU>
<TI>Efficacy and safety of a multiherbal formula with vitamin C and zinc (Immumax) in the management of the common cold</TI>
<SO>International Journal of General Medicine</SO>
<YR>2011</YR>
<VL>4</VL>
<PG>45-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zimmer-1985" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Zimmer 1985" YEAR="1985">
<REFERENCE MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Zimmer M. Gezielte konservative Therapie der akuten Sinusitis in der HNO-Praxis. Therapiewoche 1985; 35,36:4024-4028.&lt;/p&gt;" NOTES_MODIFIED="2013-10-23 22:59:43 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zimmer M</AU>
<TO>Gezielte konservative Therapie der akuten Sinusitis in der HNO-Praxis</TO>
<SO>Therapiewoche</SO>
<YR>1985</YR>
<VL>35</VL>
<NO>36</NO>
<PG>4024-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2013-06-26 15:11:40 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Rahmati-2012" MODIFIED="2013-06-26 15:11:40 +1000" MODIFIED_BY="[Empty name]" NAME="Rahmati 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-06-26 15:11:40 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rahmati MB, Fatemeh S, Hamedi Y, Khadem AA, Rezai MS</AU>
<TI>Efficacy and safety of echinacea root extracts in the treatment ot pediatric common cold: a randomized clinical trial</TI>
<TO>&#64509;&#64404;&#1583;&#1585;&#65262;&#65191;&#65166;&#65251;&#65198;&#65203; &#1606;&#65166;&#65251;&#1585;&#1583; &#1585;&#1583; &#65258;&#65203;&#65166;&#65256;&#64511;&#64400;&#1575; &#65258;&#65208;&#64510;&#1585; &#1607;&#65198;&#64511;&#65207; &#1590;&#1585;&#1575;&#65262;&#65227; &#1608; &#64509;&#65208;&#65192;&#65169; &#65198;&#65179;&#1575;&#1585;&#1583; &#1606;&#65166;&#64400;&#1583;&#65262;&#64400; : &#1607;&#65194;&#65207; &#64509;&#65235;&#1583;&#65166;&#65212;&#65175; &#64509;&#65256;&#64511;&#65247;&#65166;&#65169; &#64509;&#65163;&#65166;&#65251;&#1586;&#1570;&#1585;&#65166;&#64400; &#65258;&#65228;&#65247;&#65166;&#65220;&#65251; &#64399;&#64510;</TO>
<SO>Journal of Mazandaran University of Medical Sciences</SO>
<YR>2012</YR>
<VL>22</VL>
<NO>93</NO>
<PG>12-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Altamirano_x002d_Dimas-2007" MODIFIED="2013-05-21 18:44:22 +1000" MODIFIED_BY="[Empty name]" NAME="Altamirano-Dimas 2007" TYPE="JOURNAL_ARTICLE">
<AU>Altamirano-Dimas M, Hudson JB, Cochrane D, Nelson C, Arnason JT</AU>
<TI>Modulation of immune response gene expression by echinacea extracts: results of a gene array analysis</TI>
<SO>Canadian Journal of Physiology and Pharmacology</SO>
<YR>2007</YR>
<VL>85</VL>
<NO>11</NO>
<PG>1091-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Barrett-1999" NAME="Barrett 1999" TYPE="JOURNAL_ARTICLE">
<AU>Barrett B, Vohmann M, Calabrese C</AU>
<TI>Echinacea for upper respiratory tract infection</TI>
<SO>Journal of Family Practice</SO>
<YR>1999</YR>
<VL>48</VL>
<PG>628-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Barrett-2003" NAME="Barrett 2003" TYPE="JOURNAL_ARTICLE">
<AU>Barrett B</AU>
<TI>Medicinal properties of Echinacea</TI>
<SO>Phytomedicine</SO>
<YR>2003</YR>
<VL>10</VL>
<PG>66-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bauer-1989" NAME="Bauer 1989" TYPE="JOURNAL_ARTICLE">
<AU>Bauer R, Remiger P, Jurcic K, Wagner H</AU>
<TI>Effect of extracts of Echinacea on phagocytic activity</TI>
<TO>Beeinflussung der Phagozytoseaktivität durch Echinacea-Extrakte</TO>
<SO>Zeitschrift für Phytotherapie</SO>
<YR>1989</YR>
<VL>10</VL>
<PG>43-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Birt-2008" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Birt 2008" TYPE="JOURNAL_ARTICLE">
<AU>Birt DF, Widrlechner MP, Lalone CA, Wu L, Bae J, Solco AKS, et al</AU>
<TI>Echinacea in infection</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2008</YR>
<VL>87</VL>
<NO>Suppl 2</NO>
<PG>488-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Blumenthal-2005" NAME="Blumenthal 2005" NOTES="&lt;p&gt;[Blumenthal 2005 - is this the full journal title? - Yes, this is the full title. Blumenthal 2005 is now published, too - Herbal Gram 2005;66:63&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Blumenthal M</AU>
<TI>Herb sales down 6 percent in mainstream market</TI>
<SO>Herbal Gram</SO>
<YR>2005</YR>
<VL>66</VL>
<PG>63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bodinet-2002" NAME="Bodinet 2002" TYPE="JOURNAL_ARTICLE">
<AU>Bodinet C, Mentel R, Wegner U, Lindequist U, Teuscher E, Freudenstein J</AU>
<TI>Effect of oral application of an immunomodulating plant extract on influenza virus type A infection in mice</TI>
<SO>Planta Medica</SO>
<YR>2002</YR>
<VL>68</VL>
<PG>896-900</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Caruso-2005" MODIFIED="2013-10-23 22:39:06 +1000" MODIFIED_BY="[Empty name]" NAME="Caruso 2005" TYPE="JOURNAL_ARTICLE">
<AU>Caruso TJ, Gwaltney JM Jr</AU>
<TI>Treatment of the common cold with Echinacea: a structured review</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>2005</YR>
<VL>40</VL>
<PG>807-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chavez-2007" MODIFIED="2013-05-21 18:44:56 +1000" MODIFIED_BY="[Empty name]" NAME="Chavez 2007" TYPE="JOURNAL_ARTICLE">
<AU>Chavez M, Chacon M, Badilla B, Arevalo C</AU>
<TI>Effect of Echinacea purpurea (Asteraceae) aqueous extract on antibody response to Bothrops asper venom and immune cell response.</TI>
<SO>Revista de Biologia Tropical</SO>
<YR>2007</YR>
<VL>55</VL>
<NO>1</NO>
<PG>113-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chicca-2009" MODIFIED="2013-05-24 14:00:04 +1000" MODIFIED_BY="[Empty name]" NAME="Chicca 2009" TYPE="JOURNAL_ARTICLE">
<AU>Chicca A, Raduner S, Pellati F, Strompen T, Altmann KH, Schoop R, et al</AU>
<TI>Synergistic immunopharmacological effects of N-alkamides in Echinacea purpurea herbal extracts</TI>
<SO>International Immunopharmacology</SO>
<YR>2009</YR>
<VL>9</VL>
<NO>7-8</NO>
<PG>850-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Denny-1995" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Denny 1995" TYPE="JOURNAL_ARTICLE">
<AU>Denny FW Jr</AU>
<TI>The clinical impact of human respiratory virus infections</TI>
<SO>American Journal of Respiratory Critical Care Medicine</SO>
<YR>1995</YR>
<VL>152</VL>
<NO>4 Pt 2</NO>
<PG>S4-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dickersin-1994" MODIFIED="2013-10-23 22:41:03 +1000" MODIFIED_BY="[Empty name]" NAME="Dickersin 1994" NOTES="&lt;p&gt;Dickersin 1994. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994; 309:1286-91.&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2013-10-23 22:41:03 +1000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Dickersin K, Scherer R, Lefebvre C</AU>
<TI>Identifying relevant studies for systematic reviews</TI>
<SO>BMJ</SO>
<YR>1994</YR>
<VL>309</VL>
<PG>1286-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Eccles-2002" MODIFIED="2013-10-23 22:41:17 +1000" MODIFIED_BY="[Empty name]" NAME="Eccles 2002" TYPE="JOURNAL_ARTICLE">
<AU>Eccles R</AU>
<TI>An explanation for the seasonality of acute respiratory tract viral infections</TI>
<SO>Acta Oto-Laryngologica</SO>
<YR>2002</YR>
<VL>122</VL>
<PG>183-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fendrick-2003" MODIFIED="2013-05-24 14:02:31 +1000" MODIFIED_BY="[Empty name]" NAME="Fendrick 2003" TYPE="JOURNAL_ARTICLE">
<AU>Fendrick AM, Monto AS, Nightengale B, Sarnes M</AU>
<TI>The economic burden of non-influenza-related viral respiratory tract infection in the United States</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2003</YR>
<VL>163</VL>
<PG>487-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fergusson-2004" MODIFIED="2013-10-23 22:41:34 +1000" MODIFIED_BY="[Empty name]" NAME="Fergusson 2004" TYPE="JOURNAL_ARTICLE">
<AU>Fergusson D, Glass KC, Waring D, Shapiro S</AU>
<TI>Turning a blind eye: The success of blinding reported in a random sample of randomised, placebo controlled trials</TI>
<SO>BMJ</SO>
<YR>2004</YR>
<VL>328</VL>
<PG>432-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gertsch-2004" NAME="Gertsch 2004" TYPE="JOURNAL_ARTICLE">
<AU>Gertsch J, Schoop R, Kuenzle U, Suter A</AU>
<TI>Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways</TI>
<SO>FEBS Letters</SO>
<YR>2004</YR>
<VL>577</VL>
<PG>563-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ghaemi-2009" MODIFIED="2013-04-23 19:33:59 +1000" MODIFIED_BY="[Empty name]" NAME="Ghaemi 2009" TYPE="JOURNAL_ARTICLE">
<AU>Ghaemi A, Soleimanjahi H, Gill P, Arefian E, Soudi S, Hassan Z</AU>
<TI>Echinacea purpurea polysaccharide reduces the latency rate in herpes simples virus type-1 infections</TI>
<SO>Intervirology</SO>
<YR>2009</YR>
<VL>52</VL>
<NO>1</NO>
<PG>29-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gilroy-2003" NAME="Gilroy 2003" TYPE="JOURNAL_ARTICLE">
<AU>Gilroy CM, Steiner JF, Byers T, Shapiro H, Georgian W</AU>
<TI>Echinacea and truth in labeling</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2003</YR>
<VL>163</VL>
<PG>699-704</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guppy-2011" MODIFIED="2013-10-11 20:52:49 +1000" MODIFIED_BY="[Empty name]" NAME="Guppy 2011" TYPE="COCHRANE_REVIEW">
<AU>Guppy MPB, Mickan SM, Del Mar CB, Thorning S, Rack A</AU>
<TI>Advising patients to increase fluid intake for treating acute respiratory infections</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2013-10-11 20:52:49 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-10-11 20:52:49 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004419.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Gurbuz-2010" MODIFIED="2013-05-24 14:03:27 +1000" MODIFIED_BY="[Empty name]" NAME="Gurbuz 2010" TYPE="JOURNAL_ARTICLE">
<AU>Gurbuz E, Balevi T, Kurtoglu V, Coskun B, Oznurlu Y, Kan Y, et al</AU>
<TI>Effects of Echinacea extract on the performance, antibody titres, and intestinal histology of layer chicks</TI>
<SO>British Poultry Science</SO>
<YR>2010</YR>
<VL>51</VL>
<NO>6</NO>
<PG>805-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hajos-2012" MODIFIED="2013-05-24 14:03:47 +1000" MODIFIED_BY="[Empty name]" NAME="Hajos 2012" TYPE="JOURNAL_ARTICLE">
<AU>Hajos N, Holderith N, Nemeth B, Papp OI, Szabo GG, Zemankovics R, et al</AU>
<TI>The effects of an Echinacea preparation on synaptic transmission and the firing properties of CA1 pyramidal cells in the hippocampus</TI>
<SO>Phytotherapy Research</SO>
<YR>2012</YR>
<VL>26</VL>
<NO>3</NO>
<PG>354-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Haller-2013" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Haller 2013" TYPE="JOURNAL_ARTICLE">
<AU>Haller J, Freund TF, Pelczer KG, Furedi J, Krecsak L, Zambori J</AU>
<TI>The anxiolytic potential and psychotropic side effects of an echinacea preparation in laboratory animals and healthy volunteers</TI>
<SO>Phytotherapy Research</SO>
<YR>2013</YR>
<VL>27</VL>
<NO>1</NO>
<PG>54-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hao-2011" MODIFIED="2013-10-11 21:21:47 +1000" MODIFIED_BY="[Empty name]" NAME="Hao 2011" TYPE="COCHRANE_REVIEW">
<AU>Hao Q, Lu Z, Dong BR, Huang CQ, Wu T</AU>
<TI>Probiotics for preventing acute upper respiratory tract infections</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>9</NO>
<IDENTIFIERS MODIFIED="2013-10-11 21:21:47 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-10-11 21:21:47 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006895.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-2013" MODIFIED="2013-10-11 20:54:05 +1000" MODIFIED_BY="[Empty name]" NAME="Hemilä 2013" TYPE="COCHRANE_REVIEW">
<AU>Hemilä H, Chalker E</AU>
<TI>Vitamin C for preventing and treating the common cold</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2013-10-11 20:54:05 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-10-11 20:54:05 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000980.pub4"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2013-10-23 22:42:41 +1000" MODIFIED_BY="[Empty name]" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011a" MODIFIED="2013-06-26 15:13:49 +1000" MODIFIED_BY="[Empty name]" NAME="Higgins 2011a" TYPE="BOOK_SECTION">
<AU>Higgins JPT, Deeks JJ (editors)</AU>
<TI>Chapter 7: Selecting studies and collecting data</TI>
<SO>Cochrane Handbook for Systematic Reviews of Interventions</SO>
<YR>2011</YR>
<EN>5.0.1</EN>
<ED>Higgins JPT, Green S</ED>
<PB>Wiley-Blackwell</PB>
<CY>Chichester, UK</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011b" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Higgins 2011b" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Altman DG, Gotzsche PC, Jüni P, Moher D Oxman AD, et al</AU>
<TI>The Cochrane Collaboration' stool for assessing risk of bias in randomised trials</TI>
<SO>BMJ</SO>
<YR>2011</YR>
<VL>343</VL>
<NO>d5928</NO>
<PG>1-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Huntley-2005" NAME="Huntley 2005" TYPE="JOURNAL_ARTICLE">
<AU>Huntley A, Coon JT, Ernst E</AU>
<TI>The safety of herbal medicine products derived from Echinacea species. A systematic review</TI>
<SO>Drug Safety</SO>
<YR>2005</YR>
<VL>28</VL>
<PG>387-400</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kassel-2010" MODIFIED="2013-10-11 20:53:07 +1000" MODIFIED_BY="[Empty name]" NAME="Kassel 2010" TYPE="COCHRANE_REVIEW">
<AU>Kassel JC, King D, Spurling GKP</AU>
<TI>Saline nasal irrigation for acute upper respiratory tract infections</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>10</NO>
<IDENTIFIERS MODIFIED="2013-10-11 20:53:07 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-10-11 20:53:07 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006821.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lalone-2009" MODIFIED="2013-05-24 14:04:20 +1000" MODIFIED_BY="[Empty name]" NAME="Lalone 2009" TYPE="JOURNAL_ARTICLE">
<AU>Lalone CA, Rizshsky L, Hammer KD, Wu L, Solco AK, Yum M, et al</AU>
<TI>Endogeneous levels of Echinacea alkylamides and ketones are important contributors to the inhibition of prostaglandin E2 and nitric oxide production in cultured macrophages</TI>
<SO>Journal of Agricultural and Food Chemistry</SO>
<YR>2009</YR>
<VL>57</VL>
<NO>19</NO>
<PG>8820-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lefebvre-2011" MODIFIED="2013-05-24 14:05:07 +1000" MODIFIED_BY="[Empty name]" NAME="Lefebvre 2011" TYPE="BOOK_SECTION">
<AU>Lefebvre C, Manheimer E, Glanville J</AU>
<TI>Chapter 6: Searching for studies</TI>
<SO>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Available from www.cochrane-handbook.org</SO>
<YR>2011</YR>
<ED>Higgins JPT, Green S</ED>
<PB>Wiley-Blackwell</PB>
<CY>Chichester, UK</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lissiman-2012" MODIFIED="2013-10-11 21:00:20 +1000" MODIFIED_BY="[Empty name]" NAME="Lissiman 2012" TYPE="COCHRANE_REVIEW">
<AU>Lissiman E, Bhasale AL, Cohen M</AU>
<TI>Garlic for the common cold</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2013-10-11 21:00:20 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-10-11 21:00:20 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006206.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Matthias-2005" MODIFIED="2013-10-23 22:43:42 +1000" MODIFIED_BY="[Empty name]" NAME="Matthias 2005" TYPE="JOURNAL_ARTICLE">
<AU>Matthias A, Addison RS, Penman KG, Dickinson RG, Bone KM, Lehmann RP</AU>
<TI>Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion</TI>
<SO>Life Sciences</SO>
<YR>2005</YR>
<VL>77</VL>
<NO>16</NO>
<PG>2018-29</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Matthias-2008" MODIFIED="2013-05-21 18:46:03 +1000" MODIFIED_BY="[Empty name]" NAME="Matthias 2008" TYPE="JOURNAL_ARTICLE">
<AU>Matthias A, Banbury L, Bone KM, Leach DN, Lehman RP</AU>
<TI>Echinacea alkamides modulate induced immune responses in T-cells</TI>
<SO>Fitoterapia</SO>
<YR>2008</YR>
<VL>79</VL>
<NO>1</NO>
<PG>53-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Melchart-1994" NAME="Melchart 1994" TYPE="JOURNAL_ARTICLE">
<AU>Melchart D, Linde K, Worku F, Bauer R, Wagner H</AU>
<TI>Immunomodulation with Echinacea - a systematic review of controlled clinical trials</TI>
<SO>Phytomedicine</SO>
<YR>1994</YR>
<VL>1</VL>
<PG>245-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Monto-1987" MODIFIED="2013-10-23 22:43:57 +1000" MODIFIED_BY="[Empty name]" NAME="Monto 1987" TYPE="JOURNAL_ARTICLE">
<AU>Monto AS, Bryan ER, Ohmit S</AU>
<TI>Rhinovirus infections in Tecimseh Michigan: frequency of illness and number of serotypes</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1987</YR>
<VL>156</VL>
<PG>43-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mullins-2002" MODIFIED="2013-04-23 17:46:35 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Mullins 2002" TYPE="JOURNAL_ARTICLE">
<AU>Mullins RJ, Heddle R</AU>
<TI>Adverse reactions associated with Echinacea: the Australian experience</TI>
<SO>Annals of Allergy, Asthma &amp; Immunology</SO>
<YR>2002</YR>
<VL>88</VL>
<PG>42-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-M_x00fc_ller_x002d_Jakic-1994" NAME="Müller-Jakic 1994" TYPE="JOURNAL_ARTICLE">
<AU>Müller-Jakic B, Breu W, Probstle A, Redl K, Greger H, Bauer R</AU>
<TI>In vitro inhibition of cyclooxygenase and 5-lipoxygenase by alkamides from Echinacea and Achillea species</TI>
<SO>Planta Medica</SO>
<YR>1994</YR>
<VL>60</VL>
<PG>37-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Qiang-2013" MODIFIED="2013-05-24 14:06:53 +1000" MODIFIED_BY="[Empty name]" NAME="Qiang 2013" TYPE="JOURNAL_ARTICLE">
<AU>Qiang Z, Hauck C, McCoy JA, Widrlechner MP, Reddy MB, Murphy PA, et al</AU>
<TI>Echinacea sanguinea and Echinacea pallida extracts stimulate glucuronidation and basolateral transfer of bauer alkamides 8 and 10 and ketone 24 and inhibit P-glycoprotein transporter in caco-2 cells</TI>
<SO>Planta Medica</SO>
<YR>2013</YR>
<VL>79</VL>
<NO>3-4</NO>
<PG>266-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ramasahayam-2011" MODIFIED="2013-05-24 14:07:19 +1000" MODIFIED_BY="[Empty name]" NAME="Ramasahayam 2011" TYPE="JOURNAL_ARTICLE">
<AU>Ramasahayam S, Baraka HN, Abdel Bar FM, Abuasal BS, Widrlechner MP, Sayed KA, et al</AU>
<TI>Effects of chemically characterized fractions from aerial parts of Echinacea purpurea and Echinacea angustofolia on myelopoiesis in rats</TI>
<SO>Planta Medica</SO>
<YR>2011</YR>
<VL>77</VL>
<NO>17</NO>
<PG>1883-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2012" MODIFIED="2013-05-27 11:06:06 +1000" MODIFIED_BY="[Empty name]" NAME="RevMan 2012" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2012</YR>
<EN>5.2</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ritchie-2011" MODIFIED="2013-05-21 18:46:40 +1000" MODIFIED_BY="[Empty name]" NAME="Ritchie 2011" TYPE="JOURNAL_ARTICLE">
<AU>Ritchie MR, Gertsch J, Klein P, Schoop R</AU>
<TI>Effects of Echinaforce ® treatment on ex vivo stimulated blood cells</TI>
<SO>Phytomedicine</SO>
<YR>2011</YR>
<VL>18</VL>
<NO>10</NO>
<PG>826-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sadigh_x002d_Eteghad-2011" MODIFIED="2013-05-21 18:47:19 +1000" MODIFIED_BY="[Empty name]" NAME="Sadigh-Eteghad 2011" TYPE="JOURNAL_ARTICLE">
<AU>Sadigh-Eteghad S, Khayat-Nuri H, Abadi N, Ghavami S, Golabi M, Shanebandi D</AU>
<TI>Synergetic effects of oral administration of levamisole and Echinacea purpurea on immune response in Wistar rat</TI>
<SO>Research in Veterinary Science</SO>
<YR>2011</YR>
<VL>91</VL>
<NO>1</NO>
<PG>82-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schoop-2006b" MODIFIED="2013-05-24 14:15:26 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Schoop 2006b" TYPE="JOURNAL_ARTICLE">
<AU>Schoop R, Klein P, Suter A, Johnston SL</AU>
<TI>Echinacea in the prevention of induced rhinovirus colds: a meta-analysis</TI>
<SO>Clinical Therapeutics</SO>
<YR>2006</YR>
<VL>28</VL>
<PG>174-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shah-2007" NAME="Shah 2007" TYPE="JOURNAL_ARTICLE">
<AU>Shah SA, Sander S, White CM, Rinaldi M, Coleman CI</AU>
<TI>Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis</TI>
<SO>Lancet Infectious Diseases</SO>
<YR>2007</YR>
<VL>7</VL>
<PG>473-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sharma-2006" MODIFIED="2013-05-21 18:47:30 +1000" MODIFIED_BY="[Empty name]" NAME="Sharma 2006" TYPE="JOURNAL_ARTICLE">
<AU>Sharma M, Anderson SA, Schoop R, Hudson JB</AU>
<TI>Introduction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract</TI>
<SO>Antiviral Research</SO>
<YR>2006</YR>
<VL>83</VL>
<NO>2</NO>
<PG>165-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Singh-2013a" MODIFIED="2013-10-11 20:57:21 +1000" MODIFIED_BY="[Empty name]" NAME="Singh 2013a" TYPE="COCHRANE_REVIEW">
<AU>Singh M, Das RR</AU>
<TI>Zinc for the common cold</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>6</NO>
<IDENTIFIERS MODIFIED="2013-10-11 20:53:30 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-10-11 20:53:30 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001364.pub4"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Singh-2013b" MODIFIED="2013-10-11 20:57:14 +1000" MODIFIED_BY="[Empty name]" NAME="Singh 2013b" TYPE="COCHRANE_REVIEW">
<AU>Singh M, Singh M</AU>
<TI>Heated, humidified air for the common cold</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>6</NO>
<IDENTIFIERS MODIFIED="2013-10-11 20:57:01 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-10-11 20:57:01 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001728.pub5"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Timmer-2009" MODIFIED="2013-10-11 21:20:23 +1000" MODIFIED_BY="[Empty name]" NAME="Timmer 2009" TYPE="COCHRANE_REVIEW">
<AU>Timmer A, Günther J, Rücker G, Motschall E, Antes G, Kern WV</AU>
<TI>Pelargonium sidoides extract for acute respiratory tract infections</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2013-10-11 21:20:23 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-10-11 21:20:23 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006323.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Uluisik-2012" MODIFIED="2013-06-18 18:16:32 +1000" MODIFIED_BY="[Empty name]" NAME="Uluisik 2012" TYPE="JOURNAL_ARTICLE">
<AU>Uluisik D, Keskin E</AU>
<TI>Effects of ginseng and echinacea on cytokine mRNA expression in rats</TI>
<SO>Scientific World Journal</SO>
<YR>2012</YR>
<VL>942025</VL>
<PG>1-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Woelkart-2005a" MODIFIED="2013-05-24 14:14:25 +1000" MODIFIED_BY="[Empty name]" NAME="Woelkart 2005a" TYPE="JOURNAL_ARTICLE">
<AU>Woelkart K, Xu W, Pei Y, Makriyannis A, Picone RP, Bauer R</AU>
<TI>The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots</TI>
<SO>Planta Medica</SO>
<YR>2005</YR>
<VL>71</VL>
<PG>701-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Woelkart-2005b" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Woelkart 2005b" TYPE="JOURNAL_ARTICLE">
<AU>Woelkart K, Koidl C, Grisold A, Gangemi JD, Turner RB, Marth E, et al</AU>
<TI>Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humans</TI>
<SO>Journal of Clinical Pharmacology</SO>
<YR>2005</YR>
<VL>45</VL>
<NO>6</NO>
<PG>683-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Woelkart-2006" MODIFIED="2013-05-24 14:09:27 +1000" MODIFIED_BY="[Empty name]" NAME="Woelkart 2006" TYPE="JOURNAL_ARTICLE">
<AU>Woelkart K, Marth E, Suter A, Schoop R, Raggam RB, Koidl C, et al</AU>
<TI>Bioavailability and pharmacokinetics of Echinacea purpurea preparations and their interaction with the immune system</TI>
<SO>International Journal of Clinical Pharmacology and Therapeutics</SO>
<YR>2006</YR>
<VL>44</VL>
<NO>9</NO>
<PG>401-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Woelkart-2007" MODIFIED="2013-10-23 22:46:04 +1000" MODIFIED_BY="[Empty name]" NAME="Woelkart 2007" TYPE="JOURNAL_ARTICLE">
<AU>Woelkart K, Bauer R</AU>
<TI>The role of alkamides as an active principle of Echinacea</TI>
<SO>Planta Medica</SO>
<YR>2007</YR>
<VL>73</VL>
<PG>615-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Woelkart-2008" MODIFIED="2013-05-21 18:47:58 +1000" MODIFIED_BY="[Empty name]" NAME="Woelkart 2008" TYPE="JOURNAL_ARTICLE">
<AU>Woelkart K, Dittrich P, Beubler E, Pinl F, Schoop R, Suter A, et al</AU>
<TI>Pharmacokinetics of the main alkamides after administration of three different Echinacea purpurea preparations in humans</TI>
<SO>Planta Medica</SO>
<YR>2008</YR>
<VL>74</VL>
<NO>6</NO>
<PG>651-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yamada-2011" MODIFIED="2013-05-21 18:48:05 +1000" MODIFIED_BY="[Empty name]" NAME="Yamada 2011" TYPE="JOURNAL_ARTICLE">
<AU>Yamada K, Hung P, Park TK, Park PJ, Lim BO</AU>
<TI>A comparison of the immunostimulatory effects of the medical herbs Echinacea, Ashwagandha and Brahmi</TI>
<SO>Journal of Ethnopharmacology</SO>
<YR>2011</YR>
<VL>137</VL>
<NO>1</NO>
<PG>231-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yu-2013" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NAME="Yu 2013" TYPE="JOURNAL_ARTICLE">
<AU>Yu D, Yuan Y, Jiang L, Tai Y, Yang X, Hu F, et al</AU>
<TI>Anti-inflammatory effects of essential oil in Echinacea purpurea L</TI>
<SO>Pakistan Journal of Pharmaceutical Sciences</SO>
<YR>2013</YR>
<VL>26</VL>
<NO>2</NO>
<PG>403-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zhai-2007" MODIFIED="2013-05-21 18:48:17 +1000" MODIFIED_BY="[Empty name]" NAME="Zhai 2007" TYPE="JOURNAL_ARTICLE">
<AU>Zhai Z, Liu Y, Wu L, Senchina DS, Wurtele ES, Murphy PA, et al</AU>
<TI>Enhancement of innate and adaptive immune functions by multiple Echinacea species</TI>
<SO>Journal of Medical Food</SO>
<YR>2007</YR>
<VL>10</VL>
<NO>3</NO>
<PG>423-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zhang-2010" MODIFIED="2013-10-11 21:03:45 +1000" MODIFIED_BY="[Empty name]" NAME="Zhang 2010" TYPE="COCHRANE_REVIEW">
<AU>Zhang X, Wu T, Zhang J, Yan Q, Xie L, Liu GJ</AU>
<TI>Chinese medicinal herbs for the common cold</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>10</NO>
<IDENTIFIERS MODIFIED="2013-10-11 21:03:45 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-10-11 21:03:45 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004782.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2013-05-24 14:13:45 +1000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Linde-2006" MODIFIED="2008-02-05 08:32:13 +1000" MODIFIED_BY="[Empty name]" NAME="Linde 2006" TYPE="COCHRANE_REVIEW">
<AU>Linde K, Barrett B, Wölkart K, Bauer R, Melchart D</AU>
<TI>Echinacea for preventing and treating the common cold</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2008-02-05 08:32:13 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-02-05 08:32:13 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000530.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Linde-2008" MODIFIED="2013-05-24 14:13:45 +1000" MODIFIED_BY="[Empty name]" NAME="Linde 2008" TYPE="COCHRANE_REVIEW">
<AU>Linde K, Barrett B, Bauer R, Melchart D, Wölkart K</AU>
<TI>Echinacea for preventing and treating the common cold</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2013-05-24 14:12:22 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-05-24 14:12:22 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000530.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Melchart-1999" MODIFIED="2008-02-05 08:33:10 +1000" MODIFIED_BY="[Empty name]" NAME="Melchart 1999" TYPE="COCHRANE_REVIEW">
<AU>Melchart D, Linde K, Fischer P, Kaesmayr J</AU>
<TI>Echinacea for preventing and treating the common cold</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1999</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2008-02-05 08:33:10 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-02-05 08:33:10 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000530.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2013-11-13 07:39:03 +1000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-11-13 07:39:03 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2013-10-30 19:43:07 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Barrett-2002">
<CHAR_METHODS MODIFIED="2013-10-30 19:43:07 +1000" MODIFIED_BY="[Empty name]">
<P>Approach: treatment trial</P>
<P>Design: randomized; placebo-controlled, double-blind<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 18:28:45 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Numbers: 73 randomized to <I>Echinacea</I>, 75 to placebo; 69 analyzed in the <I>Echinacea</I> group and 73 in the placebo group<BR/>Setting: University Family Medicine Dept., USA</P>
<P>Participants: university students</P>
<P>Demographics: mean age 21 years, 69% female</P>
<P>Main selection criteria: at least 2 of 15 cold symptoms for less than 36 hours<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 18:28:46 +1000" MODIFIED_BY="Jenny Bellorini">
<P>
<I>Echinacea</I>: capsules containing 50% <I>E. angustifolia</I> root (123 mg per capsule), 25% <I>E. purpurea </I>root (62 mg), 25% <I>E. purpurea</I> herb (62 mg) and thyme and peppermint to disguise taste and flavor<BR/>Placebo: capsules containing 333 mg alfalfa<BR/>Dosage and treatment duration: 6 x 4 capsules in the first 24 hours, then 3 x 4 capsules up to 10 days</P>
<P>Concurrent medication: "Patients using antibiotics, antihistamines or decongestants were excluded." No further information on the actual intake of concurrent medication is reported</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Primary: severity score, duration, severity of single symptoms (daily reporting)</P>
<P>Secondary: not defined</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: U.S. Department of Health and Human Services and the National Institutes of health; Shaklee Tecnica</P>
<P>Conflict of interest: none disclosed<BR/>Additional information provided by author</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-11-13 07:38:47 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barrett-2010">
<CHAR_METHODS MODIFIED="2013-10-30 19:43:24 +1000" MODIFIED_BY="[Empty name]">
<P>Approach: treatment trial</P>
<P>Design: randomized; placebo-controlled, double-blind</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 18:28:50 +1000" MODIFIED_BY="[Empty name]">
<P>Numbers: 184 randomized to the blinded <I>Echinacea</I> group, 179 to the blinded placebo group, 183 analyzed in the blinded <I>Echinacea </I>group and 176 in the blinded placebo group</P>
<P>Setting: 2 centers in Wisconsin</P>
<P>Participants: recruited via newspaper advertisements, posters community talks, targeted mailings, e-mails and word of mouth</P>
<P>Demographics: mean age 34 years, 65% female</P>
<P>Main selection criteria: cold symptoms since up to 36 hours</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-11-13 07:38:47 +1000" MODIFIED_BY="[Empty name]">
<P>
<I>Echinacea</I>: tablets containing 675 mg of <I>E. purpurea</I> root and 600 mg of <I>E. angustifolia</I> root, each standardized to 2.1 mg of alkamides. Manufacturer MediHerb (Australia)</P>
<P>Placebo: "Tablet excipients included calcium acid phosphate, cellulose, silica, sodium starch glycolate, hypromellose and magnesium stearate. Placebo and <I>Echinacea</I> tablets contained the same proportion of inert ingredients and were covered with identical digestible coatings."</P>
<P>Dosage and treatment duration: 2 tablets doses 4 times within the first 24 hours of enrolment, then 1 tablet 4 times daily for 4 days; that means 10.2 g of dried <I>Echinacea</I> root during first 24 hours, 5.1 g during each of the next days</P>
<P>Concurrent medication: "Patients receiving antibiotics, antivirals, nasal steroids, decongestants, antihistamines, combination of cold formulas, <I>Echinacea</I>, zinc or vitamin C were excluded." No further information on the actual intake of concurrent medication is provided</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Primary: area under the curve for global severity, with duration and severity assessed twice daily by self report, duration, severity score (Wisconsin Upper Respiratory Symptom Survey, short version; WURSS-21)</P>
<P>Secondary: self report on psycho-social questionnaires and biomarker of immune response and inflammation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: National Center for Complementary and Alternative Medicine at the National Institute of Health, Robert Wood Johnson Foundation Generalist Physician Faculty Scholars Program; MediHerb (Queensland , Australia) provided the placebo and <I>Echinacea</I> tablets and conducted the phytochemical assays; financial support facilitated by Deans Robert Golden and Paul DeLuca of the University of Wisconsin Medical School</P>
<P>Conflict of interest: no relevant conflict of interest reported</P>
<P>The trial had 2 additional arms (open <I>Echinacea</I> and no treatment) to investigate placebo and expectation effects in colds. These 2 arms were not included in this review</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-30 19:43:39 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Brinkeborn-1999">
<CHAR_METHODS MODIFIED="2013-10-30 19:43:39 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Approach: treatment trial</P>
<P>Design: randomized; placebo-controlled, double-blind<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Numbers: 3 <I>Echinacea</I> groups and 1 placebo group, 559 randomized, 246 got a cold and started treatment, 2 dropped out, 181 in per protocol analysis (41/49/44/46), 246 in intent-to-treat analysis (55/64/63/64)<BR/>Setting: infectious disease center in Sweden</P>
<P>Demographics: 74% female, mean age 41 years</P>
<P>Main selection criteria: healthy volunteers, prone to common cold<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-24 00:45:20 +1000" MODIFIED_BY="[Empty name]">
<P>
<I>Echinacea</I> 1: Echinaforce tablets (6.78 mg <I>E. purpurea</I> crude extract based on 95% herb and 5% roots)<BR/>
<I>Echinacea</I> 2: concentrate preparation (48.27 mg of the same extract)<BR/>
<I>Echinacea</I> 3: 29.6 mg crude extract based on root only</P>
<P>Placebo: not described<BR/>Dosage and treatment duration: 3 x 2 tablets daily up to a maximum of 7 days</P>
<P>Concurrent medication: patients were excluded if they were taking "other medications which may affect the immune system like immunostimulants and antibiotics or may influence the symptoms like nose-drops or anticoughs". No further information on the actual intake of concurrent medication is reported</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Primary: relative reduction of the complaint index (= sum score) based on 12 symptoms according to doctor's record</P>
<P>Secondary: relative reduction of the complaint index according to the patient's diary, assessment of efficacy and tolerance by the investigator and the patients, the frequency and severity of adverse events</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Funding source: Bioforce AG, Switzerland</P>
<P>Conflict of interest: not stated</P>
<P>Additional information provided by sponsor</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-30 19:48:48 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Br_x00e4_unig-1992">
<CHAR_METHODS MODIFIED="2013-10-30 19:48:48 +1000" MODIFIED_BY="[Empty name]">
<P>Approach: treatment trial</P>
<P>Design: randomized; placebo-controlled. Comparison of the lower dosage of <I>Echinacea</I> and placebo probably double-blind, group receiving the higher dosage probably not blinded (it seems that all patients received 90 drops placebo)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Numbers: 60 persons were randomized to treatment group 1, 60 to treatment group 2 and 60 to placebo group, only 1 drop-out in the placebo group<BR/>Setting: 1 general practice, Germany</P>
<P>Demographics: not reported</P>
<P>Main selection criteria: influenza-like URTI<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>
<I>Echinacea</I> 1: <I>Echinacea purpurea</I> root extract 90 drops (450 mg) daily for 8 to 10 days<BR/>
<I>Echinacea</I> 2: <I>Echinacea purpurea</I> root extract 180 drops (900 mg) daily for 8 to 10 days<BR/>Placebo: mixture of ethanol and water (50 vol. %) with caramel color</P>
<P>Dosage and treatment duration: <I>Echinacea</I> (see above), for placebo not mentioned explicitly</P>
<P>Concurrent medication: patients were excluded, if they were using antihistamines, antibiotics or other relevant medication influencing the clinical picture. No further information on the actual intake of concurrent medication is provided</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-27 11:56:58 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Duration of disease was described as a main outcome measure but results were not reported</P>
<P>2 scores on 5 medical findings (assessed by the physician after 3 to 4 and 8 to 10 days) and 8 symptoms (assessed by the patient)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: Fink GmbH Herrenberg, Firma Salus-Haus Bruckmühl</P>
<P>Conflict of interest: not stated</P>
<P>Study not truly double-blind<BR/>Additional information provided by author</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-30 19:55:45 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Dorn-1997">
<CHAR_METHODS MODIFIED="2013-10-30 19:55:45 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Approach: treatment trial</P>
<P>Design: randomized; placebo-controlled, double-blind<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Numbers: 160 randomized to <I>Echinacea</I> group and analyzed, 160 randomized to placebo group and analyzed<BR/>Setting: 1 general practice, Germany</P>
<P>Demographics: 48% female, age not reported</P>
<P>Man inclusion criteria: upper respiratory tract infection (viral origin was suspected in 114 patients (70 <I>Echinacea</I> versus 44 placebo), bacterial in 46 (10 <I>Echinacea</I> versus 36 placebo))<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>
<I>Echinacea</I>:<I> Echinacea pallida </I>root extract<BR/>Placebo: "coloured aqueous alcoholic solution"</P>
<P>Dosage and treatment duration: 90 drops (900 mg <I>Echinacea</I>) daily for 8 to 10 days</P>
<P>Concurrent medication: patients were excluded if they "were being treated with other drugs that might interact with a herbal preparation". No detailed information on the actual intake of concurrent medication is provided</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-27 11:59:36 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Length of illness, symptoms, clinical findings (assessed after 3 to 4 and 8 to 10 days), lymphocytes and granulocytes, effect of the frequency of URTI during the previous 3 years on the treatment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-03-15 22:09:33 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: not stated, but probably funding by Pascoe GmbH, Germany</P>
<P>Conflict of interest: not stated<BR/>Additional information provided by author</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-30 19:56:02 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Galea-1996">
<CHAR_METHODS MODIFIED="2013-10-30 19:56:02 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Approach: treatment trial</P>
<P>Design: randomized; placebo-controlled, double-blind<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Numbers: 395 randomized, 235 returned symptom checklist, 192 had a cold, 2 incomplete checklists due to drop-out, 106 participants in the <I>Echinacea</I> group and 84 in the placebo group completed the trial<BR/>Setting: Family Medicine Department, Canada</P>
<P>Demographics: no information</P>
<P>Main selection criteria: healthy students<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 18:29:34 +1000" MODIFIED_BY="Jenny Bellorini">
<P>
<I>Echinacea</I>: capsules with 250 mg <I>E. angustifolia</I> (standardized on 4% content of echinacoside)<BR/>Placebo: placebo capsules (filled with vegetable oil)<BR/>Dosage and treatment duration: 3 x 1 capsule for 10 days</P>
<P>Concurrent medication: not reported</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-05-09 19:03:54 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Number of symptoms (4 major and 4 minor; single and summed) over 10-day period</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: the authors thank C.E. Jamieson and Co. Ltd. and R. P. Scherer Canada Inc (Windsor, Ontario) for supplying the <I>Echinacea</I>, placebo and remuneration for the trial participants. No direct financial support stated</P>
<P>Conflict of interest: not stated</P>
<P>Simple, unpublished trial; only short report available<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-30 19:56:21 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Goel-2004">
<CHAR_METHODS MODIFIED="2013-10-30 19:56:21 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Approach: treatment trial</P>
<P>Design: randomized; placebo-controlled, double-blind<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Numbers: 282 randomized, 128 contracted a cold and were included in the analysis (ITT: 59 <I>Echinacea</I>, 69 placebo; PP: 54 <I>Echinacea</I>, 57 placebo)<BR/>Demographics: 54% in <I>Echinacea</I> and 75% in placebo group female, mean age 32 years</P>
<P>Setting: University of Alberta, Canada</P>
<P>Main selection criteria: healthy adults with at least 2 colds last year<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>
<I>Echinacea</I>: <I>Echinacea purpurea </I>extract containing 0.25 mg/ml alkamides, 2.5 mg/ml cichoric acid, 25.5 mg/ml polysaccharides<BR/>Placebo: "Placebo made to look, taste and smell like the echinacea extract"<BR/>Dosage and treatment duration: 10 x 4 ml the first day, then 4 x 4 ml for 6 days</P>
<P>Concurrent medication: "Volunteers were excluded if they...were on immunosuppressive drugs such as corticosteroids or cyclosporine...The subjects were instructed not to take any other medication during the treatment." Subjects using "concomitant relief medications on a regular basis during the treatment period" were excluded from the PP population</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-12-06 22:10:30 +1000" MODIFIED_BY="[Empty name]">
<P>Total daily symptom score, 13 symptoms (reported daily by patients and on day 3 and 8 by nurse)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Funding source: treatment provided by Factors R&amp;D Technologies, Canada</P>
<P>Conflict of interest: not stated</P>
<P>5 (<I>Echinacea</I>) versus 12 (placebo) drop-outs/excluded patients<BR/>Additional information provided by author</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-30 19:56:34 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Goel-2005">
<CHAR_METHODS MODIFIED="2013-10-30 19:56:34 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Approach: treatment trial</P>
<P>Design: randomized; placebo-controlled, double-blind<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 20:54:05 +1000" MODIFIED_BY="[Empty name]">
<P>Numbers: 150 randomized, 62 contracted a cold (26 <I>Echinacea</I>, 36 placebo), 56 were analyzed (25 <I>Echinacea</I>, 31 placebo)<BR/>Setting: University of Alberta, Canada</P>
<P>Demographics: 59% female, mean age 40 years</P>
<P>Main selection criteria: volunteers between 18 and 65 years with 2 or more colds previous year<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>
<I>Echinacea</I>: <I>Echinacea purpurea</I> extract containing 0.25 mg/ml alkamides, 2.5 mg/ml cichoric acid, 25.5 mg/ml polysaccharides<BR/>Placebo: "The placebo contained similar ingredients without the echinacea." (40% ethanol)<BR/>Dosage and treatment duration: 8 x 5 ml the first day, then 3 x 5 ml for 6 days</P>
<P>Concurrent medication: "Volunteers were excluded if they...were on immunosuppressive drugs such as corticosteroids or cyclosporine...Participants reporting the concomitant use of other relief medications on a regular basis during their cold were excluded from the study."</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Diary with 8 cold symptoms, multiple physiological measures</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Funding source: <I>Echinacea</I> and placebo "were provided by Factors R &amp; D Technologies, Burnaby, BC, Canada." No direct financial support stated</P>
<P>Conflict of interest: not stated</P>
<P>Subsequent trial after the Goel 2004 trial focusing on physiological outcomes and reporting clinical outcomes only briefly. Author (T. K. Basu) provided additional information. Patients in the <I>Echinacea</I> group had higher symptom scores at baseline. Analyses of % change from day 1 showed significant differences in favor of the <I>Echinacea</I> group, however, absolute values (provided for us by the author) at defined time points were similar in both groups</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-30 19:56:52 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Grimm-1999">
<CHAR_METHODS MODIFIED="2013-10-30 19:56:52 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Approach: prevention trial</P>
<P>Design: randomized; placebo-controlled, double-blind<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 20:55:22 +1000" MODIFIED_BY="[Empty name]">
<P>Numbers: 109 randomized, 108 analyzed (54 <I>Echinacea</I>, 54 placebo)<BR/>Setting: 1 general practice, Germany</P>
<P>Demographics: 62% female, mean age 40 years</P>
<P>Main selection criteria: volunteers with more than 3 URTIs in the previous 6 months of winter<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>
<I>Echinacea</I>: pressed juice of <I>Echinacea purpurea</I> herb in 22% alcohol</P>
<P>Placebo: alcohol/water solution with artificial color<BR/>Dosage and treatment duration: 2 x 4 ml daily for 8 weeks</P>
<P>Concurrent medication: "Use of immunostimulating drugs within 4 weeks before study entry" was an exclusion criterion. No further information on the actual intake of concurrent medication reported</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Primary: incidence, number, severity and duration of infections; time to first infection, CD4/CD8-ratio</P>
<P>Secondary: side effects</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: "The study was sponsored by Madaus AG, Cologne, Germany."</P>
<P>Conflict of interest: not stated<BR/>No additional information sought</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-30 19:57:08 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hall-2007">
<CHAR_METHODS MODIFIED="2013-10-30 19:57:08 +1000" MODIFIED_BY="[Empty name]">
<P>Approach: prevention trial<BR/>Design: randomized; placebo-controlled, double-blind</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Numbers: 32 analyzed (<I>Echinacea</I>: 18; placebo: 14); number randomized not reported</P>
<P>Setting: not reported, probably Dept. of Kinesiology, Elmhurst College (USA)</P>
<P>Demographics: mean age 26 years, gender not reported</P>
<P>Main selection criteria: active, non-smoking adults aged 19 to 46 years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>
<I>Echinacea</I>: <I>E. purpurea</I> herb 1.2 g in capsules</P>
<P>Placebo: gelatin capsules containing sugar mixture</P>
<P>Dosage and treatment duration: 8 capsules/day for 4 weeks</P>
<P>Concurrent medication: "Only those subjects that were...not taking any medications and / or dietary supplements...were included in the study." No further information on the actual intake of concurrent medication is provided</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-12-19 22:35:20 +1000" MODIFIED_BY="[Empty name]">
<P>Number and duration of URTI additionally to salival IgA, secretion rate of IgA and salival flow rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: study medication was provided by Nature's Way, Springville (USA), no financial support reported</P>
<P>Conflict of interest: not stated</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-31 10:01:07 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Hoheisel-1997">
<CHAR_METHODS MODIFIED="2013-10-31 10:01:07 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Approach: treatment trial</P>
<P>Design: randomized; placebo-controlled, double-blind<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Numbers: 120 randomized and analyzed (60 <I>Echinacea</I>, 60 placebo)<BR/>Setting: company physician of a large furniture-making factory</P>
<P>Demographics: 10% female, mean age 36.5 years</P>
<P>Main inclusion criteria: patients presenting with first symptoms of an URTI and having a history of recurrent URTI (&gt; 3 episodes in the previous 12 months) (employees of the furniture-making factory)<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-30 20:03:29 +1000" MODIFIED_BY="Jenny Bellorini">
<P>
<I>Echinacea</I>: pressed juice of <I>Echinacea purpurea</I> herb<BR/>Placebo: "identical in color and ethanol concentration"<BR/>Dosage and treatment duration: on day 1 every 2 hours 20 drops, then up to maximally 10 days 3 x 20 drops daily</P>
<P>Concurrent medication: "Nine patients in the Echinagard group and 4 in the placebo group reported taking concomitant medication, mainly analgesics and anti-ulcer agents." These patients were at least included in the ITT-analysis<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Primary: number of patients who developed a 'full' common cold and days until improvement</P>
<P>Secondary: symptom diary, global assessments</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: not stated<BR/>Conflict of interest: not stated<BR/>No diary data presented, subjective patient definition what was considered a 'full' cold (could be a major problem if patients should have been unblinded)</P>
<P>No additional information received</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-31 10:01:17 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jawad-2012">
<CHAR_METHODS MODIFIED="2013-10-31 10:01:17 +1000" MODIFIED_BY="[Empty name]">
<P>Approach: prevention trial</P>
<P>Design: randomized; placebo-controlled, double-blind</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Numbers: <I>Echinacea</I>: 379 randomized, 325 analyzed; placebo: 376 randomized, 348 analyzed</P>
<P>Setting: Common Cold Center in Cardiff University (United Kingdom)</P>
<P>Demographics: <I>Echinacea</I>: 68.7% female, mean age 23.6. Placebo: 62.7% female, mean age 23.2</P>
<P>Main selection criteria: healthy adults with 2 or more colds per year</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 18:30:26 +1000" MODIFIED_BY="[Empty name]">
<P>
<I>Echinacea</I>: alcoholic extraction from freshly harvested <I>E. purpurea </I>with 95% herb and 5% roots</P>
<P>Placebo: "Placebo drops were similar in shape, color, consistency, odor, flavor and they contained the same amount of alcohol."</P>
<P>Dosage and treatment duration: 3 x 0.9 ml per day for illness prevention (2400 mg of extract per day), during acute stages of cold dose was increased to 5 x 0.9 ml per day (4000 mg of extract per day). Treatment duration was 4 months</P>
<P>Concurrent medication: "The exclusion criteria were...currently taking antimicrobial or antiviral medication...corticosteroid treated asthma, medicinal treated atopy or allergy...In the <I>Echinacea</I> and placebo groups, 58 and 88 episodes, respectively, were treated with aspirin, paracetamol, or ibuprofen. Thus, significantly more (+52%) cold episodes in the placebo group were additionally treated with pain medication..."</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Adverse effects, multiple physiological measures, prevalence of colds, symptom scores</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: not stated in the publication. Sponsoring by A. Vogel Bioforce AG, Switzerland stated in additional information by the authors</P>
<P>Conflict of interest: no conflicts of interest of first and last author, conflicts of interest of the other authors not stated</P>
<P>Some information relevant for this review is missing in the publication. Additional information was requested from the authors and has partly been provided</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-30 19:57:51 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Kim-2002a">
<CHAR_METHODS MODIFIED="2013-10-30 19:57:51 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Approach: treatment trial</P>
<P>Design: randomized; placebo-controlled, double-blind<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 18:30:29 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Numbers: <I>Echinacea</I>: 27; placebo: 30 (no treatment: 25)<BR/>Setting: Cornell University, Ithaca, NY, USA</P>
<P>Demographics: 55% female, mean age 20 years</P>
<P>Main outcome criteria: healthy students<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>
<I>Echinacea</I>: extract from 80% <I>E. purpurea</I> herb, 20% <I>E. angustifolia</I> root<BR/>Control 1: placebo: parsley juice and orange extract.<BR/>Control 2: no treatment<BR/>Dosage and treatment duration: 101 ml containing 1000 mg (dry plant) per day for at least 5 days</P>
<P>Concurrent medication: "Screening criteria included...those who were taking medication for seasonal allergies and those who had taken <I>Echinacea</I>." Further information on the actual intake of concurrent medication is not provided</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-12-10 18:05:23 +1000" MODIFIED_BY="[Empty name]">
<P>Duration, retrospective assessment of 11 cold symptoms</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Funding source: not stated</P>
<P>Conflict of interest: not stated<BR/>
</P>
<P>Unpublished 3-armed study<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-31 10:01:34 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Lindenmuth-2000">
<CHAR_METHODS MODIFIED="2013-10-31 10:01:34 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Approach: treatment trial</P>
<P>Design: placebo-controlled, double-blind; quasi-randomized but adequate concealment likely<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Numbers: 95 allocated, 95 analyzed (<I>Echinacea</I>: 48; placebo: 47)<BR/>Setting: nursing and rehabilitation center in York, PN, USA</P>
<P>Demographics: 85% women, mean age 40 years</P>
<P>Main inclusion criteria: employees of a nursing and rehabilitation center with earliest symptoms of a cold<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-24 00:46:13 +1000" MODIFIED_BY="Jenny Bellorini">
<P>
<I>Echinacea</I>: tea preparation from aerial parts of <I>E. purpurea</I> and <I>E. angustifolia</I> and <I>E. purpurea</I> root. The <I>Echinacea</I> tea contained small amounts of 2 flavoring components (lemon grass leaf and spearmint leaf)<BR/>Placebo: placebo tea (cinnamon bark, ginger rhizome, peppermint leaf, sweet fennel seed, rose hip, papaya leaf, alfalfa leaf)<BR/>Dosage and treatment duration: 5 to 6 cups on day 1, titration to 1 cup on day 5</P>
<P>Concurrent medication: "Subjects who were excluded included...those who...were already taking antibiotics." No further information on the actual intake of concurrent medication is reported</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-12-10 18:37:10 +1000" MODIFIED_BY="[Empty name]">
<P>Global assessment of effectiveness and duration</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: donation of treatment and placebo teas from Traditional Medicinals Inc., no direct financial funding stated</P>
<P>Conflict of interest: not stated<BR/>Additional information sought but no answer received</P>
<P>Simple study with insufficient outcome measurement. Not truly randomized but adequately concealed alternate allocation. Duration of symptoms has been coded reciprocally ("1" for "more then 5 days" and "5" for "immediately", "4" for "2 days" etc.). Thus the numeric results in the publication dissemble an effect favoring placebo. Therefore, the group results were exchanged between <I>Echinacea</I> and placebo group for the analysis with regard to the fact that the text of the publication describes results favoring <I>Echinacea</I>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-30 19:58:43 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Melchart-1998">
<CHAR_METHODS MODIFIED="2013-10-30 19:58:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Approach: prevention trial</P>
<P>Design: randomized; placebo-controlled, double-blind<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Numbers: 302 were randomized; 289 participants were analyzed by intention-to-treat, 214 complied fully with the protocol. (<I>Echinacea</I> 1: 103/99/85; <I>Echinacea</I> 2: 103/100/84; placebo: 96/90/75)<BR/>Setting: 5 centers (4 military centers, 1 industrial plant, Munich, Germany)</P>
<P>Demographics: 29% female, mean age 29.5 years</P>
<P>Main inclusion criteria: healthy volunteers<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-24 00:46:18 +1000" MODIFIED_BY="Jenny Bellorini">
<P>
<I>Echinacea</I> 1: <I>Echinacea angustifolia</I> root extract (plant extract ratio 1:11 in 30% alcohol)<BR/>
<I>Echinacea</I> 2: <I>Echinacea purpurea</I> root extract (plant extract ratio 1:11 in 30% alcohol)<BR/>Placebo: colored ethanolic solution<BR/>Dosage and treatment duration: 2 x 50 drops daily from Monday to Friday for 12 weeks</P>
<P>Concurrent medication: exclusion criteria were: "systemic intake of corticosteroids, antibiotics, or immunostimulants in the previous 2 weeks." Further information on the actual intake of concurrent medication is not provided</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Predefined main outcome measure: time until occurrence of first URTI<BR/>Secondary outcomes: proportions with at least 1 URTI; number, severity and duration of episodes, global assessment. Predefined subgroup analysis on patients with more than 3 infections in the previous 12 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: Bavarian Parliament, Plantapharmazie (Göttingen, Germany)</P>
<P>Conflict of interest: not stated<BR/>Treatment preparations characterized by the content of glycoproteins/polysaccharides (additional information from manufacturer)<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-30 19:58:55 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-O_x0027_Neill-2008">
<CHAR_METHODS MODIFIED="2013-10-30 19:58:55 +1000" MODIFIED_BY="[Empty name]">
<P>Approach: prevention trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Numbers: 90 randomized, 58 analyzed (<I>Echinacea</I>: 45 randomized, 28 analyzed; placebo: 45 randomized, 30 analyzed)</P>
<P>Setting: University Medical Center and Family Health Center at the University of California San Francisco-Fresno (USA)</P>
<P>Demographics: mean age 40 years, sex not reported</P>
<P>Main selection criteria: healthy adults recruited from hospital personnel</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>
<I>Echinacea</I>: <I>E. purpurea</I> dried plant extract in capsules</P>
<P>Placebo: parsley capsules</P>
<P>Dosage and treatment duration: 3 capsules 2 times daily for 8 weeks (300 mg per capsule)</P>
<P>Concurrent medication: "Persons with...immunosuppressive therapy...were excluded...Individuals currently using <I>Echinacea</I> were not considered for the study, whereas those using other upper respiratory tract infection preventive measures were allowed to continue their use...Participants with symptoms were asked about...any medications used to treat symptoms (e.g., aspirin, acetaminophen, vitamins and cold formulas)"</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-12-10 20:32:30 +1000" MODIFIED_BY="[Empty name]">
<P>Days with symptoms, days missed from work, medications used to treat symptoms, adverse effects</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: grant from Health Resources and Services Administration Border Health Education and Training Center, Medication used was donated by Natures Resource, Mission Hills, California (USA)</P>
<P>Conflict of interest: none</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-30 19:59:09 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Schulten-2001">
<CHAR_METHODS MODIFIED="2013-10-30 19:59:09 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Approach: treatment trial</P>
<P>Design: randomized; placebo-controlled, double-blind<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Numbers: 80 randomized and analyzed in ITT-analysis (ITT: <I>Echinacea</I>: 41; placebo: 39; per protocol: <I>Echinacea</I>: 37; placebo: 33)<BR/>Setting: industrial plant in Germany</P>
<P>Demographics: 49% female, mean age 39 years</P>
<P>Main inclusion criteria: patients (employees of the manufacturer) with subjective sensation of a cold and at least 1 of 8 symptoms<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>
<I>Echinacea</I>: <I>E. purpurea</I> herb (pressed juice from fresh flowering plants)<BR/>Placebo: not described<BR/>Dosage and treatment duration: 2 x 5 ml for 10 days</P>
<P>Concurrent medication: "Therapy with immunosuppressants in the week prior to the trial and therapy with immunostimulants (herbal immunostimulants, cytokines, thymus fractions), zinc or antibiotics during 2 weeks before commencement of the trial were not allowed." No further information on the actual intake of concurrent medication is provided</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Primary: number of days with illness, number of patients with a "full" cold, area under the curve for the daily symptom score (modified Jackson score) and single symptoms, symptom score</P>
<P>Secondary: subjective efficacy assessment by patients</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: Madaus AG, Cologne, Germany</P>
<P>Conflict of interest: not stated, but study was performed by and with Madaus employees<BR/>Additional information sought but not received</P>
<P>Rigorous and well-reported study, however, performed in employees of the manufacturer without testing the success of blinding. Adaptive design with early stopping after 80 patients as a significant difference was detected</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-31 10:01:45 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sperber-2004">
<CHAR_METHODS MODIFIED="2013-10-31 10:01:45 +1000" MODIFIED_BY="[Empty name]">
<P>Approach: prevention trial (experimental rhinovirus colds)</P>
<P>Design: randomized; placebo-controlled, double-blind</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Numbers: 48 randomized, 46 analyzed (<I>Echinacea</I>: 24; placebo: 22)</P>
<P>Setting: not clearly described, probably Department of Internal Medicine, Hackensack University Center, Hackensack (USA)</P>
<P>Demographics: mean age 33 years, <I>Echinacea</I>: 50% female, placebo: 58% female</P>
<P>Main selection criteria: healthy adults, aged 18 to 65 years, antibody titers of =&lt; 1:2 to Rhinovirus type 39</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>
<I>Echinacea</I>: pressed juice of <I>E. purpurea</I> in 22% alcohol</P>
<P>Placebo: "matching placebo", not described</P>
<P>Dosage and treatment duration: 2.5 ml 3 times daily for 14 days (intranasal virus inoculation with RV-39 after 7 days)</P>
<P>Concurrent medication: "Individuals who had received medication known to affect rhinorrhea, cough, or nasal congestion within 7 days (4 weeks for cromolyn sodium and long-acting antihistamines) before study initiation were excluded." Further information on actual intake of concurrent medication is not reported</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Primary: occurrence and severity of symptoms</P>
<P>Secondary: increase in RV-39 neutralizing antibody titer and/or recovery of rhinovirus on viral culture</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: Madaus AG, Cologne, Germany</P>
<P>Conflict of interest: not stated</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-30 19:59:31 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Taylor-2003">
<CHAR_METHODS MODIFIED="2013-10-30 19:59:31 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Approach: treatment trial<BR/>Design: randomized; placebo-controlled, double-blind<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Numbers: 524 randomized, probably 436 with infection, 407 analyzed (<I>Echinacea</I>: 200; placebo: 207)<BR/>Setting: 7 private practices and 1 inner-city clinic, USA</P>
<P>Demographics: 50% female, mean age 5.5 years<BR/>Main inclusion criteria: healthy children between 2 and 11 years<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>
<I>Echinacea</I>: <I>E. purpurea</I> herb harvested at flowering, in syrup<BR/>Placebo: syrup<BR/>Dosage and treatment duration: 7.5 ml/day in children 2 to 5 years and 10 ml/day in those 6 to 11 years up to a maximum of 10 days</P>
<P>Concurrent medication: "...and those receiving chronic medications of any kind or herbal, mineral, or specific vitamin supplements were excluded...parents were asked to not give their child any medication other than the study medication and acetaminophen (if desired) unless prescribed by a physician. However, if another medication was administered, the parent was requested to record the name." Use of concomitant medication was reported (secondary outcome)<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Primary: duration, severity, adverse events</P>
<P>Secondary: peak severity, number of days with fever, parental global assessment of severity, concomitant medication</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: grant from the National Center for Complementary and Alternative Medicine. Study medication and placebo provided by Madaus AG, Cologne, Germany<BR/>Conflict of interest: not stated<BR/>Additional information on results in the first cold episode was provided from authors. Additional publication: Weber 2005. In the "Data and analyses" section of this review the outcome "the number of adverse effects per URI" reported in this trial is used as an equivalent to the outcome "number of patients reporting adverse effects per number of participants"</P>
<P>Rigorous and well-reported study; complex analysis as several infections per child were monitored</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-30 19:59:44 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tiralongo-2012">
<CHAR_METHODS MODIFIED="2013-10-30 19:59:44 +1000" MODIFIED_BY="[Empty name]">
<P>Approach: prevention trial</P>
<P>Design: randomized; placebo-controlled, double-blind</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Numbers: 175 randomized, 170 analyzed (ITT; <I>Echinacea</I>: 85; placebo: 85)</P>
<P>Setting: not clearly described, probably School of Pharmacy, Griffith Health Institute, Griffith University, Gold Coast Australia</P>
<P>Demographics: mean age 43 years, 67% female</P>
<P>Main inclusion criteria: healthy adults, traveling on intercontinental flights, 18 to 65 years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>
<I>Echinacea</I>: tablets containing 112.5 mg <I>E. purpurea</I> root 6:1 extract (equivalent to 675 mg dry root) and 150 mg <I>E. angustofolia</I> root 4:1 extract (equivalent to 600 mg dry root)</P>
<P>Placebo: not clearly described, tablets covered identically</P>
<P>Dosage and treatment duration: days -14 to -3: 1 tablet. twice a day; days -2 to +7: 2 tablets twice a day; +8 to +32 1 tablet twice a day; +33 to +42 2 tablets twice a day; +43 to +49 1 tablet twice a day. For shorter travels the dose between day 8 and 32 was shortened, reflecting the time the patient was spending abroad</P>
<P>Concurrent medication: "Volunteers were excluded if they...were on regular treatment with <I>Echinacea</I>, antibiotics, corticosteroids, antihistamines and immunosuppressants." Further details on the actual intake of concurrent medication are not provided</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Primary: symptom score, URI symptom-related quality of life</P>
<P>Secondary: occurrence and duration of jet lag, headache, sleep pattern, herpes simplex scores</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: Integria Healthcare Pty. Ltd.</P>
<P>Conflict of interest: not stated</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-30 20:00:05 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Turner-2000">
<CHAR_METHODS MODIFIED="2013-10-30 20:00:05 +1000" MODIFIED_BY="[Empty name]">
<P>Approach: prevention trial (experimental rhinovirus colds)</P>
<P>Design: randomized; placebo-controlled, double-blind</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Numbers: 117 randomized, 92 challenged with rhinovirus type 23, infection occurred in 22 of 50 in <I>Echinacea</I> group and in 24 of 42 in placebo group</P>
<P>Setting: not clearly stated, probably Department of Pediatrics and Medicine, Medical University of South Carolina (USA)</P>
<P>Demographics: not reported</P>
<P>Main selection criteria: healthy young adults with a titer of neutralizing antibody of &#8804; 1:4 to rhinovirus type 23</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>
<I>Echinacea</I>: 4% phenolic extract of a mixture of <I>E. purpurea</I> and <I>E. angustofolia</I> formulated as powder, containing 0.16% cichoric acid with almost no echinacosides or alkamides</P>
<P>Placebo: not described</P>
<P>Dosage and treatment duration: 1 capsule containing 900 mg <I>Echinacea</I> of placebo once a day, for 14 days prior to virus challenge and 5 days after virus challenge</P>
<P>Concurrent medication: according to additional information provided by author exclusion criteria were "use of any anti-inflammatory (steroids or NSAIDs) or couch/cold preparation in the 2 weeks prior to the study, use of astemizole in the month prior to the study..." No detailed information on the actual intake of concurrent medication is reported</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-12-12 20:25:45 +1000" MODIFIED_BY="[Empty name]">
<P>Number of rhinovirus infections, incidence of clinical colds, severity of symptoms</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: grant from the Procter &amp; Gamble Company, Cincinnati, Ohio (USA)</P>
<P>Conflict of interest: not stated, but the second author is a Procter &amp; Gamble employee</P>
<P>Publication is a short report. Some additional information (study protocol) was provided by author</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-30 20:00:22 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Turner-2005">
<CHAR_METHODS MODIFIED="2013-10-30 20:00:22 +1000" MODIFIED_BY="[Empty name]">
<P>Approach: prevention and treatment trial (experimental rhinovirus colds)</P>
<P>Design: randomized; placebo-controlled, double-blind</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Numbers: the trial consisted of a prophylaxis phase of 7 days, then a challenge with rhinovirus inoculation, followed by a 5-day treatment phase. Participants were allocated to 7 study groups. 3 groups received 1 of 3 different <I>Echinacea</I> preparations in the prophylaxis phase and in the treatment phase. 3 groups received placebo in the prophylaxis phase and 1 of the 3 different <I>Echinacea</I> preparations in the treatment phase. The control group received placebo in both the prophylaxis and the treatment phase. 437 were randomized and 399 analyzed. E1/E1: 52; E2/E2: 52; E3/E3: 45; placebo/E1: 48; placebo/E2: 51; placebo/E3: 48; placebo/placebo: 103 (<I>Echinacea</I> = E)</P>
<P>Setting: University of Virginia School of Medicine, Charlottesville (USA)</P>
<P>Demographics: mean age 21 years, 60% female</P>
<P>Main selection criteria: healthy young adults, serum-neutralizing antibody titer =&lt; 1:4 to rhinovirus type 39</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>
<I>Echinacea</I>: <I>E. angustofolia</I> root extract with CO<SUB>2</SUB>, with 60% ethanol or with 20% ethanol</P>
<P>Placebo: mixture of alcoholic beverages, denatonium benzoate and tap water</P>
<P>Dosage and treatment duration: 1.5 ml (equivalent of 300 mg <I>Echinacea</I> root) tincture 3 times daily for 13 days (prophylaxis groups) or placebo for 7 days and <I>Echinacea</I> for 5 days (treatment groups), the control group received placebo for 13 days</P>
<P>Concurrent medication: not reported</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Primary: symptom score</P>
<P>Secondary: testing of infection with rhinovirus type 39, nasal secretion weight, assessment of inflammation in nasal lavage specimens</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: grant from the National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health</P>
<P>Conflict of interest: first author has served as a consultant for Wyeth Consumer Healthcare, Schering-Plough Research Institute, Nordic Phytopharma A7S, the Dial Corporation and Procter &amp; Gamble and having received grant support from Biopolymer Engineering, the Dial Corporation and Procter &amp; Gamble. The last author has received grant support from the U.S. Department of Defense</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-30 20:00:34 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Yale-2004">
<CHAR_METHODS MODIFIED="2013-10-30 20:00:34 +1000" MODIFIED_BY="[Empty name]">
<P>Aproach: treatment trial</P>
<P>Design: randomized; placebo-controlled, double-blind<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Numbers: 128 (<I>Echinacea</I>: 63, placebo: 65)<BR/>Setting: clinic network, USA</P>
<P>Demographics: 86% female, mean age 38 years</P>
<P>Main inclusion criteria: adult patients presenting with acute sneezing and nasal discharge for 6 to 24 hours<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>
<I>Echinacea</I>: <I>Echinacea</I> fresh capsule (freeze-dried pressed juice from <I>E. purpurea</I> herb standardized on a content of 2.4% soluble beta-1,2-D-fructofuranosides)<BR/>Placebo: capsules with lactose<BR/>Dosage and treatment duration: 3 x 100 mg up to a maximum of 14 days</P>
<P>Concurrent medication: "Exclusion from the study occurred if thee patient...received antibiotics, antihistamines, decongestants, nasal sprays, or corticosteroids in the 48 hours before enrolment,...used corticosteroids during the 8 weeks before enrolment...Patients were encouraged not to take any other cold remedies, including antihistamines, decongestants, cough suppressants, corticosteroids, or isotonic sodium chloride solution during the study. Acetaminophen was allowed, if needed." Actual intake is reported</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Severity score, single symptoms (daily reporting), duration, global assessment, adverse effects</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: Marshfield Clinic Research Foundation, Wisconsin (USA), Enzymatic Therapy provided study materials<BR/>Conflict of interest: not stated<BR/>Some additional information received from author</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-30 20:00:44 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2003">
<CHAR_METHODS MODIFIED="2013-10-30 20:00:44 +1000" MODIFIED_BY="[Empty name]">
<P>Approach: prevention trial</P>
<P>Design: randomized; placebo-controlled, double-blind</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Numbers: 120 randomized, 111 analyzed (<I>Echinacea</I>: 54; placebo: 57)</P>
<P>Setting: University of Wolverhampton (USA)</P>
<P>Demographics: 57% female, median age 25</P>
<P>Main inclusion criteria: healthy participants, 18 to 65 years old</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>
<I>Echinacea</I>: <I>E. purpurea</I> root extract (capsules containing 294 mg <I>E. purpurea </I>root extract, 4.4 mg cichoric acid and 500 mg of non-specified herb powder)</P>
<P>Placebo: capsules containing 500 mg herb powder</P>
<P>Dosage and treatment duration: 1 capsule daily for 8 weeks</P>
<P>Concurrent medication: "The general exclusion criteria were...use of antibiotics / corticosteroids within 2 weeks or immunostimulating drugs within 4 weeks of study entry..." No detailed information on the actual intake of concurrent medication is provided</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-25 21:40:54 +1000" MODIFIED_BY="[Empty name]">
<P>Symptom and severity score, total episodes of URI, missed doses, experience of side effects</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Funding source: not stated</P>
<P>Conflict of interest: not stated</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>
<B>Abbreviations:</B>
<BR/>
</P>
<P>URTI = upper respiratory tract infection<BR/>URI = upper respiratory infection<BR/>ITT = intention-to-treat<BR/>PP = per protocol</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2013-10-23 21:21:46 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Baetgen-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 21:21:46 +1000" MODIFIED_BY="[Empty name]">
<P>Not randomized<BR/>Not common cold (pertussis)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 21:21:49 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Baetgen-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 21:21:49 +1000" MODIFIED_BY="[Empty name]">
<P>Not randomized<BR/>Not common cold (acute bronchitis)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Bendel-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Not common cold (reduction of immunosuppressive side effects of combined radio-chemotherapy in patients with breast cancer), combination of <I>Echinacea</I> with other herbal extracts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Bendel-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Not common cold (reduction of immunosuppressive side effects of radiotherapy in patients with breast cancer), combination of <I>Echinacea</I> with other herbal extracts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Blumr_x00f6_der-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Not common cold (angina lacunaris), combination of <I>Echinacea</I> with other herbal extracts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 21:22:17 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Coeugniet-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 21:22:17 +1000" MODIFIED_BY="[Empty name]">
<P>Not randomized<BR/>Not common cold (recurrent vaginal candida infection)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cohen-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Randomized trial of a combination</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cubasch-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only measurement of laboratory and psychological parameters</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Di-Pierro-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized trial about enhancement of immune response to influenza vaccines, not common cold</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Dorn-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Randomized trial of a combination of <I>Echinacea</I> with other herbal extracts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ehringer-1968">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not common cold (venous insufficiency)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 21:22:34 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Engel-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 21:22:34 +1000" MODIFIED_BY="[Empty name]">
<P>Not randomized</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Forth-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Randomized trial of a combination of <I>Echinacea</I> with other herbal extracts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Freitag-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not common cold (pertussis)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Freyer-1974">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Trial of a combination of <I>Echinacea</I> with other herbal extracts, with alternate allocation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hauke-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Trial of Esberitox® as supportive therapy to antibiotics, not common cold (acute exacerbation of chronic bronchitis)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Heinen_x002d_Kammerer-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Open study, not a randomized controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Helbig-1961">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Trial of a combination of <I>Echinacea</I> with other herbal extracts, with alternate allocation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Henneicke-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Randomized trial of a combination of <I>Echinacea</I> with other herbal extracts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hill-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not common cold (topical treatment of insect bites)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hill-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not common cold (topical treatment of insect bites)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hill-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not common cold (topical treatment of insect bites)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Isbaniah-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Trial of a combination of <I>Echinacea</I> with other agents, not common cold (chronic obstructive pulmonary disease)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kim-2002b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Measurement of physiological outcomes in healthy volunteers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Kleinschmidt-1965">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Trial of a combination of <I>Echinacea</I> with other herbal extracts with alternate allocation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Melchart-1995a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Measurement of immunological parameters in healthy volunteers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Melchart-1995b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Measurement of immunological parameters in healthy volunteers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Melchart-1995c">
<CHAR_REASON_FOR_EXCLUSION>
<P>Measurement of immunological parameters in healthy volunteers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Melchart-1995d">
<CHAR_REASON_FOR_EXCLUSION>
<P>Measurement of immunological parameters in healthy volunteers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Melchart-1995e">
<CHAR_REASON_FOR_EXCLUSION>
<P>Measurement of immunological parameters in healthy volunteers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Minetti-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Trial of a combination of <I>Echinacea</I> with other herbal extracts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Narimanian-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized trial of a combination of <I>Echinacea</I> with other herbal extracts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Naser-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized trial of a combination of <I>Echinacea</I> with other herbal extracts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 21:24:05 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pohl-1970">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 21:24:05 +1000" MODIFIED_BY="[Empty name]">
<P>Not randomized<BR/>Not common cold (reduction of radiotherapy-induced leukopenia)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Quadripur-1976">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not common cold (skin infections)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Reitz-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Randomized trial of a combination of <I>Echinacea</I> with other herbal extracts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sartor-1972">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not common cold (reduction of radiotherapy-induced leukopenia)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Saunders-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Open-label study, not a randomized controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Scaglione-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Randomized trial of a combination of <I>Echinacea</I> with other herbal extracts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schapowal-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized trial of a combination of <I>Echinacea</I> with other herbal extracts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Schmidt-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Randomized trial of a combination of <I>Echinacea</I> with other herbal extracts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schoop-2006a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Open study, not a randomized controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Schwarz-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Measurement of immunological parameters in healthy volunteers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-12-11 18:34:22 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Spasov-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-12-11 18:34:22 +1000" MODIFIED_BY="[Empty name]">
<P>Unblinded study without placebo control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 21:25:23 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stolze-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 21:25:23 +1000" MODIFIED_BY="[Empty name]">
<P>Not randomized<BR/>Not common cold (variety of respiratory tract infections treated with antibiotics)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Thom-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Randomized trial of a combination</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Timmermanns-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not common cold (urinary dysfunction)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-05-09 19:11:20 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Vonau-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-05-09 19:11:20 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Randomized trial of <I>Echinacea purpurea</I> for recurrent genital herpes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Vorberg-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Randomized trial of a combination of <I>Echinacea</I> with other herbal extracts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Vorberg-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Randomized trial of a combination of <I>Echinacea</I> with other herbal extracts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wahl-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized trial of <I>Echinacea</I> in combination with osteopathic treatment in children with recurrent otitis media</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yakoot-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized trial of a combination of <I>Echinacea</I> with other herbal extracts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zimmer-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not common cold (acute sinusitis)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2013-10-30 20:06:53 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2013-10-30 20:06:53 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rahmati-2012">
<CHAR_METHODS MODIFIED="2013-10-30 20:05:14 +1000" MODIFIED_BY="[Empty name]">
<P>Approach: treatment trial</P>
<P>Design: randomized; placebo-controlled, double-blind</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-30 20:05:50 +1000" MODIFIED_BY="[Empty name]">
<P>100 children aged 5 to 11 years with upper respiratory tract infection</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-30 20:06:02 +1000" MODIFIED_BY="[Empty name]">
<P>Echinacea root extract or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-30 20:06:20 +1000" MODIFIED_BY="[Empty name]">
<P>Duration and severity of symptoms</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-30 20:06:53 +1000" MODIFIED_BY="[Empty name]">
<P>Study in Persian language identified in the update search</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2013-11-13 07:39:03 +1000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2013-11-13 07:39:03 +1000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-04 20:31:41 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barrett-2002">
<DESCRIPTION>
<P>"...random number-generator (MS Excel) and a balanced blocks-of-four design."<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-27 11:54:50 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barrett-2010">
<DESCRIPTION>
<P>"We used SAS (SAS Institute, Cary, North Carolina) to generate a single block of 804 unique identification numbers so that each of 12 cells (3 clinician groups by 4 pill groups) was represented equally."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-13 07:38:49 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brinkeborn-1999">
<DESCRIPTION>
<P>"computer-generated randomization list in blocks of four"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-13 07:38:49 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Br_x00e4_unig-1992">
<DESCRIPTION>
<P>"randomized", not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 20:41:04 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dorn-1997">
<DESCRIPTION>
<P>Computer-generated randomization list (provided by author)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-24 21:08:00 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Galea-1996">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-13 07:38:51 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goel-2004">
<DESCRIPTION>
<P>"The randomization list was generated using a computer program."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-13 07:38:51 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goel-2005">
<DESCRIPTION>
<P>"The randomization codes were generated using an Excel 97 computer program."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-13 07:38:51 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grimm-1999">
<DESCRIPTION>
<P>"computer-generated randomization list"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-19 22:45:28 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hall-2007">
<DESCRIPTION>
<P>"...randomly assigned to a group based on a computer generated table of random numbers..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-13 07:38:54 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hoheisel-1997">
<DESCRIPTION>
<P>"Patients were randomized to treatment groups (using the programme Random V5.0)..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-13 07:38:57 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jawad-2012">
<DESCRIPTION>
<P>"The randomization code was prepared in block-sizes of 6 with "RANCODE Professional 3.6" program."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-10 18:07:12 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kim-2002a">
<DESCRIPTION>
<P>Randomization not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 21:05:52 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lindenmuth-2000">
<DESCRIPTION>
<P>Not truly randomized: "...allocation was accomplished by utilization of alternation for assignment..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-13 07:38:57 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Melchart-1998">
<DESCRIPTION>
<P>"stratified for participants with up to 3 and more than 3 colds in the last year; computer-generated randomization list, block size 15..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-24 14:42:21 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-O_x0027_Neill-2008">
<DESCRIPTION>
<P>"...list generated using the random-number generator in a spreadsheet program (Microsoft Excel....)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-13 07:38:57 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schulten-2001">
<DESCRIPTION>
<P>"computer generated randomization list"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-10 22:23:13 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sperber-2004">
<DESCRIPTION>
<P>Randomization only stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-13 07:38:57 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Taylor-2003">
<DESCRIPTION>
<P>"Randomization was performed using a computer-generated randomization list and was stratified by site and in blocks of 10."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-13 07:38:57 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tiralongo-2012">
<DESCRIPTION>
<P>"The random allocation sequence provided by the sponsor was computer generated using a randomization plan from http://www.randomization.com/ with randomization in blocks of 10."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 21:17:54 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Turner-2000">
<DESCRIPTION>
<P>Unpublished study protocol provided by author states that allocation is randomized but does not report further details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-11 22:24:19 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Turner-2005">
<DESCRIPTION>
<P>"randomly assigned in blocks" no further description of the sequence generation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-13 07:39:03 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yale-2004">
<DESCRIPTION>
<P>"...randomization list sent from the Biostatistics and Bioinformatics core to the Investigational Drug Pharmacy..." (information from author)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-13 07:39:03 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2003">
<DESCRIPTION>
<P>"...stratified randomization procedure...", "In order of their recruitment subjects in each pre-treatment URI score group were grouped into blocks of 4 and 2 subjects in each block of 4 were allocated randomly to <I>Echinacea</I> and the other 2 to placebo by using separate sets of randomized numbers provided for each of the 2 pre-treatment URI categories. The randomized number sequences were generated by a statistician..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2013-11-13 07:38:47 +1000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-27 10:54:00 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barrett-2002">
<DESCRIPTION>
<P>Sequentially labeled bottles, allocation concealed until data had been collected, entered and cleaned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-13 07:38:47 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barrett-2010">
<DESCRIPTION>
<P>"Using these codes, the UW Hospitals Pharmaceutical Research Center Investigational Drug Service prepared consecutively numbered, sealed envelopes to direct allocation. An envelope-within envelope strategy was used, so that group assignment would be revealed as soon as the participant gave consent and the research assistant opened the larger outer envelope.<BR/>Allocation concealment for the 2 blinded pill groups was accomplished by using identical coated tablets and plastic pill bottles. For the 2 thirds of the sample who would see a clinician, a second, smaller envelope that directed allocation to a standard or enhanced visit group was opened by the study clinician before entering the examination room.<BR/>The randomized allocation key was not shared with investigators until after all data were collected, entered and cleaned and analysis strategies were determined."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-05 18:36:41 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brinkeborn-1999">
<DESCRIPTION>
<P>"consecutively numbered drug bottles"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-24 20:54:29 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Br_x00e4_unig-1992">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-24 14:39:52 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dorn-1997">
<DESCRIPTION>
<P>"neutral packaging with appropriate code numbers" (author confirmed "consecutively numbered")</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-24 21:08:05 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Galea-1996">
<DESCRIPTION>
<P>Insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-24 21:21:34 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goel-2004">
<DESCRIPTION>
<P>Numbered drugs (information from author)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-24 21:31:56 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goel-2005">
<DESCRIPTION>
<P>Numbered bottles</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-07 18:28:14 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Grimm-1999">
<DESCRIPTION>
<P>Probably numbered drug containers, not clearly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-24 21:57:21 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hall-2007">
<DESCRIPTION>
<P>"The placebo and echinacea capsules were placed into identical containers... and were randomly assigned and coded, by a third party,to assure allocation concealment"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-24 22:00:18 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hoheisel-1997">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-07 19:46:50 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jawad-2012">
<DESCRIPTION>
<P>"Each participant received treatment based on his/her identification number, which was allocated according to the time point of inclusion."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-24 14:41:44 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kim-2002a">
<DESCRIPTION>
<P>Identically labeled bottles</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-27 11:59:03 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lindenmuth-2000">
<DESCRIPTION>
<P>"The random assignment was accomplished by specific trained secretary personnel not associated with the study and having no prior knowledge of the groups or <I>which of the </I>2<I> boxes of tea bags </I>contained the packets of<I> Echinacea</I> Plus tea bags and that contained the packets of placebo tea bags. These personnel <I>used a numbered system</I>..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-25 20:36:03 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Melchart-1998">
<DESCRIPTION>
<P>"concealment by consecutively numbered medication"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-O_x0027_Neill-2008">
<DESCRIPTION>
<P>The method of concealment is not described in sufficient detail to allow a definite judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 21:09:07 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schulten-2001">
<DESCRIPTION>
<P>Consecutive randomization, identical packaging</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-10 22:23:25 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sperber-2004">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-10 22:55:57 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Taylor-2003">
<DESCRIPTION>
<P>"...unique study number corresponding to the numbers on the bottles of study medication"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-11 20:46:48 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tiralongo-2012">
<DESCRIPTION>
<P>"...allocation was concealed by providing each participant with a number...Labelling only identified the patient number."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-27 12:10:59 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Turner-2000">
<DESCRIPTION>
<P>See above</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-25 21:28:44 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Turner-2005">
<DESCRIPTION>
<P>Not clearly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-27 12:11:34 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yale-2004">
<DESCRIPTION>
<P>No exact description but all persons were blinded except the clinical pharmacist</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-24 14:44:10 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2003">
<DESCRIPTION>
<P>"The <I>Echinacea</I> and placebo dose-pots were then labeled with the numbers that had been allocated to individual subjects..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barrett-2002">
<DESCRIPTION>
<P>Exit interview: blinding successful</P>
<P>Placebo and <I>Echinacea</I> indistinguishable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barrett-2010">
<DESCRIPTION>
<P>"Blinding was tested at the exit interview by asking participants which group they thought they had been assigned to." Group differences were not statistically significant. "Placebo and echinacea tablets were covered with identical digestible coatings." (There were also an open-label group and a no treatment group examined in the study, which are not taken into account for this review)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-05-24 14:39:06 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brinkeborn-1999">
<DESCRIPTION>
<P>"The trial doses of the four treatments were presented in identical vials with identical labels and could almost not be distinguished from one another by their smell or taste."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-23 18:29:15 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Br_x00e4_unig-1992">
<DESCRIPTION>
<P>For treatment group 1: low</P>
<P>For treatment group 2: high</P>
<P>Double-blinding stated but 1 group received more medication (180 drops instead of 90 drops in the first <I>Echinacea</I> group and in the placebo group) and was therefore not truly double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-12-05 20:41:34 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dorn-1997">
<DESCRIPTION>
<P>"The study was double blind: ...received a coloured aqueous alcoholic solution that mimicked and was indistinguishable..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-23 18:29:36 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Galea-1996">
<DESCRIPTION>
<P>Placebo capsules were filled with vegetable oil. They may have been distinguishable from <I>Echinacea</I> capsules by taste</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-05-27 12:05:38 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goel-2004">
<DESCRIPTION>
<P>"Placebo made to look, taste and smell like the echinacea extract." Blinding tested after completion of the study and was maintained adequately during the treatment period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-04-24 21:32:01 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goel-2005">
<DESCRIPTION>
<P>Double-blind ("indistinguishable as to appearance, color, or flavor")</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grimm-1999">
<DESCRIPTION>
<P>"According to the manufacturer, verum and placebo were indistinguishable as to appearance, color, flavor." Adequacy of blinding assessed at the end of follow-up: "27 (50%) of 54 patients in the echinacea group stated that they would like to continue to take the allocated medicine compared to 23 (43%) of 54 patients in the placebo group (P=0.54)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-05-27 12:06:37 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hall-2007">
<DESCRIPTION>
<P>Placebo: "same weight, shape and color as the echinacea capsules", identical containers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hoheisel-1997">
<DESCRIPTION>
<P>"Placebo identical in colour and ethanol concentration; identical bottles". Taste not mentioned, no test of blinding, no description of development/testing of liquid placebo</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-05-27 12:07:33 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jawad-2012">
<DESCRIPTION>
<P>"...double blind...", "Placebo drops similar in shape, colour, consistency, odor, flavor and they contained the same amount of alcohol.", "Primary and secondary packaging was identical..." Blinding was tested in 79 persons and was found to be adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-12-10 18:11:08 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kim-2002a">
<DESCRIPTION>
<P>Post cold survey to test success of blinding: blinding effective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-06 23:21:53 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lindenmuth-2000">
<DESCRIPTION>
<P>"....each subject was given 21 tea bags of the same appearance..." "...this tea... does not have any obvious or easily recognizable flavor characteristics that would make it easily distinguishable from the <I>Echinacea</I> Plus tea by an untrained palate."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-05-27 12:08:37 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Melchart-1998">
<DESCRIPTION>
<P>More volunteers in treatment groups correctly guessed that they had received a true treatment (P &lt; 0.001; some unblinding likely)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-05-27 10:54:03 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-O_x0027_Neill-2008">
<DESCRIPTION>
<P>"...indistinguishable in size, color and smell...Participants, the main investigator and all persons involved in the study remained blinded to the identity of each group until data analyses were completed."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schulten-2001">
<DESCRIPTION>
<P>"indistinguishable in terms of appearance, taste, smell, colour and packaging", but we are uncertain: Can Madaus employees recognize the taste of their <I>Echinacea</I> product?</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sperber-2004">
<DESCRIPTION>
<P>Double-blinding stated. "The active medication and placebo were identical in appearance, taste and smell and were packaged in identical 100ml bottles."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Taylor-2003">
<DESCRIPTION>
<P>"Placebo identical in appearance and similar in taste and smell..." Blinding tested: only 35.1%/22.7% correct guesses</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-05-27 10:54:03 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tiralongo-2012">
<DESCRIPTION>
<P>"Placebo tablets were manufactured to match the <I>Echinacea</I> tablets in size, excipients and colour. Both sets of tablets were coated with a brown colour and hypromellose to make them indistinguishable. Tablets were packed in identical amber glass bottles with identical labelling."</P>
<P>Blinding tested and successful</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-05-27 12:11:02 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Turner-2000">
<DESCRIPTION>
<P>Blinding not mentioned; assessment of blinding with some (non-significant) differences in correct guesses - therefore blinding of participants done; blinding of providers unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-04-25 21:28:47 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Turner-2005">
<DESCRIPTION>
<P>Blinding tested and successful</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yale-2004">
<DESCRIPTION>
<P>"...identical-appearing lactose placebo capsule...", "treatments and group assignments remained blinded to patients and investigators, with the exception of the clinical pharmacist." Blinding tested and successful</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhang-2003">
<DESCRIPTION>
<P>" <I>Echinacea</I> and the identical placebo doses were enclosed in cellulose capsules...This enabled concealment of colour differences.", "Subjects were advised not to open the capsules since the taste/smell/colour of the contents might lead to identification of the doses."</P>
<P>By testing of blinding 82% in the placebo group correctly identified their group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2013-10-24 00:51:13 +1000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barrett-2002">
<DESCRIPTION>
<P>&lt; 5% drop-outs, available case analysis considered appropriate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-27 11:59:01 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barrett-2010">
<DESCRIPTION>
<P>"... 719 were enrolled and randomly assigned. Retention was high. 2 participants were lost to follow-up and 4 withdrew before primary outcome data could be gathered;..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-27 11:56:28 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brinkeborn-1999">
<DESCRIPTION>
<P>Only 2 drop-outs and ITT-analysis available (although methods for replacing data not clear)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Br_x00e4_unig-1992">
<DESCRIPTION>
<P>1 drop-out in the placebo group is mentioned in the publication, but it is not stated if the results of this participant were included in the analysis. (Author confirmed in personal communication that there were no drop-outs and withdrawals)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-04-24 21:06:48 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dorn-1997">
<DESCRIPTION>
<P>Report suggests that there were no drop-outs or withdrawals</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-04-24 21:11:53 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Galea-1996">
<DESCRIPTION>
<P>&gt; 20% attrition for unclear reasons, not partitioned between treatment and placebo groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-27 12:05:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goel-2004">
<DESCRIPTION>
<P>Treatment group with 9% attrition, placebo group with 17% attrition, ITT analysis done. Plausible method for replacing missing data described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-12-07 17:55:51 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Goel-2005">
<DESCRIPTION>
<P>Almost 10% of the participants excluded from analysis, no ITT analysis performed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grimm-1999">
<DESCRIPTION>
<P>Drop-outs: 1 of 109 (before starting treatment)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hall-2007">
<DESCRIPTION>
<P>Number randomized and drop-outs not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-23 20:59:42 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hoheisel-1997">
<DESCRIPTION>
<P>All 120 patients randomized completed the study and were analyzed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jawad-2012">
<DESCRIPTION>
<P>Population not clearly described. Drop-outs relatively few, but distribution disproportionate: 54/379 versus 28/376</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kim-2002a">
<DESCRIPTION>
<P>Loss to follow-up and missing data not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-23 21:06:04 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lindenmuth-2000">
<DESCRIPTION>
<P>All included patients remained in the study and were analyzed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-24 00:51:13 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Melchart-1998">
<DESCRIPTION>
<P>Drop-outs: 58/302, intention-to-treat analysis performed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-O_x0027_Neill-2008">
<DESCRIPTION>
<P>Large number of drop-outs (32/90), no ITT analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schulten-2001">
<DESCRIPTION>
<P>3/80, ITT analysis performed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-27 12:09:35 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sperber-2004">
<DESCRIPTION>
<P>Only 2/48 excluded (&lt; 5%)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Taylor-2003">
<DESCRIPTION>
<P>Drop-outs: 36/436. Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tiralongo-2012">
<DESCRIPTION>
<P>27 patients lost to follow-up (16% drop-outs, no real ITT)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Turner-2000">
<DESCRIPTION>
<P>24 drop-outs before virus challenge</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Turner-2005">
<DESCRIPTION>
<P>Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yale-2004">
<DESCRIPTION>
<P>According to information provided by author only 1 non-completer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2003">
<DESCRIPTION>
<P>Drop-outs: 9/120, no ITT</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-04 20:34:05 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barrett-2002">
<DESCRIPTION>
<P>Relevant outcomes presented in the manuscript</P>
<P>Additional information provided from author</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-27 11:55:40 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barrett-2010">
<DESCRIPTION>
<P>All predefined main outcome measures and secondary outcomes are well reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-21 21:27:56 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brinkeborn-1999">
<DESCRIPTION>
<P>Predefined relevant outcomes adequately reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-27 11:57:19 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Br_x00e4_unig-1992">
<DESCRIPTION>
<P>Duration of disease was described as a main outcome measure but results were not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dorn-1997">
<DESCRIPTION>
<P>Insufficiently reported trial; relevant group differences regarding suspected cause (more bacterial infections in the placebo group than in <I>Echinacea</I> group: 36 versus 10)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-27 12:05:17 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Galea-1996">
<DESCRIPTION>
<P>Reporting does not seem systematically biased but several outcomes are reported insufficiently to allow effect size calculation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-27 12:05:40 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goel-2004">
<DESCRIPTION>
<P>The published report includes all expected outcomes, including those that were pre-specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-27 12:06:02 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goel-2005">
<DESCRIPTION>
<P>Publication includes all expected outcomes, including those that were pre-specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-07 18:27:58 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grimm-1999">
<DESCRIPTION>
<P>Extractable data provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hall-2007">
<DESCRIPTION>
<P>Gender not reported, side effects not examined/reported, relevant results without numerical standard deviation or not shown numerically, unclear if other outcomes have been examined</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-27 12:06:57 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hoheisel-1997">
<DESCRIPTION>
<P>"Recorded subjective symptoms daily in diary card" not shown in tables. Subsample record only of those who report "real cold" may introduce bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jawad-2012">
<DESCRIPTION>
<P>Most results adequately reported but N of patients with at least 1 infection not reported. No P value for accumulated number of cold episodes reported. Severity and duration mentioned, but not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-25 20:15:52 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kim-2002a">
<DESCRIPTION>
<P>Study focuses on single cold symptoms; no evidence of selective reporting</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-10 18:52:42 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lindenmuth-2000">
<DESCRIPTION>
<P>Results for all measured outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-25 20:36:21 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Melchart-1998">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-24 14:42:33 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-O_x0027_Neill-2008">
<DESCRIPTION>
<P>All mentioned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 22:59:43 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schulten-2001">
<DESCRIPTION>
<P>Median duration versus mean (not reported); were URIs defined a priori?</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-10 22:25:50 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sperber-2004">
<DESCRIPTION>
<P>Measured outcomes well reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-27 12:10:09 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Taylor-2003">
<DESCRIPTION>
<P>All mentioned outcomes have been reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-25 21:22:17 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tiralongo-2012">
<DESCRIPTION>
<P>All outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-27 12:11:03 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Turner-2000">
<DESCRIPTION>
<P>Relevant outcomes seem to be reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-21 22:07:35 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Turner-2005">
<DESCRIPTION>
<P>Relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-25 21:35:55 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yale-2004">
<DESCRIPTION>
<P>Additional results provided by author</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-25 21:42:00 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2003">
<DESCRIPTION>
<P>All outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2013-10-30 20:08:28 +1000" MODIFIED_BY="Jenny Bellorini">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2013-10-30 20:08:28 +1000" MODIFIED_BY="Jenny Bellorini" NO="1">
<TITLE MODIFIED="2013-10-23 21:26:14 +1000" MODIFIED_BY="[Empty name]">Details of the preparations used in the included trials</TITLE>
<TABLE COLS="10" ROWS="31">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Reference</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Preparation</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Manufacturer</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Species, part</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Extraction</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Content details</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Galenic form</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Dosage</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Treatment period</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Remarks</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Barrett 2002</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Shaklee Tecninca, Pleasanton, California</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Unrefined <I>E. ang.</I> root (50%), <I>E. purp.</I> herb (25%) and root (25%)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not applicable (dried <I>Echinacea</I>)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.20% to 0.26% echinacoside, 0.77% to 0.84% dichroic acid, 0.82% alkamides, 0.03% chlorogenic acid, 0.33% cafeolytartaric acid</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Capsules</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 x 4 capsules (6 g) during first 24 hours, then 3 x 4 capsules (3 g/day)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Barrett</P>
<P>2010</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MediHerb, Warwick, Queensland, Australia</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp.</I> root, <I>E.ang.</I> root</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.1 mg of alkamides per tablet</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Tablets</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 x 2 tablet during first 24 hours, then 4 x 1 tablet per day for the next 4 days; that means 10.2 g of dried <I>Echinacea</I> root during first 24 hours, 5.1 g during each of the next days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Brinkeborn 1999, Group 1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Echinaforce</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bioforce, Roggwil, Switzerland</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp</I>. herb (95%) and root (5%)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Alcoholic aqueous extract</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6.78 mg crude extract</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Tablets</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 x 3 (40.68 mg/day)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Max. 7 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Brinkeborn 1999, Group 2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No brand name</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bioforce, Roggwil, Switzerland</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp.</I> herb (95%) and root (5%)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Alcoholic aqueous extract</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>48.27 mg crude extract</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Tablets</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 x 3 (289.62 mg/day)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Max. 7 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Brinkeborn 1999, Group 3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No brand name</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bioforce, Roggwil, Switzerland</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp</I>. root</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Alcoholic aqueous extract</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>29.60 mg crude extract</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Tablets</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 x 3 (177.6 mg/day)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Max. 7 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bräunig 1992, group 1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp.</I> root</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>55% v/v ethanolic extract, DER 1:5</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Tincture</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>180 drops (900 mg/day)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Probably 8 to 10 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bräunig 1992, group 2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp</I>. root</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>55% v/v ethanolic extract, DER 1:5</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Tincture</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>90 drops (450 mg/day)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Probably 8 to 10 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Dorn 1997</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. pallida</I> root</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Tincture</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>90 drops (900 mg/day)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 to 10 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Galea (unpublished)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Local pharmacist</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. ang.</I> (part not specified)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Powder standardized at 4% content of echinacoside</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Capsules</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 x 1 (750 mg/day)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Goel 2004</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Echinilin</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Natural Factors Nutritional Products, Inc., Vancouver, BC, Canada</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp.</I> (various parts)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Aqueous and alcoholic extract combined to a 40% ethanolic formulation</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Standardized for 0.25 mg/ml alkamides, 2.5 mg/ml cichoric acid, 25 mg/ml polysaccharides</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Liquid</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 x 4 ml day 1, then 6 days 4 x 4 ml</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Extract standardized on the basis of 3 known active components</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Goel 2005</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Echinilin</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Natural Factors Nutritional Products, Inc., Vancouver, BC, Canada</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp.</I> (various parts)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Aqueous and alcoholic extract combined to a 40% ethanolic formulation</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Standardized for 0.25 mg/ml alkamides, 2.5 mg/ml cichoric acid, 25 mg/ml polysaccharides</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Liquid</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 x 5 ml day 1, then 6 days 3 x 5 ml</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Extract standardized on the basis of 3 known active components</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Grimm 1999</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Echinacin</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Madaus AG, Cologne, Germany</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp. </I>aerial parts</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Fresh expressed juice of whole flowering plants harvested without roots, containing 22% alcohol</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Liquid</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 x 4 ml day</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Hall 2007</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>Echinacea</I> Standardized</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Nature´s Way, Springville, UT (USA)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp.</I> (part not specified)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Capsules</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 capsules/day (3 x 2 with each meal and 2 at bedtime)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Hoheisel 1997</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Echinagard (Echinacin)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Madaus AG, Cologne, Germany</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp.</I> aerial parts</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Fresh expressed juice of whole flowering plants harvested without roots, stabilized with 20% ethanol</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Liquid</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 drops every 2 hours day 1, then 3 x 20 drops/day</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Max. 10 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Jawad 2012</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Echinaforce drops</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>A. Vogel, Bioforce, Switzerland</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp.</I> (95% herb, 5% roots)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Alcohol (57%) extract from freshly harvested <I>E. purp.</I>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 mg/100g of dodecatetraenoic acid isobutylamide</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Liquid</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 x 0.9 ml/day (2400 mg of extract/day); in case of cold: 5 x 0.9ml/day (4000 mg of extract/day)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Each single dose was diluted in water and retained in mouth for 10 seconds</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Kim (unpublished)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Nature's Way products, Inc. R/O America's Natural healthcare Company, Springville, Utah</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp.</I> herb (80%), <I>E. ang</I>. roots (20%)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No detailed information; final tincture with 25% to 35% alcohol</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Liquid</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>101 ml (1000 mg dry plant) per day</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>At least 5 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lindenmuth</P>
<P>2000</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>Echinacea</I> Plus herbal tea</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Dry extract ingredient by Emil Flachsmann AG, Zurich, Switzerland</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp.</I> and <I>E. ang.</I> aerial parts; <I>E. purp.</I> roots</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp.</I> root water soluble dry extract DER 6:1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.275 mg per tea bag serving</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Tea bag</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 to 6 cups day 1, titration to one cup on day 5</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Melchart 1998 Group 1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No brand name</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Plantapharmazie, Göttingen, Germany</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. ang.</I> root</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30% ethanolic extract, DER 1:11</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Extract contained 1007.9 µg/ml glycoproteins/polysaccharides and echinacoside</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Tincture</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 x 50 drops</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 weeks (intake on 5 days per week)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Melchart 1998 Group 2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No brand name</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Plantapharmazie, Göttingen, Germany</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp.</I> root</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30% ethanolic extract, DER 1:11</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Extract contained 1026.2 µg/ml glycoproteins/polysaccharides and cichoric acid</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Tincture</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 x 50 drops</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 weeks (intake on 5 days per week)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>O'Neil 2008</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No brand name</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Natures Resource, Mission Hill, California</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp. </I>(part not specified)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Capsules</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 x 2 capsules/day (1 capsule containing 300 mg <I>E. purp.</I>)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Schulten 2001</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Echinacin</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Madaus AG, Cologne, Germany</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp.</I> aerial parts</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Fresh expressed juice of whole flowering plants harvested without roots, stabilized with 20% ethanol, DER 1.7-2.5:1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Liquid</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 x 5 ml/day</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Sperber 2004</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>EchinaGuard</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Madaus AG, Cologne, Germany</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp.</I> aerial parts</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Pressed juice in 22% alcohol base</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Liquid</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 x 2.5 ml/day</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>14 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Taylor 2003</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Echinacin</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Madaus AG, Cologne, Germany</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp.</I> aerial parts</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Pressed juice, combined with syrup</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Liquid (dried pressed juice dissolved in syrup)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 x 3.75 ml/day (children 2 to 5 years), 2 x 5 ml/day (6 to 11 years)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Max. 10 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Tiralongo 2012</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MediHerb</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Integria Healthcare Pty Ltd., Australia</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp.</I> root, <I>E. ang.</I> root</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Extract, details not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Tablets standardized for a content of 4.4 mg alkylamides with 112.5 mg <I>E. purp.</I> 6:1 extract and 150 mg <I>E. ang.</I> 4:1 extract (detailed alkamide composition is summarized in a table with e.g. a content of 1.504 mg/tablet dodecatetraenoic acid isobutyl amides)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Tablets</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Priming dose 2 x 1 tablet/day, flying dose 2 x 2 tablets/day, overseas dose 2 x 1 tablet/day, after-travel dose 2 x 1 tablet/day, sick dose 2 x 3 tablets/day</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>35 days if 1 week of travel (14 days primary dose, 7 days overseas, 14 days after-travel dose) or 63 days if 5 weeks of travel (11 days with priming dose, 10 days flying dose, 25 days overseas dose, 10 days flying dose and 7 days after travel dose)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Turner 2005 Group 1 and 4</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No brand name</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. ang.</I> root</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Extraction with supercritical carbon dioxide</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No polysaccharides, 73.8% alkamides, no echinacosides</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Liquid</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 x 1.5 ml/day (3 x equivalent of 300 mg <I>Echinacea</I> root)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 days (virus challenge on day 8)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Turner 2005 Group 2 and 5</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No brand name</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. ang.</I> root</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Extraction with 60% ethanol</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>48.9% polysaccharides, 2.3% alkamides, no echinacosides, 0.16 mg/ml cynarine)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Liquid</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 x 1.5 ml/day (3 x equivalent of 300 mg <I>Echinacea</I> root)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 days (virus challenge on day 8)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Turner 2005 Group 3 and 6</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No brand name</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. ang.</I> root</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Extraction with 20% ethanol</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>42.1% polysaccharides, 0.1% alkamides, no echinacosides</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Liquid</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 x 1.5 ml/day (3 x equivalent of 300 mg <I>Echinacea</I> root)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 days (virus challenge on day 8)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Turner 2000</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No brand name</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp.</I> and <I>E. ang.</I>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4% phenolic extract</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.16% cichoric acid, almost no echinacosides or alkamides</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Capsules with powder</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 x 300 mg/day</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>19 days (virus challenge on day 14)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yale 2004</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>EchinaFresh</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Enzymatic Therapy, Green Bay, Wisconsin</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purpurea </I>aerial parts</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Pressed juice</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Standardized for a content of 2.4% soluble beta-1,2-D-fructofuranosides</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Capsules with freeze dried juice</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 x 1 capsule/day</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 days, if symptoms not resolved max. 14 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Zhang 2003</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No brand name</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<I>E. purp.</I> root</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Root powder</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4.4 mg cichoric acid</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Capsules with 294 mg powder</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 capsule/day</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<I>E. ang</I>:<I> </I>
<I>Echinacea angustifolia</I>
<BR/>
<I>E. pallida</I>:<I> </I>
<I>Echinacea pallida</I>
<BR/>
<I>E. purp</I>:<I> </I>
<I>Echinacea purpurea</I>
<BR/>v/v: volume/volume</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2014-07-02 23:17:47 +1000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2013-10-30 19:29:21 +1000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Echinacea versus placebo to prevent common cold</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="285" EVENTS_2="428" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2013-10-23 22:50:36 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="5.16" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="666" TOTAL_2="797" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants with at least 1 cold episode</NAME>
<GROUP_LABEL_1>Echinacea</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors Echinacea</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="7" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 18:51:14 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb</NAME>
<DICH_DATA CI_END="1.6981746081346563" CI_START="0.35622854605594834" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.22998234282825936" LOG_CI_START="-0.44827128167839536" LOG_EFFECT_SIZE="-0.10914446942506803" MODIFIED="2012-12-19 22:48:23 +1000" MODIFIED_BY="[Empty name]" ORDER="122" O_E="0.0" SE="0.3984095364447979" STUDY_ID="STD-Hall-2007" TOTAL_1="18" TOTAL_2="14" VAR="0.15873015873015872" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="49" EVENTS_2="58" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:28:46 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="78" TOTAL_2="76" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb pressed juice</NAME>
<DICH_DATA CI_END="1.1257987471849447" CI_START="0.6800727056362803" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="40" LOG_CI_END="0.05146076103144214" LOG_CI_START="-0.16744465498681563" LOG_EFFECT_SIZE="-0.057991946977686754" MODIFIED="2013-02-11 19:45:37 +1000" MODIFIED_BY="[Empty name]" ORDER="356" O_E="0.0" SE="0.12858612496840996" STUDY_ID="STD-Grimm-1999" TOTAL_1="54" TOTAL_2="54" VAR="0.01653439153439154" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.0544240675342302" CI_START="0.4820794613931985" EFFECT_SIZE="0.7129629629629629" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="18" LOG_CI_END="0.02301531026019527" LOG_CI_START="-0.31688137088913093" LOG_EFFECT_SIZE="-0.14693303031446786" MODIFIED="2012-12-10 22:33:24 +1000" MODIFIED_BY="[Empty name]" ORDER="110" O_E="0.0" SE="0.19965699302282117" STUDY_ID="STD-Sperber-2004" TOTAL_1="24" TOTAL_2="22" VAR="0.039862914862914864" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="22" EVENTS_2="27" I2="0.0" ID="CMP-001.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:45:52 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="30" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea dried plant extract</NAME>
<DICH_DATA CI_END="1.095764805549069" CI_START="0.695547722173613" EFFECT_SIZE="0.873015873015873" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="27" LOG_CI_END="0.03971734738424221" LOG_CI_START="-0.1576730673029179" LOG_EFFECT_SIZE="-0.05897785995933786" MODIFIED="2013-02-05 22:56:04 +1000" MODIFIED_BY="[Empty name]" ORDER="139" O_E="0.0" SE="0.11594810668554897" STUDY_ID="STD-O_x0027_Neill-2008" TOTAL_1="28" TOTAL_2="30" VAR="0.013443963443963446" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="25" EVENTS_2="33" I2="0.0" ID="CMP-001.01.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:45:52 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="54" TOTAL_2="57" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root extract</NAME>
<DICH_DATA CI_END="1.1492524928652421" CI_START="0.5564150583081463" EFFECT_SIZE="0.7996632996632996" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="33" LOG_CI_END="0.060415454459714725" LOG_CI_START="-0.25460112517236866" LOG_EFFECT_SIZE="-0.097092835356327" MODIFIED="2012-12-12 22:51:50 +1000" MODIFIED_BY="[Empty name]" ORDER="124" O_E="0.0" SE="0.18504229823310395" STUDY_ID="STD-Zhang-2003" TOTAL_1="54" TOTAL_2="57" VAR="0.03424065213538899" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="29" EVENTS_2="33" I2="0.0" ID="CMP-001.01.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:45:52 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="99" TOTAL_2="90" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root alcoholic extract</NAME>
<DICH_DATA CI_END="1.2027456448623663" CI_START="0.5306509581414691" EFFECT_SIZE="0.7988980716253443" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="33" LOG_CI_END="0.08017379299869937" LOG_CI_START="-0.27519104727301225" LOG_EFFECT_SIZE="-0.09750862713715645" ORDER="357" O_E="0.0" SE="0.2087430662599329" STUDY_ID="STD-Melchart-1998" TOTAL_1="99" TOTAL_2="90" VAR="0.04357366771159874" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="37" EVENTS_2="49" I2="0.0" ID="CMP-001.01.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 21:31:06 +1000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="85" TOTAL_2="85" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root and E. angustofolia root</NAME>
<DICH_DATA CI_END="1.0223841698085718" CI_START="0.5576955403679028" EFFECT_SIZE="0.7551020408163265" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="49" LOG_CI_END="0.00961411642268853" LOG_CI_START="-0.25360282834572595" LOG_EFFECT_SIZE="-0.1219943559615187" MODIFIED="2013-02-13 21:31:06 +1000" MODIFIED_BY="[Empty name]" ORDER="110" O_E="0.0" SE="0.15461493630185688" STUDY_ID="STD-Tiralongo-2012" TOTAL_1="85" TOTAL_2="85" VAR="0.023905778527627264" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="14" I2="0.0" ID="CMP-001.01.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:45:52 +1000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="55" TOTAL_2="46" WEIGHT="0.0" Z="0.0">
<NAME>4% phenolic extract of E. purpurea and E. angustofolia</NAME>
<DICH_DATA CI_END="1.3046049988486743" CI_START="0.33100956617135247" EFFECT_SIZE="0.6571428571428571" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="14" LOG_CI_END="0.11547903827372613" LOG_CI_START="-0.48015945493909173" LOG_EFFECT_SIZE="-0.18234020833268275" MODIFIED="2013-01-21 23:06:32 +1000" MODIFIED_BY="[Empty name]" ORDER="120" O_E="0.0" SE="0.34988099937130274" STUDY_ID="STD-Turner-2000" TOTAL_1="55" TOTAL_2="46" VAR="0.12241671372106154" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="32" EVENTS_2="33" I2="0.0" ID="CMP-001.01.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:45:52 +1000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="100" TOTAL_2="90" WEIGHT="0.0" Z="0.0">
<NAME>E. angustifolia root alcoholic extract</NAME>
<DICH_DATA CI_END="1.2943647560361486" CI_START="0.5884376015416725" EFFECT_SIZE="0.8727272727272727" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="33" LOG_CI_END="0.11205667912341613" LOG_CI_START="-0.23029958336072948" LOG_EFFECT_SIZE="-0.05912145211865665" ORDER="358" O_E="0.0" SE="0.20110176327401805" STUDY_ID="STD-Melchart-1998" TOTAL_1="100" TOTAL_2="90" VAR="0.04044191919191919" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="25" EVENTS_2="58" I2="0.0" ID="CMP-001.01.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 22:46:22 +1000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="103" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root extract with CO2</NAME>
<DICH_DATA CI_END="1.3475860170456568" CI_START="0.7222989044029164" EFFECT_SIZE="0.9865900383141762" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="58" LOG_CI_END="0.12955649596341773" LOG_CI_START="-0.14128304388555998" LOG_EFFECT_SIZE="-0.0058632739610711485" MODIFIED="2013-02-13 22:46:22 +1000" MODIFIED_BY="[Empty name]" ORDER="114" O_E="0.0" SE="0.15909248638463394" STUDY_ID="STD-Turner-2005" TOTAL_1="45" TOTAL_2="103" VAR="0.025310419224044933" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="24" EVENTS_2="58" I2="0.0" ID="CMP-001.01.10" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 22:46:24 +1000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="52" TOTAL_2="103" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root extract with 60% ethanol</NAME>
<DICH_DATA CI_END="1.150726817803653" CI_START="0.5837972218440803" EFFECT_SIZE="0.8196286472148541" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="58" LOG_CI_END="0.06097223448813769" LOG_CI_START="-0.2337379760500541" LOG_EFFECT_SIZE="-0.08638287078095824" MODIFIED="2013-02-13 22:46:24 +1000" MODIFIED_BY="[Empty name]" ORDER="115" O_E="0.0" SE="0.1731142365092039" STUDY_ID="STD-Turner-2005" TOTAL_1="52" TOTAL_2="103" VAR="0.02996853888216459" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="24" EVENTS_2="58" I2="0.0" ID="CMP-001.01.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 22:46:29 +1000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="52" TOTAL_2="103" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root extract with 20% ethanol</NAME>
<DICH_DATA CI_END="1.150726817803653" CI_START="0.5837972218440803" EFFECT_SIZE="0.8196286472148541" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="58" LOG_CI_END="0.06097223448813769" LOG_CI_START="-0.2337379760500541" LOG_EFFECT_SIZE="-0.08638287078095824" MODIFIED="2013-02-13 22:46:29 +1000" MODIFIED_BY="[Empty name]" ORDER="116" O_E="0.0" SE="0.1731142365092039" STUDY_ID="STD-Turner-2005" TOTAL_1="52" TOTAL_2="103" VAR="0.02996853888216459" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="46" EVENTS_2="63" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-10-23 22:51:41 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="608" TOTAL_2="596" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants with more than 1 cold</NAME>
<GROUP_LABEL_1>Echinacea</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors Echinacea</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="8" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:28:58 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="54" TOTAL_2="54" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb pressed juice</NAME>
<DICH_DATA CI_END="2.243660378264327" CI_START="0.34123925680422257" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.3509571186231792" LOG_CI_START="-0.4669410125785528" LOG_EFFECT_SIZE="-0.057991946977686754" ORDER="359" O_E="0.0" SE="0.48043741092894277" STUDY_ID="STD-Grimm-1999" TOTAL_1="54" TOTAL_2="54" VAR="0.23082010582010581" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="28" EVENTS_2="43" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 18:59:30 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="355" TOTAL_2="362" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea alcoholic extract with 95% herb and 5% root</NAME>
<DICH_DATA CI_END="1.0443647051934277" CI_START="0.42217003090035143" EFFECT_SIZE="0.6640026203734032" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="43" LOG_CI_END="0.0188521862084082" LOG_CI_START="-0.37451259972699963" LOG_EFFECT_SIZE="-0.1778302067592957" MODIFIED="2012-12-07 20:02:59 +1000" MODIFIED_BY="[Empty name]" ORDER="100" O_E="0.0" SE="0.23106442244555275" STUDY_ID="STD-Jawad-2012" TOTAL_1="355" TOTAL_2="362" VAR="0.05339076732009686" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="6" I2="0.0" ID="CMP-001.02.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 18:59:30 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="99" TOTAL_2="90" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root alcoholic extract</NAME>
<DICH_DATA CI_END="2.0787183542342" CI_START="0.17669996393227883" EFFECT_SIZE="0.6060606060606061" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3177956507129269" LOG_CI_START="-0.7527635391407395" LOG_EFFECT_SIZE="-0.21748394421390627" ORDER="360" O_E="0.0" SE="0.6288517674735004" STUDY_ID="STD-Melchart-1998" TOTAL_1="99" TOTAL_2="90" VAR="0.3954545454545454" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="6" I2="0.0" ID="CMP-001.02.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 18:59:24 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="100" TOTAL_2="90" WEIGHT="0.0" Z="0.0">
<NAME>E. angustifolia root alcoholic extract</NAME>
<DICH_DATA CI_END="3.00828625749409" CI_START="0.3664877294351587" EFFECT_SIZE="1.05" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.47831915975703115" LOG_CI_START="-0.4359405616171549" LOG_EFFECT_SIZE="0.021189299069938092" ORDER="361" O_E="0.0" SE="0.5370406859938066" STUDY_ID="STD-Melchart-1998" TOTAL_1="100" TOTAL_2="90" VAR="0.2884126984126984" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2013-10-23 22:51:55 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="14.21" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="299" TOTAL_2="281" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Duration: mean difference</NAME>
<GROUP_LABEL_1>Echinacea</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors Echinacea</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.01" MODIFIED="2013-02-14 19:14:05 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb</NAME>
<CONT_DATA CI_END="-2.1328509354808007" CI_START="-8.267149064519199" EFFECT_SIZE="-5.199999999999999" ESTIMABLE="YES" MEAN_1="3.4" MEAN_2="8.6" MODIFIED="2013-02-14 19:14:05 +1000" MODIFIED_BY="[Empty name]" ORDER="146" SD_1="3.18" SD_2="5.14" SE="1.5649007271115587" STUDY_ID="STD-Hall-2007" TOTAL_1="18" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.02" MODIFIED="2013-02-14 19:15:14 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="30" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea dried plant extract</NAME>
<CONT_DATA CI_END="7.390699771750649" CI_START="-6.19069977175065" EFFECT_SIZE="0.5999999999999996" ESTIMABLE="YES" MEAN_1="14.6" MEAN_2="14.0" MODIFIED="2013-02-14 19:15:14 +1000" MODIFIED_BY="[Empty name]" ORDER="147" SD_1="14.8" SD_2="11.2" SE="3.464706405482357" STUDY_ID="STD-O_x0027_Neill-2008" TOTAL_1="28" TOTAL_2="30" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.03" MODIFIED="2013-02-14 19:15:51 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="54" TOTAL_2="57" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root extract</NAME>
<CONT_DATA CI_END="0.43232661604040645" CI_START="-2.1723266160404058" EFFECT_SIZE="-0.8699999999999997" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="3.07" MODIFIED="2013-02-14 19:15:51 +1000" MODIFIED_BY="[Empty name]" ORDER="148" SD_1="3.45" SD_2="3.55" SE="0.6644645648149621" STUDY_ID="STD-Zhang-2003" TOTAL_1="54" TOTAL_2="57" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.04" MODIFIED="2013-02-14 19:16:22 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="99" TOTAL_2="90" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root alcoholic extract</NAME>
<CONT_DATA CI_END="1.0658565330305043" CI_START="-1.465856533030503" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="8.5" MEAN_2="8.7" MODIFIED="2013-02-14 19:16:22 +1000" MODIFIED_BY="[Empty name]" ORDER="149" SD_1="5.2" SD_2="3.6" SE="0.6458570376881506" STUDY_ID="STD-Melchart-1998" TOTAL_1="99" TOTAL_2="90" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.05" MODIFIED="2013-02-14 19:16:45 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="100" TOTAL_2="90" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root alcoholic extract</NAME>
<CONT_DATA CI_END="0.030258011700589282" CI_START="-2.430258011700588" EFFECT_SIZE="-1.1999999999999993" ESTIMABLE="YES" MEAN_1="7.5" MEAN_2="8.7" MODIFIED="2013-02-14 19:16:45 +1000" MODIFIED_BY="[Empty name]" ORDER="150" SD_1="5.0" SD_2="3.6" SE="0.6276941930590086" STUDY_ID="STD-Melchart-1998" TOTAL_1="100" TOTAL_2="90" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2013-10-23 22:52:07 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1.85" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="304" TOTAL_2="442" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Total severity score</NAME>
<GROUP_LABEL_1>Echinacea</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors Echinacea</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.04.01" MODIFIED="2013-02-11 20:29:24 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="22" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb pressed juice</NAME>
<CONT_DATA CI_END="0.28744837105370347" CI_START="-0.8763943711663427" EFFECT_SIZE="-0.2944730000563196" ESTIMABLE="YES" MEAN_1="9.34" MEAN_2="12.17" MODIFIED="2013-01-21 19:34:59 +1000" MODIFIED_BY="[Empty name]" ORDER="124" SD_1="9.34" SD_2="9.56" SE="0.2969041144123793" STUDY_ID="STD-Sperber-2004" TOTAL_1="24" TOTAL_2="22" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.04.02" MODIFIED="2013-02-13 22:23:17 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="54" TOTAL_2="57" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root extract</NAME>
<CONT_DATA CI_END="0.022047935662984186" CI_START="-0.7283374182234099" EFFECT_SIZE="-0.35314474128021284" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="1.21" MODIFIED="2013-02-13 22:23:17 +1000" MODIFIED_BY="[Empty name]" ORDER="127" SD_1="1.04" SD_2="1.35" SE="0.19142835271600345" STUDY_ID="STD-Zhang-2003" TOTAL_1="54" TOTAL_2="57" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.04.03" MODIFIED="2013-02-11 19:03:01 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="85" TOTAL_2="85" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root and E. angustofolia root</NAME>
<CONT_DATA CI_END="9.232359961209302E-4" CI_START="-0.6038525532258814" EFFECT_SIZE="-0.30146465861488025" ESTIMABLE="YES" MEAN_1="13.0" MEAN_2="26.0" MODIFIED="2013-01-21 19:44:29 +1000" MODIFIED_BY="[Empty name]" ORDER="125" SD_1="42.93" SD_2="42.93" SE="0.15428237304164683" STUDY_ID="STD-Tiralongo-2012" TOTAL_1="85" TOTAL_2="85" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.04.04" MODIFIED="2013-02-11 19:02:58 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>4% phenolic extract of E. purpurea and E. angustofolia</NAME>
<CONT_DATA CI_END="0.6157607373614478" CI_START="-0.9671850060712999" EFFECT_SIZE="-0.17571213435492605" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="13.6" MODIFIED="2013-01-21 19:51:34 +1000" MODIFIED_BY="[Empty name]" ORDER="126" SD_1="12.69" SD_2="11.64" SE="0.4038201099404942" STUDY_ID="STD-Turner-2000" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.04.05" MODIFIED="2013-01-24 21:58:46 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="88" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root extract with CO2</NAME>
<CONT_DATA CI_END="0.40246547307841873" CI_START="-0.3450695760606697" EFFECT_SIZE="0.028697948508874506" ESTIMABLE="YES" MEAN_1="15.45" MEAN_2="15.05" MODIFIED="2013-01-24 21:58:46 +1000" MODIFIED_BY="[Empty name]" ORDER="133" SD_1="14.8" SD_2="13.41" SE="0.19070122079679766" STUDY_ID="STD-Turner-2005" TOTAL_1="40" TOTAL_2="88" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.04.06" MODIFIED="2013-01-24 21:59:08 +1000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="88" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root extract with 60% ethanol</NAME>
<CONT_DATA CI_END="0.22823439809668356" CI_START="-0.5077379554162341" EFFECT_SIZE="-0.13975177865977528" ESTIMABLE="YES" MEAN_1="13.21" MEAN_2="15.05" MODIFIED="2013-01-24 21:59:08 +1000" MODIFIED_BY="[Empty name]" ORDER="134" SD_1="12.38" SD_2="13.41" SE="0.18775149934339957" STUDY_ID="STD-Turner-2005" TOTAL_1="42" TOTAL_2="88" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.04.07" MODIFIED="2013-01-24 21:59:44 +1000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="88" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root extract with 20% ethanol</NAME>
<CONT_DATA CI_END="0.12322570853542081" CI_START="-0.5823229100469344" EFFECT_SIZE="-0.22954860075575678" ESTIMABLE="YES" MEAN_1="12.06" MEAN_2="15.05" MODIFIED="2013-01-24 21:59:44 +1000" MODIFIED_BY="[Empty name]" ORDER="135" SD_1="12.06" SD_2="13.41" SE="0.17999019985765877" STUDY_ID="STD-Turner-2005" TOTAL_1="48" TOTAL_2="88" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2013-10-30 19:29:21 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="166.81" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="849" TOTAL_2="822" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients dropping out due to adverse effects</NAME>
<GROUP_LABEL_1>Echinacea</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors Echinacea</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-001.05.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-12 19:17:49 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="79" TOTAL_2="78" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb pressed juice</NAME>
<DICH_DATA CI_END="22.728278125841555" CI_START="0.1759922145378927" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3565665352071012" LOG_CI_START="-0.7545065438791386" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-02-12 19:17:49 +1000" MODIFIED_BY="[Empty name]" ORDER="365" O_E="0.0" SE="1.2400547766355339" STUDY_ID="STD-Grimm-1999" TOTAL_1="55" TOTAL_2="54" VAR="1.5377358490566038" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-12-10 22:37:22 +1000" MODIFIED_BY="[Empty name]" ORDER="112" O_E="0.0" SE="0.0" STUDY_ID="STD-Sperber-2004" TOTAL_1="24" TOTAL_2="24" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="3" I2="0.0" ID="CMP-001.05.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:51:39 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="45" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea dried plant extract</NAME>
<DICH_DATA CI_END="5.240788167404054" CI_START="0.19081099408284896" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.7193966058795148" LOG_CI_START="-0.7193966058795148" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-12-10 20:58:08 +1000" MODIFIED_BY="[Empty name]" ORDER="107" O_E="0.0" SE="0.8451542547285166" STUDY_ID="STD-O_x0027_Neill-2008" TOTAL_1="45" TOTAL_2="45" VAR="0.7142857142857143" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="0" I2="0.0" ID="CMP-001.05.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 18:30:06 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="379" TOTAL_2="376" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea alcoholic extract with 95% herb and 5% root</NAME>
<DICH_DATA CI_END="135.98416530036474" CI_START="0.36033607215787045" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.133488339818373" LOG_CI_START="-0.4432922597898591" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-02-13 18:30:06 +1000" MODIFIED_BY="[Empty name]" ORDER="102" O_E="0.0" SE="1.5136136794795578" STUDY_ID="STD-Jawad-2012" TOTAL_1="379" TOTAL_2="376" VAR="2.2910263707076455" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-001.05.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 19:58:15 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="103" TOTAL_2="96" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root alcoholic extract</NAME>
<DICH_DATA CI_END="21.086838341281982" CI_START="0.16782358175672513" EFFECT_SIZE="1.881188118811881" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.324011468603068" LOG_CI_START="-0.7751470142626954" LOG_EFFECT_SIZE="0.27443222717018634" MODIFIED="2013-02-13 19:58:15 +1000" MODIFIED_BY="[Empty name]" ORDER="366" O_E="0.0" SE="1.2330560838374236" STUDY_ID="STD-Melchart-1998" TOTAL_1="103" TOTAL_2="96" VAR="1.5204273058884836" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-001.05.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:51:39 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="85" TOTAL_2="85" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root and E. angustofolia root</NAME>
<DICH_DATA CI_END="22.75236973680886" CI_START="0.1800676687904199" EFFECT_SIZE="2.0240963855421685" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3570266365985089" LOG_CI_START="-0.744564257898931" LOG_EFFECT_SIZE="0.30623118934978893" MODIFIED="2012-12-11 21:11:34 +1000" MODIFIED_BY="[Empty name]" ORDER="112" O_E="0.0" SE="1.234484894470502" STUDY_ID="STD-Tiralongo-2012" TOTAL_1="85" TOTAL_2="85" VAR="1.5239529546758463" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-001.05.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:51:39 +1000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="55" TOTAL_2="46" WEIGHT="0.0" Z="0.0">
<NAME>4% phenolic extract of E. purpurea and E. angustofolia</NAME>
<DICH_DATA CI_END="64.34761858373044" CI_START="0.10181761780447243" EFFECT_SIZE="2.5596330275229358" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.80853247890035" LOG_CI_START="-0.992177068234402" LOG_EFFECT_SIZE="0.40817770533297393" MODIFIED="2013-01-21 23:12:29 +1000" MODIFIED_BY="[Empty name]" ORDER="122" O_E="0.0" SE="1.645150651722803" STUDY_ID="STD-Turner-2000" TOTAL_1="55" TOTAL_2="46" VAR="2.7065206668639634" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="1" I2="0.0" ID="CMP-001.05.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 19:58:34 +1000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="103" TOTAL_2="96" WEIGHT="0.0" Z="0.0">
<NAME>E. angustifolia root alcoholic extract</NAME>
<DICH_DATA CI_END="57.388247457286354" CI_START="0.8361378092728646" EFFECT_SIZE="6.927083333333333" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" LOG_CI_END="1.7588229623100984" LOG_CI_START="-0.07772213778302593" LOG_EFFECT_SIZE="0.8405504122635362" MODIFIED="2013-02-13 19:58:34 +1000" MODIFIED_BY="[Empty name]" ORDER="367" O_E="0.0" SE="1.078795682839565" STUDY_ID="STD-Melchart-1998" TOTAL_1="103" TOTAL_2="96" VAR="1.1638001253132833" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="137" EVENTS_2="114" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-10-23 22:52:22 +1000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="135.1" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="1075" TOTAL_2="1211" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients dropping out</NAME>
<GROUP_LABEL_1>Echinacea</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors Echinacea</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-001.06.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:29:37 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="79" TOTAL_2="78" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb pressed juice</NAME>
<DICH_DATA CI_END="75.27645135042197" CI_START="0.1195593022591327" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8766591375810535" LOG_CI_START="-0.9224166281417289" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-11 19:49:02 +1000" MODIFIED_BY="[Empty name]" ORDER="362" O_E="0.0" SE="1.6441909604340637" STUDY_ID="STD-Grimm-1999" TOTAL_1="55" TOTAL_2="54" VAR="2.7033639143730883" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.035905287327896" CI_START="0.008358953185264318" EFFECT_SIZE="0.1836734693877551" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6059409658717351" LOG_CI_START="-2.0778481070501127" LOG_EFFECT_SIZE="-0.7359535705891888" MODIFIED="2012-12-10 22:36:12 +1000" MODIFIED_BY="[Empty name]" ORDER="111" O_E="0.0" SE="1.5764709864044617" STUDY_ID="STD-Sperber-2004" TOTAL_1="24" TOTAL_2="24" VAR="2.4852607709750565" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="17" EVENTS_2="15" I2="0.0" ID="CMP-001.06.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:49:17 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="45" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea dried plant extract</NAME>
<DICH_DATA CI_END="2.8824089223895406" CI_START="0.5115477489904531" EFFECT_SIZE="1.2142857142857142" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="15" LOG_CI_END="0.45975559345899775" LOG_CI_START="-0.291113822058926" LOG_EFFECT_SIZE="0.08432088570003587" MODIFIED="2012-12-10 20:56:35 +1000" MODIFIED_BY="[Empty name]" ORDER="106" O_E="0.0" SE="0.4410644115387801" STUDY_ID="STD-O_x0027_Neill-2008" TOTAL_1="45" TOTAL_2="45" VAR="0.1945378151260504" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="54" EVENTS_2="28" I2="0.0" ID="CMP-001.06.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:49:17 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="379" TOTAL_2="376" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea alcoholic extract with 95% herb and 5% root</NAME>
<DICH_DATA CI_END="3.3400331886372294" CI_START="1.2767693269047498" EFFECT_SIZE="2.065054945054945" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="28" LOG_CI_END="0.5237507822518037" LOG_CI_START="0.10611244064510779" LOG_EFFECT_SIZE="0.3149316114484558" MODIFIED="2012-12-07 20:10:33 +1000" MODIFIED_BY="[Empty name]" ORDER="101" O_E="0.0" SE="0.24532282920290582" STUDY_ID="STD-Jawad-2012" TOTAL_1="379" TOTAL_2="376" VAR="0.060183290528118105" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="3" I2="0.0" ID="CMP-001.06.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:49:17 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root extract</NAME>
<DICH_DATA CI_END="8.866030153404651" CI_START="0.5026815887542786" EFFECT_SIZE="2.111111111111111" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.9477292040031287" LOG_CI_START="-0.29870702097612045" LOG_EFFECT_SIZE="0.3245110915135041" MODIFIED="2012-12-12 22:56:49 +1000" MODIFIED_BY="[Empty name]" ORDER="127" O_E="0.0" SE="0.7321628085116324" STUDY_ID="STD-Zhang-2003" TOTAL_1="60" TOTAL_2="60" VAR="0.5360623781676412" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="18" EVENTS_2="21" I2="0.0" ID="CMP-001.06.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:49:17 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="103" TOTAL_2="96" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root alcoholic extract</NAME>
<DICH_DATA CI_END="1.5260010427407389" CI_START="0.3748316595225588" EFFECT_SIZE="0.7563025210084033" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="21" LOG_CI_END="0.18355483037927728" LOG_CI_START="-0.4261637342856891" LOG_EFFECT_SIZE="-0.1213044519532059" ORDER="363" O_E="0.0" SE="0.35815170303977256" STUDY_ID="STD-Melchart-1998" TOTAL_1="103" TOTAL_2="96" VAR="0.12827264239028943" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="2" I2="0.0" ID="CMP-001.06.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:49:17 +1000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="88" TOTAL_2="87" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root and E. angustofolia root</NAME>
<DICH_DATA CI_END="9.204961540530016" CI_START="0.24443339497868738" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9640219783076616" LOG_CI_START="-0.6118394601962991" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2012-12-11 21:07:42 +1000" MODIFIED_BY="[Empty name]" ORDER="111" O_E="0.0" SE="0.9256688096171541" STUDY_ID="STD-Tiralongo-2012" TOTAL_1="88" TOTAL_2="87" VAR="0.8568627450980392" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="4" I2="0.0" ID="CMP-001.06.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:49:17 +1000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="55" TOTAL_2="46" WEIGHT="0.0" Z="0.0">
<NAME>4% phenolic extract of E. purpurea and E. angustofolia</NAME>
<DICH_DATA CI_END="4.16238348331758" CI_START="0.2648722791685848" EFFECT_SIZE="1.05" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6193420895749238" LOG_CI_START="-0.5769634914350474" LOG_EFFECT_SIZE="0.021189299069938092" MODIFIED="2013-01-21 23:10:00 +1000" MODIFIED_BY="[Empty name]" ORDER="121" O_E="0.0" SE="0.7027158200933887" STUDY_ID="STD-Turner-2000" TOTAL_1="55" TOTAL_2="46" VAR="0.4938095238095238" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="19" EVENTS_2="21" I2="0.0" ID="CMP-001.06.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:49:17 +1000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="103" TOTAL_2="96" WEIGHT="0.0" Z="0.0">
<NAME>E. angustifolia root alcoholic extract</NAME>
<DICH_DATA CI_END="1.6175183461916642" CI_START="0.4034440843842423" EFFECT_SIZE="0.8078231292517006" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="21" LOG_CI_END="0.2088492152168544" LOG_CI_START="-0.39421664811939827" LOG_EFFECT_SIZE="-0.09268371645127195" ORDER="364" O_E="0.0" SE="0.35424387334788343" STUDY_ID="STD-Melchart-1998" TOTAL_1="103" TOTAL_2="96" VAR="0.12548872180451126" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="6" I2="0.0" ID="CMP-001.06.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:58:51 +1000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="54" TOTAL_2="109" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root extract with CO2</NAME>
<DICH_DATA CI_END="10.219325640228078" CI_START="1.153479025208428" EFFECT_SIZE="3.433333333333333" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="6" LOG_CI_END="1.0094222382262257" LOG_CI_START="0.062009701744793935" LOG_EFFECT_SIZE="0.5357159699855097" MODIFIED="2013-02-11 20:58:51 +1000" MODIFIED_BY="[Empty name]" ORDER="117" O_E="0.0" SE="0.5565148136968842" STUDY_ID="STD-Turner-2005" TOTAL_1="54" TOTAL_2="109" VAR="0.30970873786407765" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="6" I2="0.0" ID="CMP-001.06.10" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:59:01 +1000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="55" TOTAL_2="109" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root extract with 60% ethanol</NAME>
<DICH_DATA CI_END="4.119719811359909" CI_START="0.23808941658747243" EFFECT_SIZE="0.9903846153846154" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.6148676799850368" LOG_CI_START="-0.623259909172253" LOG_EFFECT_SIZE="-0.004196114593608135" MODIFIED="2013-02-11 20:59:01 +1000" MODIFIED_BY="[Empty name]" ORDER="118" O_E="0.0" SE="0.7272822747014028" STUDY_ID="STD-Turner-2005" TOTAL_1="55" TOTAL_2="109" VAR="0.5289395070948468" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="6" I2="0.0" ID="CMP-001.06.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:59:17 +1000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="54" TOTAL_2="109" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root extract with 20% ethanol</NAME>
<DICH_DATA CI_END="3.3856364152896377" CI_START="0.12876117627869588" EFFECT_SIZE="0.6602564102564102" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.5296403172366695" LOG_CI_START="-0.8902150645352483" LOG_EFFECT_SIZE="-0.1802873736492894" MODIFIED="2013-02-11 20:59:17 +1000" MODIFIED_BY="[Empty name]" ORDER="119" O_E="0.0" SE="0.8340300796503167" STUDY_ID="STD-Turner-2005" TOTAL_1="54" TOTAL_2="109" VAR="0.6956061737615136" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="102" EVENTS_2="76" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-10-23 22:52:30 +1000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="169.54" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="868" TOTAL_2="847" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients reporting adverse effects</NAME>
<GROUP_LABEL_1>Echinacea</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors Echinacea</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="13" EVENTS_2="11" I2="0.0" ID="CMP-001.07.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:30:15 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="78" TOTAL_2="76" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb pressed juice</NAME>
<DICH_DATA CI_END="4.830221696848205" CI_START="0.610774688103367" EFFECT_SIZE="1.717607973421927" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.6839670643971093" LOG_CI_START="-0.2141189693969111" LOG_EFFECT_SIZE="0.23492404750009915" MODIFIED="2013-02-11 19:52:47 +1000" MODIFIED_BY="[Empty name]" ORDER="368" O_E="0.0" SE="0.5275401818481725" STUDY_ID="STD-Grimm-1999" TOTAL_1="54" TOTAL_2="54" VAR="0.278298643464403" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.4949108339828974" CI_START="0.06707869861371313" EFFECT_SIZE="0.4090909090909091" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.3970550289168517" LOG_CI_START="-1.1734153716826143" LOG_EFFECT_SIZE="-0.38818017138288136" MODIFIED="2012-12-10 22:39:41 +1000" MODIFIED_BY="[Empty name]" ORDER="113" O_E="0.0" SE="0.922502087265986" STUDY_ID="STD-Sperber-2004" TOTAL_1="24" TOTAL_2="22" VAR="0.851010101010101" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="3" I2="0.0" ID="CMP-001.07.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 20:22:53 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="30" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea dried plant extract</NAME>
<DICH_DATA CI_END="13.019174508591828" CI_START="0.6912880685377228" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="1.114583448308296" LOG_CI_START="-0.1603409388689709" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-02-13 20:22:53 +1000" MODIFIED_BY="[Empty name]" ORDER="108" O_E="0.0" SE="0.7488968960054252" STUDY_ID="STD-O_x0027_Neill-2008" TOTAL_1="28" TOTAL_2="30" VAR="0.5608465608465607" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="35" EVENTS_2="35" I2="0.0" ID="CMP-001.07.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:52:59 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="355" TOTAL_2="362" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea alcoholic extract with 95% herb and 5% root</NAME>
<DICH_DATA CI_END="1.6733996112152427" CI_START="0.6240162293731317" EFFECT_SIZE="1.021875" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="35" LOG_CI_END="0.2235996637490754" LOG_CI_START="-0.20480411506831503" LOG_EFFECT_SIZE="0.009397774340380135" MODIFIED="2013-01-21 23:45:06 +1000" MODIFIED_BY="[Empty name]" ORDER="103" O_E="0.0" SE="0.2516465003102414" STUDY_ID="STD-Jawad-2012" TOTAL_1="355" TOTAL_2="362" VAR="0.06332596111839231" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="15" EVENTS_2="4" I2="0.0" ID="CMP-001.07.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 21:00:28 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root extract</NAME>
<DICH_DATA CI_END="15.045766414573244" CI_START="1.4474355893684454" EFFECT_SIZE="4.666666666666667" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="4" LOG_CI_END="1.1774143151164698" LOG_CI_START="0.16059924680068163" LOG_EFFECT_SIZE="0.6690067809585756" MODIFIED="2013-02-11 21:00:28 +1000" MODIFIED_BY="[Empty name]" ORDER="128" O_E="0.0" SE="0.5972822044444583" STUDY_ID="STD-Zhang-2003" TOTAL_1="60" TOTAL_2="60" VAR="0.35674603174603176" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="11" I2="0.0" ID="CMP-001.07.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:52:59 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="99" TOTAL_2="90" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root alcoholic extract</NAME>
<DICH_DATA CI_END="2.001472867150555" CI_START="0.3253412208093649" EFFECT_SIZE="0.8069458631256384" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" LOG_CI_END="0.3013497069933777" LOG_CI_START="-0.4876609080187706" LOG_EFFECT_SIZE="-0.09315560051269639" ORDER="369" O_E="0.0" SE="0.46346874092367" STUDY_ID="STD-Melchart-1998" TOTAL_1="99" TOTAL_2="90" VAR="0.21480327381337197" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-001.07.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:52:59 +1000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="85" TOTAL_2="85" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root and E. angustofolia root</NAME>
<DICH_DATA CI_END="30.151751819700106" CI_START="0.31322817999755026" EFFECT_SIZE="3.073170731707317" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4793125497606536" LOG_CI_START="-0.5041391729649987" LOG_EFFECT_SIZE="0.48758668839782743" MODIFIED="2012-12-11 21:18:06 +1000" MODIFIED_BY="[Empty name]" ORDER="113" O_E="0.0" SE="1.1650893601734222" STUDY_ID="STD-Tiralongo-2012" TOTAL_1="85" TOTAL_2="85" VAR="1.3574332171893146" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-001.07.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 22:04:34 +1000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="63" TOTAL_2="54" WEIGHT="0.0" Z="0.0">
<NAME>4% phenolic extract of E. purpurea and E. angustofolia</NAME>
<DICH_DATA CI_END="65.5492227420247" CI_START="0.10440178714144455" EFFECT_SIZE="2.616" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.81656754635637" LOG_CI_START="-0.9812920670519107" LOG_EFFECT_SIZE="0.41763773965222967" MODIFIED="2013-02-13 22:04:34 +1000" MODIFIED_BY="[Empty name]" ORDER="123" O_E="0.0" SE="1.6434765865444745" STUDY_ID="STD-Turner-2000" TOTAL_1="63" TOTAL_2="54" VAR="2.7010152905198774" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="18" EVENTS_2="11" I2="0.0" ID="CMP-001.07.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 19:52:59 +1000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="100" TOTAL_2="90" WEIGHT="0.0" Z="0.0">
<NAME>E. angustifolia root alcoholic extract</NAME>
<DICH_DATA CI_END="3.548218035939626" CI_START="0.7004478693645647" EFFECT_SIZE="1.5764966740576496" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="11" LOG_CI_END="0.5500102991236117" LOG_CI_START="-0.15462418142000006" LOG_EFFECT_SIZE="0.19769305885180574" ORDER="370" O_E="0.0" SE="0.4139057818682499" STUDY_ID="STD-Melchart-1998" TOTAL_1="100" TOTAL_2="90" VAR="0.17131799626396726" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2014-07-02 23:17:47 +1000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Echinacea versus placebo to treat patients with common cold</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2013-10-23 22:54:24 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="11.98" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="252" TOTAL_2="249" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Duration: mean difference</NAME>
<GROUP_LABEL_1>Echinacea</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors Echinacea</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.01.01" MODIFIED="2013-04-24 19:05:48 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="73" WEIGHT="0.0" Z="0.0">
<NAME>Mixture of E. angustifolia root (50%), E. purpurea root (25%) and E. purpurea herb (25%)</NAME>
<CONT_DATA CI_END="1.290055709413669" CI_START="-0.25005570941366995" EFFECT_SIZE="0.5199999999999996" ESTIMABLE="YES" MEAN_1="6.27" MEAN_2="5.75" MODIFIED="2013-02-14 19:02:23 +1000" MODIFIED_BY="[Empty name]" ORDER="144" SD_1="2.34" SD_2="2.34" SE="0.39289278552451506" STUDY_ID="STD-Barrett-2002" TOTAL_1="69" TOTAL_2="73" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.01.02" MODIFIED="2013-04-24 19:05:48 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="183" TOTAL_2="176" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root and E. angustofolia root</NAME>
<CONT_DATA CI_END="0.1883374078291573" CI_START="-1.2483374078291578" EFFECT_SIZE="-0.5300000000000002" ESTIMABLE="YES" MEAN_1="6.34" MEAN_2="6.87" MODIFIED="2013-02-14 19:02:46 +1000" MODIFIED_BY="[Empty name]" ORDER="145" SD_1="3.31" SD_2="3.62" SE="0.3665054120868094" STUDY_ID="STD-Barrett-2010" TOTAL_1="183" TOTAL_2="176" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<IV_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_DATA="NO" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2014-07-02 23:17:47 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Duration (inverse variance)</NAME>
<GROUP_LABEL_1>Echinacea</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors Echinacea</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<EFFECT_MEASURE>Mean Difference</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-04-24 19:19:24 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb freeze-dried pressed juice</NAME>
<IV_DATA CI_END="4.683895555166157" CI_START="-6.683895555166157" EFFECT_SIZE="-1.0" ESTIMABLE="YES" ESTIMATE="-1.0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-04-24 19:19:24 +1000" MODIFIED_BY="[Empty name]" ORDER="143" SE="2.9" STUDY_ID="STD-Yale-2004" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.02.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2014-07-02 23:17:19 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb pressed juice</NAME>
<IV_DATA CI_END="-0.395207864546268" CI_START="-5.604792135453732" EFFECT_SIZE="-3.0" ESTIMABLE="YES" ESTIMATE="-3.0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-02 23:17:19 +1000" MODIFIED_BY="[Empty name]" ORDER="139" SE="1.329" STUDY_ID="STD-Schulten-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0"/>
<IV_DATA CI_END="0.7095069624034996" CI_START="-0.7095069624034996" EFFECT_SIZE="0.0" ESTIMABLE="YES" ESTIMATE="0.0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-04-24 19:20:19 +1000" MODIFIED_BY="[Empty name]" ORDER="140" SE="0.362" STUDY_ID="STD-Taylor-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.02.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2014-07-02 23:17:23 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Tea E. purpurea and angustifolia</NAME>
<IV_DATA CI_END="-1.1805348743849575" CI_START="-2.7994651256150425" EFFECT_SIZE="-1.99" ESTIMABLE="YES" ESTIMATE="-1.99" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-04-24 19:20:37 +1000" MODIFIED_BY="[Empty name]" ORDER="144" SE="0.413" STUDY_ID="STD-Lindenmuth-2000" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.02.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-04-24 19:20:48 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Mixture of E. angustifolia root (50%), E. purpurea root (25%) and E. purpurea herb (25%)</NAME>
<IV_DATA CI_END="0.17462797083637815" CI_START="-1.134627970836378" EFFECT_SIZE="-0.48" ESTIMABLE="YES" ESTIMATE="-0.48" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-04-24 19:20:48 +1000" MODIFIED_BY="[Empty name]" ORDER="141" SE="0.334" STUDY_ID="STD-Barrett-2002" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.02.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-04-24 19:21:32 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root and E. angustofolia root</NAME>
<IV_DATA CI_END="1.2393067823261998" CI_START="-0.19930678232619992" EFFECT_SIZE="0.52" ESTIMABLE="YES" ESTIMATE="0.52" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-04-24 19:21:32 +1000" MODIFIED_BY="[Empty name]" ORDER="142" SE="0.367" STUDY_ID="STD-Barrett-2010" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2013-10-23 22:54:42 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="0.87" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="841" TOTAL_2="973" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Total severity and duration measures (for example, area under the curve)</NAME>
<GROUP_LABEL_1>Echinacea</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors Echinacea</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.01" MODIFIED="2013-02-11 20:30:42 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="241" TOTAL_2="246" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea pressed juice</NAME>
<CONT_DATA CI_END="-0.10579474856483967" CI_START="-1.0000276512451831" EFFECT_SIZE="-0.5529111999050114" ESTIMABLE="YES" MEAN_1="36.18" MEAN_2="51.63" ORDER="373" SD_1="22.12" SD_2="32.51" SE="0.2281248302861528" STUDY_ID="STD-Schulten-2001" TOTAL_1="41" TOTAL_2="39" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.1467673839034612" CI_START="-0.24195287579344701" EFFECT_SIZE="-0.0475927459449929" ESTIMABLE="YES" MEAN_1="30.53" MEAN_2="31.63" MODIFIED="2013-02-11 19:59:37 +1000" MODIFIED_BY="[Empty name]" ORDER="374" SD_1="22.41" SD_2="23.69" SE="0.09916515373830438" STUDY_ID="STD-Taylor-2003" TOTAL_1="200" TOTAL_2="207" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.02" MODIFIED="2013-02-14 18:41:56 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="84" TOTAL_2="100" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea standardized</NAME>
<CONT_DATA CI_END="0.009064814173471769" CI_START="-0.6911741680286294" EFFECT_SIZE="-0.3410546769275788" ESTIMABLE="YES" MEAN_1="16.3" MEAN_2="19.9" ORDER="375" SD_1="10.6" SD_2="10.4" SE="0.1786356758913676" STUDY_ID="STD-Goel-2004" TOTAL_1="59" TOTAL_2="69" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.6011515856683401" CI_START="-0.45294325437652655" EFFECT_SIZE="0.07410416564590679" ESTIMABLE="YES" MEAN_1="7.4" MEAN_2="7.0" ORDER="376" SD_1="5.7" SD_2="5.0" SE="0.2689066861328658" STUDY_ID="STD-Goel-2005" TOTAL_1="25" TOTAL_2="31" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.03" MODIFIED="2013-02-14 18:42:24 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="30" WEIGHT="0.0" Z="0.0">
<NAME>Mixture of 80% E. purpurea herb and 20% E. angustifolia roots</NAME>
<CONT_DATA CI_END="0.5199277641891917" CI_START="-0.5199277641891917" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="2.5" MEAN_2="2.5" MODIFIED="2013-02-14 18:42:24 +1000" MODIFIED_BY="[Empty name]" ORDER="141" SD_1="0.6" SD_2="0.9" SE="0.2652741419180738" STUDY_ID="STD-Kim-2002a" TOTAL_1="27" TOTAL_2="30" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.04" MODIFIED="2013-02-11 20:00:24 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="73" WEIGHT="0.0" Z="0.0">
<NAME>Mixture of E. angustifolia root (50%), E. purpurea root (25%) and E. purpurea herb (25%)</NAME>
<CONT_DATA CI_END="0.36195609501755954" CI_START="-0.2962567962183167" EFFECT_SIZE="0.03284964939962145" ESTIMABLE="YES" MEAN_1="206.06" MEAN_2="202.27" ORDER="378" SD_1="116.1" SD_2="113.47" SE="0.16791453731491382" STUDY_ID="STD-Barrett-2002" TOTAL_1="69" TOTAL_2="73" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.05" MODIFIED="2013-02-11 20:00:28 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="183" TOTAL_2="176" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root and E. angustofolia root</NAME>
<CONT_DATA CI_END="0.0655530739957507" CI_START="-0.34882147425105625" EFFECT_SIZE="-0.14163420012765277" ESTIMABLE="YES" MEAN_1="236.0" MEAN_2="264.0" MODIFIED="2012-12-03 20:38:01 +1000" MODIFIED_BY="[Empty name]" ORDER="233" SD_1="182.0" SD_2="212.0" SE="0.10570973536129757" STUDY_ID="STD-Barrett-2010" TOTAL_1="183" TOTAL_2="176" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.06" MODIFIED="2013-02-11 20:00:28 +1000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="106" TOTAL_2="84" WEIGHT="0.0" Z="0.0">
<NAME>E. angustifolia</NAME>
<CONT_DATA CI_END="0.16906497057091718" CI_START="-0.404046999918116" EFFECT_SIZE="-0.1174910146735994" ESTIMABLE="YES" MEAN_1="14.18" MEAN_2="14.9" ORDER="377" SD_1="5.78" SD_2="6.49" SE="0.14620471983405492" STUDY_ID="STD-Galea-1996" TOTAL_1="106" TOTAL_2="84" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.07" MODIFIED="2013-01-24 21:35:01 +1000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="88" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root extract with CO2</NAME>
<CONT_DATA CI_END="0.32952664704759843" CI_START="-0.39987830847835987" EFFECT_SIZE="-0.03517583071538072" ESTIMABLE="YES" MEAN_1="14.6" MEAN_2="15.05" MODIFIED="2013-01-24 21:35:01 +1000" MODIFIED_BY="[Empty name]" ORDER="124" SD_1="11.15" SD_2="13.41" SE="0.18607611192843632" STUDY_ID="STD-Turner-2005" TOTAL_1="43" TOTAL_2="88" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.08" MODIFIED="2013-01-24 21:35:06 +1000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="88" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root extract with 60% ethanol</NAME>
<CONT_DATA CI_END="0.6584194954998275" CI_START="-0.06893679861344915" EFFECT_SIZE="0.29474134844318917" ESTIMABLE="YES" MEAN_1="19.2" MEAN_2="15.05" MODIFIED="2013-01-24 21:35:06 +1000" MODIFIED_BY="[Empty name]" ORDER="125" SD_1="15.12" SD_2="13.41" SE="0.1855534846177201" STUDY_ID="STD-Turner-2005" TOTAL_1="44" TOTAL_2="88" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.09" MODIFIED="2013-01-24 21:35:10 +1000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="88" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root extract with 20% ethanol</NAME>
<CONT_DATA CI_END="0.40603210485019003" CI_START="-0.31781319768172667" EFFECT_SIZE="0.04410945358423168" ESTIMABLE="YES" MEAN_1="15.64" MEAN_2="15.05" MODIFIED="2013-01-24 21:35:10 +1000" MODIFIED_BY="[Empty name]" ORDER="126" SD_1="13.07" SD_2="13.41" SE="0.18465780704174056" STUDY_ID="STD-Turner-2005" TOTAL_1="44" TOTAL_2="88" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2013-10-23 22:54:51 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1.72" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="703" TOTAL_2="727" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Sum score after 2 to 4 days</NAME>
<GROUP_LABEL_1>Echinacea</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors Echinacea</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.04.01" MODIFIED="2013-02-13 23:08:05 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="63" TOTAL_2="64" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb freeze-dried pressed juice</NAME>
<CONT_DATA CI_END="0.2532106579787962" CI_START="-0.4428890974264991" EFFECT_SIZE="-0.09483921972385145" ESTIMABLE="YES" MEAN_1="6.72" MEAN_2="7.24" MODIFIED="2013-02-13 23:08:05 +1000" MODIFIED_BY="[Empty name]" ORDER="382" SD_1="5.45" SD_2="5.45" SE="0.1775797312848709" STUDY_ID="STD-Yale-2004" TOTAL_1="63" TOTAL_2="64" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.04.02" MODIFIED="2013-02-11 20:31:06 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="185" TOTAL_2="195" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb pressed juice</NAME>
<CONT_DATA CI_END="0.1845259747028639" CI_START="-0.21779650545075266" EFFECT_SIZE="-0.016635265373944386" ESTIMABLE="YES" MEAN_1="4.15" MEAN_2="4.19" ORDER="381" SD_1="2.41" SD_2="2.39" SE="0.10263517169883858" STUDY_ID="STD-Taylor-2003" TOTAL_1="185" TOTAL_2="195" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.04.03" MODIFIED="2013-01-22 20:13:20 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="84" TOTAL_2="100" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea standardized</NAME>
<CONT_DATA CI_END="-0.16851136299030794" CI_START="-0.8756253897241357" EFFECT_SIZE="-0.5220683763572218" ESTIMABLE="YES" MEAN_1="20.0" MEAN_2="25.5" ORDER="383" SD_1="11.0" SD_2="10.0" SE="0.18038954600988918" STUDY_ID="STD-Goel-2004" TOTAL_1="59" TOTAL_2="69" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.7041545172914901" CI_START="-0.3517280430922002" EFFECT_SIZE="0.17621323709964498" ESTIMABLE="YES" MEAN_1="9.7" MEAN_2="8.9" ORDER="384" SD_1="4.8" SD_2="4.2" SE="0.26936274561990864" STUDY_ID="STD-Goel-2005" TOTAL_1="25" TOTAL_2="31" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.04.04" MODIFIED="2013-02-11 20:05:06 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="59" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root 450 mg</NAME>
<CONT_DATA CI_END="0.009087983802284871" CI_START="-0.7153861038479792" EFFECT_SIZE="-0.3531490600228471" ESTIMABLE="YES" MEAN_1="12.9" MEAN_2="13.9" MODIFIED="2012-12-03 20:27:36 +1000" MODIFIED_BY="[Empty name]" ORDER="386" SD_1="2.5" SD_2="3.1" SE="0.18481821435618795" STUDY_ID="STD-Br_x00e4_unig-1992" TOTAL_1="60" TOTAL_2="59" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.04.05" MODIFIED="2013-02-11 20:05:06 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="59" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root 900 mg</NAME>
<CONT_DATA CI_END="-0.8832498297338434" CI_START="-1.6742776632716974" EFFECT_SIZE="-1.2787637465027704" ESTIMABLE="YES" MEAN_1="10.1" MEAN_2="13.9" MODIFIED="2012-12-03 20:27:13 +1000" MODIFIED_BY="[Empty name]" ORDER="385" SD_1="2.8" SD_2="3.1" SE="0.2017965227364841" STUDY_ID="STD-Br_x00e4_unig-1992" TOTAL_1="60" TOTAL_2="59" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.04.06" MODIFIED="2013-01-22 20:13:20 +1000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="68" TOTAL_2="73" WEIGHT="0.0" Z="0.0">
<NAME>Mixture of E. angustifolia root (50%), E. purpurea root (25%) and E. purpurea herb (25%)</NAME>
<CONT_DATA CI_END="0.15720253336416906" CI_START="-0.504727641897406" EFFECT_SIZE="-0.17376255426661846" ESTIMABLE="YES" MEAN_1="33.25" MEAN_2="36.37" ORDER="388" SD_1="16.42" SD_2="19.1" SE="0.16886284148147512" STUDY_ID="STD-Barrett-2002" TOTAL_1="68" TOTAL_2="73" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.04.07" MODIFIED="2013-01-28 18:47:32 +1000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="183" TOTAL_2="177" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root and E. angustofolia root</NAME>
<CONT_DATA CI_END="0.1202357510057777" CI_START="-0.29321357998998404" EFFECT_SIZE="-0.08648891449210318" ESTIMABLE="YES" MEAN_1="38.07" MEAN_2="40.34" MODIFIED="2013-01-28 18:47:32 +1000" MODIFIED_BY="[Empty name]" ORDER="136" SD_1="25.25" SD_2="27.13" SE="0.10547370621526653" STUDY_ID="STD-Barrett-2010" TOTAL_1="183" TOTAL_2="177" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.05" MODIFIED="2013-10-23 22:54:59 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="2.76" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="735" TOTAL_2="778" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Sum scores after 5 to 10 days</NAME>
<GROUP_LABEL_1>Echinacea</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors Echinacea</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.05.01" MODIFIED="2013-02-13 23:08:28 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="63" TOTAL_2="61" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb freeze-dried pressed juice</NAME>
<CONT_DATA CI_END="0.5399957155966003" CI_START="-0.16572524310834338" EFFECT_SIZE="0.18713523624412845" ESTIMABLE="YES" MEAN_1="3.19" MEAN_2="2.45" MODIFIED="2013-02-13 23:08:28 +1000" MODIFIED_BY="[Empty name]" ORDER="392" SD_1="3.93" SD_2="3.93" SE="0.18003416498251512" STUDY_ID="STD-Yale-2004" TOTAL_1="63" TOTAL_2="61" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.05.02" MODIFIED="2013-02-11 20:31:26 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="105" TOTAL_2="119" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb pressed juice</NAME>
<CONT_DATA CI_END="0.10367227122624337" CI_START="-0.42201823417512796" EFFECT_SIZE="-0.15917298147444228" ESTIMABLE="YES" MEAN_1="4.68" MEAN_2="7.55" ORDER="391" SD_1="13.32" SD_2="21.24" SE="0.13410718501665106" STUDY_ID="STD-Taylor-2003" TOTAL_1="105" TOTAL_2="119" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.05.03" MODIFIED="2013-01-22 20:13:33 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="84" TOTAL_2="100" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea standardized</NAME>
<CONT_DATA CI_END="-0.14124798601556238" CI_START="-0.8471200202127922" EFFECT_SIZE="-0.4941840031141773" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="10.7" ORDER="393" SD_1="7.0" SD_2="7.8" SE="0.1800727053571031" STUDY_ID="STD-Goel-2004" TOTAL_1="59" TOTAL_2="69" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.4957851859785351" CI_START="-0.5579929176761258" EFFECT_SIZE="-0.03110386584879535" ESTIMABLE="YES" MEAN_1="2.7" MEAN_2="2.8" ORDER="394" SD_1="3.0" SD_2="3.3" SE="0.2688258845485754" STUDY_ID="STD-Goel-2005" TOTAL_1="25" TOTAL_2="31" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.05.04" MODIFIED="2013-10-23 22:53:16 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="55" TOTAL_2="64" WEIGHT="0.0" Z="0.0">
<NAME>95% E. purpurea herb and 5% E. purpurea root (39 mg crude extract/day)</NAME>
<CONT_DATA CI_END="-0.5694489712273372" CI_START="-1.3308638413230438" EFFECT_SIZE="-0.9501564062751905" ESTIMABLE="YES" MEAN_1="4.1" MEAN_2="5.3" ORDER="399" SD_1="1.2" SD_2="1.3" SE="0.19424205651268336" STUDY_ID="STD-Brinkeborn-1999" TOTAL_1="55" TOTAL_2="64" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.05.05" MODIFIED="2013-10-23 22:53:35 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="64" TOTAL_2="64" WEIGHT="0.0" Z="0.0">
<NAME>95% E. purpurea herb and 5% E. purpurea root (290 mg crude extract/day)</NAME>
<CONT_DATA CI_END="-1.2840271970411994" CI_START="-2.0945248166761763" EFFECT_SIZE="-1.6892760068586878" ESTIMABLE="YES" MEAN_1="3.4" MEAN_2="5.3" ORDER="400" SD_1="0.9" SD_2="1.3" SE="0.20676339617158235" STUDY_ID="STD-Brinkeborn-1999" TOTAL_1="64" TOTAL_2="64" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.05.06" MODIFIED="2013-02-11 20:07:54 +1000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="63" TOTAL_2="64" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root (178 mg crude extract/day)</NAME>
<CONT_DATA CI_END="-0.6996337034997336" CI_START="-1.4451481919514628" EFFECT_SIZE="-1.0723909477255982" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="5.3" ORDER="397" SD_1="1.1" SD_2="1.3" SE="0.19018576217018582" STUDY_ID="STD-Brinkeborn-1999" TOTAL_1="63" TOTAL_2="64" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.05.07" MODIFIED="2013-02-11 20:07:54 +1000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="59" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root 450 mg</NAME>
<CONT_DATA CI_END="0.35935189607879353" CI_START="-0.35935189607879353" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="10.1" MEAN_2="10.1" MODIFIED="2012-12-03 20:27:58 +1000" MODIFIED_BY="[Empty name]" ORDER="396" SD_1="3.5" SD_2="4.2" SE="0.18334617315079021" STUDY_ID="STD-Br_x00e4_unig-1992" TOTAL_1="60" TOTAL_2="59" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.05.08" MODIFIED="2013-02-11 20:07:44 +1000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="59" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root 900 mg</NAME>
<CONT_DATA CI_END="-1.0115169141736386" CI_START="-1.817848115319135" EFFECT_SIZE="-1.4146825147463868" ESTIMABLE="YES" MEAN_1="4.4" MEAN_2="10.1" MODIFIED="2012-12-03 20:27:49 +1000" MODIFIED_BY="[Empty name]" ORDER="395" SD_1="3.8" SD_2="4.2" SE="0.20570051478132606" STUDY_ID="STD-Br_x00e4_unig-1992" TOTAL_1="60" TOTAL_2="59" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.05.09" MODIFIED="2013-02-14 18:43:25 +1000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="68" TOTAL_2="73" WEIGHT="0.0" Z="0.0">
<NAME>Mixture of E. angustifolia root (50%), E. purpurea root (25%) and E. purpurea herb (25%)</NAME>
<CONT_DATA CI_END="0.5253918989489593" CI_START="-0.13685772504273333" EFFECT_SIZE="0.19426708695311298" ESTIMABLE="YES" MEAN_1="11.01" MEAN_2="8.0" ORDER="402" SD_1="16.08" SD_2="14.76" SE="0.16894433500192685" STUDY_ID="STD-Barrett-2002" TOTAL_1="68" TOTAL_2="73" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.05.10" MODIFIED="2013-02-14 18:43:25 +1000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="113" TOTAL_2="115" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root and E. angustofolia root</NAME>
<CONT_DATA CI_END="0.18191800607251457" CI_START="-0.33750891576539715" EFFECT_SIZE="-0.07779545484644129" ESTIMABLE="YES" MEAN_1="16.04" MEAN_2="17.52" MODIFIED="2013-01-28 18:52:37 +1000" MODIFIED_BY="[Empty name]" ORDER="137" SD_1="19.63" SD_2="18.28" SE="0.13250930270532646" STUDY_ID="STD-Barrett-2010" TOTAL_1="113" TOTAL_2="115" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="147" EVENTS_2="248" I2="0.0" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-10-23 22:55:08 +1000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="248" TOTAL_2="408" WEIGHT="0.0" Z="0.0">
<NAME>Early treatment of prodromi: patients developing a 'full' cold</NAME>
<GROUP_LABEL_1>Echinacea</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors Echinacea</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="59" EVENTS_2="74" I2="0.0" ID="CMP-002.06.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:30:53 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="101" TOTAL_2="99" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb pressed juice</NAME>
<DICH_DATA CI_END="0.967524388575274" CI_START="0.45936252325268007" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="36" LOG_CI_END="-0.014338078825674469" LOG_CI_START="-0.3378444392856881" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="371" O_E="0.0" SE="0.19002923751652304" STUDY_ID="STD-Hoheisel-1997" TOTAL_1="60" TOTAL_2="60" VAR="0.03611111111111112" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.0043402498445666" CI_START="0.76427477926873" EFFECT_SIZE="0.8761232349165597" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="38" LOG_CI_END="0.0018808677857420776" LOG_CI_START="-0.11675047170528367" LOG_EFFECT_SIZE="-0.057434801959770784" ORDER="372" O_E="0.0" SE="0.06968463605162985" STUDY_ID="STD-Schulten-2001" TOTAL_1="41" TOTAL_2="39" VAR="0.004855948501648111" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="27" EVENTS_2="58" I2="0.0" ID="CMP-002.06.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 22:47:15 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="103" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root extract with CO2</NAME>
<DICH_DATA CI_END="1.3510549414553243" CI_START="0.7385680316622685" EFFECT_SIZE="0.9989224137931034" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="58" LOG_CI_END="0.13067301022537053" LOG_CI_START="-0.13160949437410047" LOG_EFFECT_SIZE="-4.682420743649936E-4" MODIFIED="2013-02-13 22:47:15 +1000" MODIFIED_BY="[Empty name]" ORDER="127" O_E="0.0" SE="0.1540660415210661" STUDY_ID="STD-Turner-2005" TOTAL_1="48" TOTAL_2="103" VAR="0.023736345149970858" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="33" EVENTS_2="58" I2="0.0" ID="CMP-002.06.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 22:47:17 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="103" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root extract with 60% ethanol</NAME>
<DICH_DATA CI_END="1.5764226617851889" CI_START="0.9455645850325081" EFFECT_SIZE="1.2209051724137931" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="58" LOG_CI_END="0.1976726694170598" LOG_CI_START="-0.024308802127989408" LOG_EFFECT_SIZE="0.0866819336445352" MODIFIED="2013-02-13 22:47:17 +1000" MODIFIED_BY="[Empty name]" ORDER="128" O_E="0.0" SE="0.1303930152115677" STUDY_ID="STD-Turner-2005" TOTAL_1="48" TOTAL_2="103" VAR="0.01700233841596413" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="28" EVENTS_2="58" I2="0.0" ID="CMP-002.06.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 22:47:21 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="51" TOTAL_2="103" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root extract with 20% ethanol</NAME>
<DICH_DATA CI_END="1.317860324263604" CI_START="0.7213147109170686" EFFECT_SIZE="0.9749830966869506" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="58" LOG_CI_END="0.11986938323518492" LOG_CI_START="-0.14187521046214938" LOG_EFFECT_SIZE="-0.01100291361348224" MODIFIED="2013-02-13 22:47:21 +1000" MODIFIED_BY="[Empty name]" ORDER="129" O_E="0.0" SE="0.153750069994449" STUDY_ID="STD-Turner-2005" TOTAL_1="51" TOTAL_2="103" VAR="0.02363908402329797" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-10-23 22:55:16 +1000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="505.59" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="1088" TOTAL_2="1118" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients dropping out due to adverse effects</NAME>
<GROUP_LABEL_1>Echinacea</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors Echinacea</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="0" I2="0.0" ID="CMP-002.07.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:20:36 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="3" TAU2="0.0" TOTAL_1="316" TOTAL_2="320" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb pressed juice</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="449" O_E="0.0" SE="0.0" STUDY_ID="STD-Hoheisel-1997" TOTAL_1="60" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="74.00182581627114" CI_START="0.11568690947248392" EFFECT_SIZE="2.925925925925926" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8692424350302934" LOG_CI_START="-0.9367157807673855" LOG_EFFECT_SIZE="0.46626332713145413" ORDER="450" O_E="0.0" SE="1.6482337456767353" STUDY_ID="STD-Schulten-2001" TOTAL_1="41" TOTAL_2="39" VAR="2.7166744803875607" WEIGHT="0.0"/>
<DICH_DATA CI_END="108.67915492185851" CI_START="0.2475970456503716" EFFECT_SIZE="5.187353629976581" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.036146252728918" LOG_CI_START="-0.6062545416607886" LOG_EFFECT_SIZE="0.7149458555340645" MODIFIED="2013-02-11 20:20:36 +1000" MODIFIED_BY="[Empty name]" ORDER="451" O_E="0.0" SE="1.5521593067193988" STUDY_ID="STD-Taylor-2003" TOTAL_1="215" TOTAL_2="221" VAR="2.4091985134356446" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:25:03 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="85" TOTAL_2="105" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea standardized</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="453" O_E="0.0" SE="0.0" STUDY_ID="STD-Goel-2004" TOTAL_1="59" TOTAL_2="69" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="454" O_E="0.0" SE="0.0" STUDY_ID="STD-Goel-2005" TOTAL_1="26" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:27:15 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="55" TOTAL_2="64" WEIGHT="0.0" Z="0.0">
<NAME>95% E. purpurea herb and 5% E. purpurea root (39 mg crude extract/day)</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-12-05 20:02:04 +1000" MODIFIED_BY="[Empty name]" ORDER="459" O_E="0.0" SE="0.0" STUDY_ID="STD-Brinkeborn-1999" TOTAL_1="55" TOTAL_2="64" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:27:23 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="64" TOTAL_2="64" WEIGHT="0.0" Z="0.0">
<NAME>95% E. purpurea herb and 5% E. purpurea root (290 mg crude extract/day)</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-12-05 20:02:14 +1000" MODIFIED_BY="[Empty name]" ORDER="460" O_E="0.0" SE="0.0" STUDY_ID="STD-Brinkeborn-1999" TOTAL_1="64" TOTAL_2="64" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:27:23 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="63" TOTAL_2="64" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root (178 mg crude extract/day)</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-12-05 20:01:26 +1000" MODIFIED_BY="[Empty name]" ORDER="457" O_E="0.0" SE="0.0" STUDY_ID="STD-Brinkeborn-1999" TOTAL_1="63" TOTAL_2="64" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:27:21 +1000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root 450 mg</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="456" O_E="0.0" SE="0.0" STUDY_ID="STD-Br_x00e4_unig-1992" TOTAL_1="60" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:27:19 +1000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root 900 mg</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="455" O_E="0.0" SE="0.0" STUDY_ID="STD-Br_x00e4_unig-1992" TOTAL_1="60" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:25:03 +1000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="47" WEIGHT="0.0" Z="0.0">
<NAME>Tea E. purpurea and angustifolia</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="462" O_E="0.0" SE="0.0" STUDY_ID="STD-Lindenmuth-2000" TOTAL_1="48" TOTAL_2="47" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:25:03 +1000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="73" TOTAL_2="75" WEIGHT="0.0" Z="0.0">
<NAME>Mixture of E. angustifolia root (50%), E. purpurea root (25%) and E. purpurea herb (25%)</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="461" O_E="0.0" SE="0.0" STUDY_ID="STD-Barrett-2002" TOTAL_1="73" TOTAL_2="75" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.10" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:25:03 +1000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="184" TOTAL_2="179" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root and E. angustofolia root</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-12-03 20:38:46 +1000" MODIFIED_BY="[Empty name]" ORDER="235" O_E="0.0" SE="0.0" STUDY_ID="STD-Barrett-2010" TOTAL_1="184" TOTAL_2="179" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:25:03 +1000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="80" TOTAL_2="80" WEIGHT="0.0" Z="0.0">
<NAME>E. pallida root</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="458" O_E="0.0" SE="0.0" STUDY_ID="STD-Dorn-1997" TOTAL_1="80" TOTAL_2="80" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="47" EVENTS_2="48" I2="0.0" I2_Q="0.0" ID="CMP-002.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-10-23 22:55:25 +1000" MODIFIED_BY="Jenny Bellorini" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="166.81" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="1315" TOTAL_2="1498" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients dropping out</NAME>
<GROUP_LABEL_1>Echinacea</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors Echinacea</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-002.08.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 23:11:37 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="63" TOTAL_2="65" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb freeze-dried pressed juice</NAME>
<DICH_DATA CI_END="78.63468168823745" CI_START="0.12570453377289637" EFFECT_SIZE="3.144" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8956141331104936" LOG_CI_START="-0.9006490583757532" LOG_EFFECT_SIZE="0.4974825373673703" MODIFIED="2013-02-13 23:11:37 +1000" MODIFIED_BY="[Empty name]" ORDER="140" O_E="0.0" SE="1.6425388404050558" STUDY_ID="STD-Yale-2004" TOTAL_1="63" TOTAL_2="65" VAR="2.6979338422391854" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="23" EVENTS_2="18" I2="0.0" ID="CMP-002.08.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 23:11:13 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="3" TAU2="0.0" TOTAL_1="322" TOTAL_2="323" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb pressed juice</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="435" O_E="0.0" SE="0.0" STUDY_ID="STD-Hoheisel-1997" TOTAL_1="60" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="22.395207364556576" CI_START="0.16956760354295924" EFFECT_SIZE="1.9487179487179487" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3501550880741082" LOG_CI_START="-0.7706571175655238" LOG_EFFECT_SIZE="0.28974898525429216" ORDER="436" O_E="0.0" SE="1.2457755877824503" STUDY_ID="STD-Schulten-2001" TOTAL_1="41" TOTAL_2="39" VAR="1.5519568151147098" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.4943711922048073" CI_START="0.6553304744120811" EFFECT_SIZE="1.278529411764706" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="17" LOG_CI_END="0.39696108215412595" LOG_CI_START="-0.1835396358569622" LOG_EFFECT_SIZE="0.1067107231485819" MODIFIED="2013-02-11 20:10:28 +1000" MODIFIED_BY="[Empty name]" ORDER="437" O_E="0.0" SE="0.34098899528461096" STUDY_ID="STD-Taylor-2003" TOTAL_1="221" TOTAL_2="224" VAR="0.11627349490520844" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="17" I2="0.0" ID="CMP-002.08.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 23:11:10 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="85" TOTAL_2="105" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea standardized</NAME>
<DICH_DATA CI_END="1.3314574795701417" CI_START="0.1452821996186019" EFFECT_SIZE="0.4398148148148148" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="12" LOG_CI_END="0.12432730169278441" LOG_CI_START="-0.8377875934169506" LOG_EFFECT_SIZE="-0.3567301458620831" ORDER="439" O_E="0.0" SE="0.5651510519329984" STUDY_ID="STD-Goel-2004" TOTAL_1="59" TOTAL_2="69" VAR="0.3193957115009747" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.2623484909263882" CI_START="0.02718590891132573" EFFECT_SIZE="0.248" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.3545595042273532" LOG_CI_START="-1.5656561425749207" LOG_EFFECT_SIZE="-0.6055483191737837" ORDER="440" O_E="0.0" SE="1.1279441761524056" STUDY_ID="STD-Goel-2005" TOTAL_1="26" TOTAL_2="36" VAR="1.272258064516129" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-002.08.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 23:11:08 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="55" TOTAL_2="64" WEIGHT="0.0" Z="0.0">
<NAME>95% E. purpurea herb and 5% E. purpurea root (39 mg crude extract/day)</NAME>
<DICH_DATA CI_END="9.552970143363416" CI_START="0.015225815205276045" EFFECT_SIZE="0.3813813813813814" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9801384204137352" LOG_CI_START="-1.817419445514461" LOG_EFFECT_SIZE="-0.418640512550363" ORDER="445" O_E="0.0" SE="1.6432993385809986" STUDY_ID="STD-Brinkeborn-1999" TOTAL_1="55" TOTAL_2="64" VAR="2.7004327161807473" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-002.08.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-10-23 22:53:59 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="64" TOTAL_2="64" WEIGHT="0.0" Z="0.0">
<NAME>95% E. purpurea herb and 5% E. purpurea root (290 mg crude extract/day)</NAME>
<DICH_DATA CI_END="8.20767961546013" CI_START="0.01312094503957561" EFFECT_SIZE="0.3281653746770026" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9142203955317045" LOG_CI_START="-1.8820348836576137" LOG_EFFECT_SIZE="-0.48390724406295454" ORDER="446" O_E="0.0" SE="1.6425341926826735" STUDY_ID="STD-Brinkeborn-1999" TOTAL_1="64" TOTAL_2="64" VAR="2.6979185741317218" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-002.08.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 23:11:03 +1000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="63" TOTAL_2="64" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root (178 mg crude extract/day)</NAME>
<DICH_DATA CI_END="16.60818861827682" CI_START="0.06216922470771163" EFFECT_SIZE="1.0161290322580645" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2203222684547108" LOG_CI_START="-1.2064245485440552" LOG_EFFECT_SIZE="0.006948859955327825" ORDER="443" O_E="0.0" SE="1.425483092895556" STUDY_ID="STD-Brinkeborn-1999" TOTAL_1="63" TOTAL_2="64" VAR="2.0320020481310803" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-002.08.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 23:11:01 +1000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root 450 mg</NAME>
<DICH_DATA CI_END="8.209331525665638" CI_START="0.01309100166639737" EFFECT_SIZE="0.3278236914600551" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9143077945695813" LOG_CI_START="-1.8830271218567451" LOG_EFFECT_SIZE="-0.4843596636435818" MODIFIED="2012-12-03 20:29:16 +1000" MODIFIED_BY="[Empty name]" ORDER="442" O_E="0.0" SE="1.6431683769399825" STUDY_ID="STD-Br_x00e4_unig-1992" TOTAL_1="60" TOTAL_2="60" VAR="2.7000023149755767" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-002.08.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 23:10:58 +1000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root 900 mg</NAME>
<DICH_DATA CI_END="8.209331525665638" CI_START="0.01309100166639737" EFFECT_SIZE="0.3278236914600551" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9143077945695813" LOG_CI_START="-1.8830271218567451" LOG_EFFECT_SIZE="-0.4843596636435818" MODIFIED="2012-12-03 20:29:04 +1000" MODIFIED_BY="[Empty name]" ORDER="441" O_E="0.0" SE="1.6431683769399825" STUDY_ID="STD-Br_x00e4_unig-1992" TOTAL_1="60" TOTAL_2="60" VAR="2.7000023149755767" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.08.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 23:10:54 +1000" MODIFIED_BY="Jenny Bellorini" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="47" WEIGHT="0.0" Z="0.0">
<NAME>Tea E. purpurea and angustifolia</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="448" O_E="0.0" SE="0.0" STUDY_ID="STD-Lindenmuth-2000" TOTAL_1="48" TOTAL_2="47" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="2" I2="0.0" ID="CMP-002.08.10" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 23:10:52 +1000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="73" TOTAL_2="75" WEIGHT="0.0" Z="0.0">
<NAME>Mixture of E. angustifolia root (50%), E. purpurea root (25%) and E. purpurea herb (25%)</NAME>
<DICH_DATA CI_END="11.92319203022685" CI_START="0.37550436650495855" EFFECT_SIZE="2.1159420289855073" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0763925385864455" LOG_CI_START="-0.42538500849208194" LOG_EFFECT_SIZE="0.3255037650471818" ORDER="447" O_E="0.0" SE="0.8821515650726778" STUDY_ID="STD-Barrett-2002" TOTAL_1="73" TOTAL_2="75" VAR="0.7781913837601748" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-002.08.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 23:10:49 +1000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="184" TOTAL_2="179" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root and E. angustofolia root</NAME>
<DICH_DATA CI_END="3.1111644533876412" CI_START="0.0330337348542161" EFFECT_SIZE="0.3205828779599271" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.49292296813574266" LOG_CI_START="-1.481042321407627" LOG_EFFECT_SIZE="-0.4940596766359421" MODIFIED="2012-12-03 20:38:28 +1000" MODIFIED_BY="[Empty name]" ORDER="234" O_E="0.0" SE="1.1595169823635478" STUDY_ID="STD-Barrett-2010" TOTAL_1="184" TOTAL_2="179" VAR="1.3444796323894683" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-002.08.12" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 23:10:47 +1000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="51" TOTAL_2="104" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root extract with CO2</NAME>
<DICH_DATA CI_END="63.502908036222" CI_START="0.6525906849236237" EFFECT_SIZE="6.4375" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.8027936137197942" LOG_CI_START="-0.1853591296212993" LOG_EFFECT_SIZE="0.8087172420492474" MODIFIED="2013-02-13 22:54:46 +1000" MODIFIED_BY="[Empty name]" ORDER="130" O_E="0.0" SE="1.1678507629533597" STUDY_ID="STD-Turner-2005" TOTAL_1="51" TOTAL_2="104" VAR="1.3638754045307442" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="1" I2="0.0" ID="CMP-002.08.13" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 23:10:45 +1000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="54" TOTAL_2="104" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root extract with 60% ethanol</NAME>
<DICH_DATA CI_END="109.92759373833586" CI_START="1.507952820240722" EFFECT_SIZE="12.875" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="2.041106721578143" LOG_CI_START="0.17838775384831393" LOG_EFFECT_SIZE="1.1097472377132287" MODIFIED="2013-02-13 22:54:48 +1000" MODIFIED_BY="[Empty name]" ORDER="131" O_E="0.0" SE="1.0941703422521" STUDY_ID="STD-Turner-2005" TOTAL_1="54" TOTAL_2="104" VAR="1.1972087378640777" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-002.08.14" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 23:10:43 +1000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="53" TOTAL_2="104" WEIGHT="0.0" Z="0.0">
<NAME>E. angustofolia root extract with 20% ethanol</NAME>
<DICH_DATA CI_END="45.59739480659383" CI_START="0.3578113054363954" EFFECT_SIZE="4.03921568627451" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.6589400300889596" LOG_CI_START="-0.4463459415465257" LOG_EFFECT_SIZE="0.606297044271217" MODIFIED="2013-02-13 22:55:30 +1000" MODIFIED_BY="[Empty name]" ORDER="132" O_E="0.0" SE="1.2366554010723168" STUDY_ID="STD-Turner-2005" TOTAL_1="53" TOTAL_2="104" VAR="1.5293165810013325" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.08.15" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-13 23:10:41 +1000" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="80" TOTAL_2="80" WEIGHT="0.0" Z="0.0">
<NAME>E. pallida root</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="444" O_E="0.0" SE="0.0" STUDY_ID="STD-Dorn-1997" TOTAL_1="80" TOTAL_2="80" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="323" EVENTS_2="293" I2="0.0" I2_Q="0.0" ID="CMP-002.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-10-23 22:55:34 +1000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="31.43" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="946" TOTAL_2="991" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients reporting adverse effects</NAME>
<GROUP_LABEL_1>Echinacea</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors Echinacea</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="159" EVENTS_2="152" I2="0.0" ID="CMP-002.09.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:24:53 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="3" TAU2="0.0" TOTAL_1="438" TOTAL_2="469" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea herb pressed juice</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="463" O_E="0.0" SE="0.0" STUDY_ID="STD-Hoheisel-1997" TOTAL_1="60" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.2175373022424276" CI_START="0.27629193023408616" EFFECT_SIZE="0.9428571428571428" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.5075235905613943" LOG_CI_START="-0.5586317995061707" LOG_EFFECT_SIZE="-0.025554104472388168" ORDER="464" O_E="0.0" SE="0.6262649536799838" STUDY_ID="STD-Schulten-2001" TOTAL_1="41" TOTAL_2="39" VAR="0.3922077922077922" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.720502672248382" CI_START="0.945980511044677" EFFECT_SIZE="1.2757593805836807" ESTIMABLE="YES" EVENTS_1="153" EVENTS_2="146" LOG_CI_END="0.2356553514944818" LOG_CI_START="-0.024117810778905714" LOG_EFFECT_SIZE="0.10576877035778802" MODIFIED="2013-02-11 20:24:53 +1000" MODIFIED_BY="[Empty name]" ORDER="465" O_E="0.0" SE="0.15259204141727975" STUDY_ID="STD-Taylor-2003" TOTAL_1="337" TOTAL_2="370" VAR="0.023284331103892816" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="2" I2="0.0" ID="CMP-002.09.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:28:10 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="31" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea standardized</NAME>
<DICH_DATA CI_END="20.569607094755757" CI_START="0.6388369471262394" EFFECT_SIZE="3.625" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="1.3132259962057031" LOG_CI_START="-0.19460997439167796" LOG_EFFECT_SIZE="0.5593080109070125" ORDER="468" O_E="0.0" SE="0.8857103130373325" STUDY_ID="STD-Goel-2005" TOTAL_1="25" TOTAL_2="31" VAR="0.7844827586206896" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="6" I2="0.0" ID="CMP-002.09.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:28:10 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="55" TOTAL_2="64" WEIGHT="0.0" Z="0.0">
<NAME>95% E. purpurea herb and 5% E. purpurea root (39 mg crude extract/day)</NAME>
<DICH_DATA CI_END="4.476932858964125" CI_START="0.44390139553868285" EFFECT_SIZE="1.4097222222222223" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.6509805812719779" LOG_CI_START="-0.35271348963605137" LOG_EFFECT_SIZE="0.1491335458179633" ORDER="473" O_E="0.0" SE="0.5895748656171561" STUDY_ID="STD-Brinkeborn-1999" TOTAL_1="55" TOTAL_2="64" VAR="0.34759852216748766" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="6" I2="0.0" ID="CMP-002.09.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:28:10 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="64" TOTAL_2="64" WEIGHT="0.0" Z="0.0">
<NAME>95% E. purpurea herb and 5% E. purpurea root (290 mg crude extract/day)</NAME>
<DICH_DATA CI_END="4.234033273109117" CI_START="0.45040493436124757" EFFECT_SIZE="1.380952380952381" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.6267542665957471" LOG_CI_START="-0.3463968602656734" LOG_EFFECT_SIZE="0.1401787031650368" ORDER="474" O_E="0.0" SE="0.5716337890941667" STUDY_ID="STD-Brinkeborn-1999" TOTAL_1="64" TOTAL_2="64" VAR="0.32676518883415434" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="6" I2="0.0" ID="CMP-002.09.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:28:10 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="63" TOTAL_2="64" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root (178 mg crude extract/day)</NAME>
<DICH_DATA CI_END="6.497958702943466" CI_START="0.7961569293741235" EFFECT_SIZE="2.2745098039215685" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.8127769469072768" LOG_CI_START="-0.09900132064931255" LOG_EFFECT_SIZE="0.3568878131289821" ORDER="471" O_E="0.0" SE="0.5355830677379557" STUDY_ID="STD-Brinkeborn-1999" TOTAL_1="63" TOTAL_2="64" VAR="0.2868492224475997" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.09.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:28:10 +1000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="47" WEIGHT="0.0" Z="0.0">
<NAME>Tea E. purpurea and angustifolia</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="476" O_E="0.0" SE="0.0" STUDY_ID="STD-Lindenmuth-2000" TOTAL_1="48" TOTAL_2="47" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="7" I2="0.0" ID="CMP-002.09.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:28:10 +1000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="73" WEIGHT="0.0" Z="0.0">
<NAME>Mixture of E. angustifolia root (50%), E. purpurea root (25%) and E. purpurea herb (25%)</NAME>
<DICH_DATA CI_END="3.613794994260556" CI_START="0.42310541448346733" EFFECT_SIZE="1.2365339578454333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" LOG_CI_END="0.5579635119806661" LOG_CI_START="-0.3735514169630892" LOG_EFFECT_SIZE="0.09220604750878841" MODIFIED="2012-12-04 21:11:02 +1000" MODIFIED_BY="[Empty name]" ORDER="475" O_E="0.0" SE="0.5471764803348265" STUDY_ID="STD-Barrett-2002" TOTAL_1="69" TOTAL_2="73" VAR="0.29940210063160877" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="124" EVENTS_2="114" I2="0.0" ID="CMP-002.09.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-02-11 20:28:10 +1000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="184" TOTAL_2="179" WEIGHT="0.0" Z="0.0">
<NAME>E. purpurea root and E. angustofolia root</NAME>
<DICH_DATA CI_END="1.8175419699308777" CI_START="0.7639649464239231" EFFECT_SIZE="1.1783625730994152" ESTIMABLE="YES" EVENTS_1="124" EVENTS_2="114" LOG_CI_END="0.2594844481962395" LOG_CI_START="-0.11692656802629067" LOG_EFFECT_SIZE="0.0712789400849744" MODIFIED="2013-01-28 18:53:36 +1000" MODIFIED_BY="[Empty name]" ORDER="138" O_E="0.0" SE="0.22110569419369488" STUDY_ID="STD-Barrett-2010" TOTAL_1="184" TOTAL_2="179" VAR="0.048887728004875716" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2013-11-13 07:39:04 +1000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2013-10-23 22:56:09 +1000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAn4AAALgCAYAAAAKvHpTAAB9fUlEQVR42uy9D2Qd2f///6GqqqpC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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2013-11-13 07:39:04 +1000" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiMAAADOCAMAAADbsfL2AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2013-11-13 07:39:04 +1000" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAARAAAAPqCAIAAADU/pcUAAAvQElEQVR42u2dv24UPReHV0JCFFuk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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2013-10-23 22:50:37 +1000" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-001.01" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_ROB_TABLE:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Echinacea versus placebo to prevent common cold, outcome: 1.1 Number of participants with at least 1 cold episode.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAq8AAAJwCAMAAACQ13hVAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2013-10-23 22:54:25 +1000" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-002.01" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_ROB_TABLE:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Echinacea versus placebo to treat patients with common cold, outcome: 2.1 Duration: mean difference.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAzgAAACwCAMAAAD0WTuYAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2013-10-30 19:29:22 +1000" MODIFIED_BY="[Empty name]" NO="6" REF_ID="CMP-001.05" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_ROB_TABLE:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Echinacea versus placebo to prevent common cold, outcome: 1.5 Number of patients dropping out due to adverse effects.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAroAAAGwCAMAAABxUDbQAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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==
</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2008-05-09 19:29:26 +1000" MODIFIED_BY="Jenny Bellorini">
<FEEDBACK_ITEM ID="FBK-01" MODIFIED="2008-05-09 19:29:26 +1000" MODIFIED_BY="Jenny Bellorini" NO="1">
<TITLE>Duration of Echinacea dosage</TITLE>
<DATE_SUBMITTED>
<DATE DAY="" MONTH="" YEAR=""/>
</DATE_SUBMITTED>
<FEEDBACK_SUMMARY>
<P>I wish to comment on the Cochrane review 'Echinacea for preventing and treating the common cold'. It is claimed in the Hot Topic of the Month (Relief from coughs and colds), August 2001, p. 5, para. 6.1, that "the German drug regulatory authority recommends that it be used for no longer than eight weeks at a time". I have asked the Consumer Network about the evidence for this and been told that it is not available. Nevertheless, I think that if it is indeed a recommendation of the German drug regulatory authority, it should be mentioned in both the review and the abstract.</P>
<P>I certify that I have no affiliations with or involvement in any organisation or entity with a direct financial interest in the subject matter of my criticisms.</P>
</FEEDBACK_SUMMARY>
<FEEDBACK_REPLY MODIFIED="2008-05-09 19:29:26 +1000" MODIFIED_BY="Jenny Bellorini">
<P>We appreciate this comment. It is correct that the German drug regulatory authority recommends that Echinacea preparations should not be taken for longer than eight weeks at a time. While there is no evidence that longer intake can be harmful, such a precaution seems justified in the absence of data on long-term use. We included a statement on this issue in the review conclusion section '<LINK TAG="IMPLICATIONS_PRACTICE" TYPE="SECTION">Implications for practice</LINK>'.</P>
<P>Klaus Linde</P>
</FEEDBACK_REPLY>
<FEEDBACK_CONTRIBUTORS>
<P>David Potter<BR/>Comment posted 02/06/2005</P>
</FEEDBACK_CONTRIBUTORS>
</FEEDBACK_ITEM>
</FEEDBACK>
<APPENDICES MODIFIED="2013-10-23 22:58:03 +1000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2013-06-05 15:02:39 +1000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2010-03-15 18:17:31 +1000" MODIFIED_BY="[Empty name]">Embase.com search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2013-06-05 15:02:39 +1000" MODIFIED_BY="[Empty name]">
<P>#10 #1 AND #9 <BR/>#9 #4 NOT #8 <BR/>#8 #5 NOT #7 <BR/>#7 #5 AND #6 <BR/>#6 'human'/de <BR/>#5 'animal'/de OR 'nonhuman'/de OR 'animal experiment'/de <BR/>#4 #2 OR #3 <BR/>#3 random*:ab,ti OR placebo*:ab,ti OR crossover*:ab,ti OR 'cross-over':ab,ti OR (doubl* NEXT/1 blind*):ab,ti OR allocat*:ab,ti OR trial:ti <BR/>#2 'randomized controlled trial'/exp OR 'single blind procedure'/exp OR 'double blind procedure'/exp OR 'crossover procedure'/exp <BR/>#1 1922<BR/>#1.6 #1.1 OR #1.2 OR #1.3 OR #1.4 OR #1.5 <BR/>#1.5 coneflower*:ab,ti <BR/>#1.4 'e. purpurea':ab,ti OR 'e. pallida':ab,ti OR 'e.angustifolia':ab,ti <BR/>#1.3 'echinacea purpurea'/de OR 'echinacea extract'/de OR 'echinacea purpurea extract'/de OR 'echinacea pallida extract'/de OR 'echinacea angustiflora extract'/de <BR/>#1.2 echinac*:ab,ti <BR/>#1.1 'echinacea'/exp </P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2013-05-14 17:43:47 +1000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2012-10-08 16:29:41 +1000" MODIFIED_BY="[Empty name]">CINAHL (EBSCO) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-10-08 16:31:41 +1000" MODIFIED_BY="[Empty name]">
<P>S15 S5 and S14 <BR/>S14 S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 <BR/>S13 TI placebo* OR AB placebo* S<BR/>S12 TI clinic* W1 trial* OR AB clinic* W1 trial* <BR/>S11 (MH "Quantitative Studies") <BR/>S10 (MH "Placebos") <BR/>S9 TI random* OR AB random* <BR/>S8 TI ((singl* or doubl* or tripl* or trebl*) W1 (blind* or mask*)) OR AB ((singl* or doubl* or tripl* or trebl*) W1 (blind* or mask*)) <BR/>S7 PT clinical trial <BR/>S6 (MH "Clinical Trials+") <BR/>S5 S1 or S2 or S3 or S4 <BR/>S4 TI coneflower* OR AB coneflower* <BR/>S3 TI ("E. purpurea" or "E. pallida" or "E. angustifolia") OR AB ("E. purpurea" or "E. pallida" or "E. angustifolia") <BR/>S2 TI echinac* OR AB echinac* <BR/>S1 (MH "Echinacea") </P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2013-05-14 17:43:49 +1000" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2010-03-15 18:17:48 +1000" MODIFIED_BY="[Empty name]">AMED (Ovid) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2010-03-15 19:25:13 +1000" MODIFIED_BY="[Empty name]">
<P>1 exp echinacea/ <BR/>2 echinac*.tw. <BR/>3 1 or 2 <BR/>4 randomized controlled trials/ <BR/>5 exp clinical trials/ <BR/>6 random allocation/ <BR/>7 double blind method/ <BR/>8 (clin* adj25 trial*).tw.<BR/>9 ((singl* or doubl* or trebl* or tripl*) adj25 (blind* or mask*)).tw.<BR/>10 placebos/ <BR/>11 placebo*.tw. <BR/>12 random*.tw.<BR/>13 or/4-12 <BR/>14 3 and 13 </P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2013-05-14 17:43:52 +1000" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2012-10-08 16:32:19 +1000" MODIFIED_BY="[Empty name]">LILACS (BIREME) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-10-08 16:32:41 +1000" MODIFIED_BY="[Empty name]">
<P>&gt; Search &gt; MH:"Echinacea angustifolia" OR MH:"Echinacea purpurea" OR MH:echinacea OR MH:HP4.018.251.105 OR MH:HP4.018.251.116 OR MH:B01.650.940.800.575.100.100.310 OR echinac$ OR "E. angustifolia" OR "E. pallida" OR "E. purpurea"</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2013-05-14 17:43:54 +1000" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2012-10-08 16:33:03 +1000" MODIFIED_BY="[Empty name]">Web of Science (Thomson Reuters) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-10-08 16:44:44 +1000" MODIFIED_BY="[Empty name]">
<TABLE COLS="3" ROWS="5">
<TR>
<TD VALIGN="TOP">
<P># 3</P>
</TD>
<TD VALIGN="TOP">
<P>
<A HREF="http://apps.webofknowledge.com/summary.do?product=WOS&amp;doc=1&amp;qid=4&amp;SID=P2nhPmBA2daDGfLEaFb&amp;search_mode=CombineSearches">209</A>
<B> </B>
</P>
</TD>
<TD VALIGN="TOP">
<P>#2 AND #1</P>
<P>
<I>Databases=SCI-EXPANDED, CPCI-S Timespan=All Years</I>
</P>
<P>
<I>Lemmatization=On   </I>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="4">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P># 2</P>
</TD>
<TD VALIGN="TOP">
<P>
<A HREF="http://apps.webofknowledge.com/summary.do?product=WOS&amp;doc=1&amp;qid=3&amp;SID=P2nhPmBA2daDGfLEaFb&amp;search_mode=GeneralSearch">1,292,302</A>
<B> </B>
</P>
</TD>
<TD VALIGN="TOP">
<P>Topic=(random* or placebo* or ((singl* or doubl*) NEAR/1 blind*) or allocat* or crossover* or "cross over") OR Title=(trial)</P>
<P>
<I>Databases=SCI-EXPANDED, CPCI-S Timespan=All Years</I>
</P>
<P>
<I>Lemmatization=On   </I>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="4">
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P># 1</P>
</TD>
<TD VALIGN="TOP">
<P>
<A HREF="http://apps.webofknowledge.com/summary.do?product=WOS&amp;doc=1&amp;qid=2&amp;SID=P2nhPmBA2daDGfLEaFb&amp;search_mode=GeneralSearch">1,605</A>
<B> </B>
</P>
</TD>
<TD VALIGN="TOP">
<P>Topic=(echinac* OR "E. purpurea" OR "E. angustifolia" OR "E. pallida" OR coneflower*)</P>
<P>
<I>Databases=SCI-EXPANDED, CPCI-S Timespan=All Years</I>
</P>
<P>
<I>Lemmatization=On   </I>
</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-06" MODIFIED="2013-10-23 22:58:03 +1000" MODIFIED_BY="[Empty name]" NO="6">
<TITLE MODIFIED="2010-03-15 18:16:49 +1000" MODIFIED_BY="[Empty name]">Previous searches</TITLE>
<APPENDIX_BODY MODIFIED="2013-10-23 22:58:03 +1000" MODIFIED_BY="[Empty name]">
<P>For the first publication of this review in <I>The Cochrane Library,</I> 1999, Issue 1 (<LINK REF="REF-Melchart-1999" TYPE="REFERENCE">Melchart 1999</LINK>) the following sources were searched:</P>
<OL>
<LI>MEDLINE (1966 to 1998): all hits for Echinac* screened;</LI>
<LI>EMBASE (1991 to 1998): all hits for Echinac* screened;</LI>
<LI>the Cochrane Acute Respiratory Infections Group Specialized Register: all hits for Echinac* screened;</LI>
<LI>the database of the Cochrane Field Complementary Medicine: all hits for Echinac* screened;</LI>
<LI>the database Phytodok (Munich, specialized on Phytomedicine) screening all clinical studies for Echinac*;</LI>
<LI>bibliographies of identified articles;</LI>
<LI>existing reviews;</LI>
<LI>manufacturers and researchers in the field (who were contacted to identify published and unpublished trials);</LI>
<LI>proceedings of phytomedicine congresses (International Congresses on Phytomedicine and Congresses of the German Society of Phytotherapy) (screened).</LI>
</OL>
<P>For the 2007 update we searched the Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I> 2007, Issue 3); PubMed (1997 to September 2007); EMBASE (1998 to April 2007); AMED (to August 2005) and the Centre for Complementary Medicine Research (in Munich) (1988 to September 2007). We also contacted experts and screened references of reviews.</P>
<P>We searched PubMed and CENTRAL using the following terms combined with the highly sensitive search strategy devised by Dickersin (<LINK REF="REF-Dickersin-1994" TYPE="REFERENCE">Dickersin 1994</LINK>).<BR/>
<BR/>1 exp ECHINACEA/<BR/>2 Echinacea<BR/>3 or/1-2</P>
<P>We searched EMBASE and AMED using adapted terms. We searched the database of the Centre of Complementary Medicine Research in Munich for controlled trials of <I>Echinacea</I>.</P>
<P>We screened bibliographies of identified trials and review articles for further potentially relevant publications. We contacted experts in the field and asked about further published and unpublished studies.</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>

<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;24 studies (in 29 publications) included in qualitative synthesis&lt;/p&gt;" WIDTH="223">
<FLOWCHARTBOX TEXT="&lt;p&gt;82 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="224">
<FLOWCHARTBOX TEXT="&lt;p&gt;559 records screened&lt;/p&gt;" WIDTH="225">
<FLOWCHARTBOX TEXT="&lt;p&gt;556 records identified through database searching (deduplicated)&lt;/p&gt;" WIDTH="186"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;3 additional records identified through other sources&lt;/p&gt;" WIDTH="180"/>
<OUT TEXT="&lt;p&gt;457 records excluded, based on title and abstract&lt;/p&gt;" WIDTH="236"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;49 studies (in 52 publications), reasons:&lt;/p&gt;&lt;p&gt;Use of a combination of Echinacea with other remedies: 18&lt;/p&gt;&lt;p&gt;Not common cold: 11&lt;/p&gt;&lt;p&gt;Not common cold and use of a combination of Echinacea with other remedies: 6&lt;/p&gt;&lt;p&gt;Not randomized controlled trial: 5&lt;/p&gt;&lt;p&gt;Not randomized controlled trial, not common cold: 5&lt;/p&gt;&lt;p&gt;No clinical outcomes, only laboratory measurements: 1&lt;/p&gt;&lt;p&gt;Only laboratory measurements, not common cold: 3&lt;/p&gt;&lt;p&gt;2012 manuscript in Persian language awaiting classification&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" WIDTH="241"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
<EXTENSION ID="AFF_85664715705711284962111120233815_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS"><ALIAS ALIAS_ID="85664715705711284962111120233815"><ADDRESS><DEPARTMENT>Arizona Center for Integrative Medicine</DEPARTMENT><ORGANISATION>University of Arizona</ORGANISATION><ADDRESS_1>PO Box 245153</ADDRESS_1><CITY>Tucson</CITY><ZIP>85724</ZIP><REGION>Arizona</REGION><COUNTRY CODE="US">USA</COUNTRY></ADDRESS></ALIAS></EXTENSION></EXTENSIONS>
</COCHRANE_REVIEW>